
<html lang="en"     class="pb-page"  data-request-id="aead335d-db48-4ce2-b53a-563621e6aee0"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.6b00469;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2016.59.issue-15;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of a Highly Potent, Selective, and Orally Bioavailable Macrocyclic Inhibitor of Blood Coagulation Factor VIIa–Tissue Factor Complex" /></meta><meta name="dc.Creator" content="Xiaojun  Zhang" /></meta><meta name="dc.Creator" content="Peter W.  Glunz" /></meta><meta name="dc.Creator" content="James A.  Johnson" /></meta><meta name="dc.Creator" content="Wen  Jiang" /></meta><meta name="dc.Creator" content="Swanee  Jacutin-Porte" /></meta><meta name="dc.Creator" content="Vladimir  Ladziata" /></meta><meta name="dc.Creator" content="Yan  Zou" /></meta><meta name="dc.Creator" content="Monique S.  Phillips" /></meta><meta name="dc.Creator" content="Nicholas R.  Wurtz" /></meta><meta name="dc.Creator" content="Brandon  Parkhurst" /></meta><meta name="dc.Creator" content="Alan R.  Rendina" /></meta><meta name="dc.Creator" content="Timothy M.  Harper" /></meta><meta name="dc.Creator" content="Daniel L.  Cheney" /></meta><meta name="dc.Creator" content="Joseph M.  Luettgen" /></meta><meta name="dc.Creator" content="Pancras C.  Wong" /></meta><meta name="dc.Creator" content="Dietmar  Seiffert" /></meta><meta name="dc.Creator" content="Ruth R.  Wexler" /></meta><meta name="dc.Creator" content="E. Scott  Priestley" /></meta><meta name="dc.Description" content="Inhibitors of the tissue factor (TF)/factor VIIa complex (TF-FVIIa) are promising novel anticoagulants which show excellent efficacy and minimal bleeding in preclinical models. Starting with an ami..." /></meta><meta name="Description" content="Inhibitors of the tissue factor (TF)/factor VIIa complex (TF-FVIIa) are promising novel anticoagulants which show excellent efficacy and minimal bleeding in preclinical models. Starting with an ami..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="August 2, 2016" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b00469" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00469" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b00469" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00469" /></link>
        
    
    

<title>Discovery of a Highly Potent, Selective, and Orally Bioavailable Macrocyclic Inhibitor of Blood Coagulation Factor VIIa–Tissue Factor Complex | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b00469" /></meta><meta property="og:title" content="Discovery of a Highly Potent, Selective, and Orally Bioavailable Macrocyclic Inhibitor of Blood Coagulation Factor VIIa–Tissue Factor Complex" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00469/20160811/images/large/jm-2016-004697_0013.jpeg" /></meta><meta property="og:description" content="Inhibitors of the tissue factor (TF)/factor VIIa complex (TF-FVIIa) are promising novel anticoagulants which show excellent efficacy and minimal bleeding in preclinical models. Starting with an aminoisoquinoline P1-based macrocyclic inhibitor, optimization of the P′ groups led to a series of highly potent and selective TF-FVIIa inhibitors which displayed poor permeability. Fluorination of the aminoisoquinoline reduced the basicity of the P1 group and significantly improved permeability. The resulting lead compound was highly potent, selective, and achieved good pharmacokinetics in dogs with oral dosing. Moreover, it demonstrated robust antithrombotic activity in a rabbit model of arterial thrombosis." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b00469"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b00469">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b00469&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b00469&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b00469&amp;href=/doi/10.1021/acs.jmedchem.6b00469" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 15</span><span class="cit-fg-pageRange">, 7125-7137</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/15" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b00403" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.6b00486" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of a Highly Potent, Selective, and Orally Bioavailable Macrocyclic Inhibitor of Blood Coagulation Factor VIIa–Tissue Factor Complex</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xiaojun++Zhang">Xiaojun Zhang</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peter+W.++Glunz">Peter W. Glunz</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=James+A.++Johnson">James A. Johnson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wen++Jiang">Wen Jiang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Swanee++Jacutin-Porte">Swanee Jacutin-Porte</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vladimir++Ladziata">Vladimir Ladziata</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yan++Zou">Yan Zou</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Monique+S.++Phillips">Monique S. Phillips</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nicholas+R.++Wurtz">Nicholas R. Wurtz</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Brandon++Parkhurst">Brandon Parkhurst</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alan+R.++Rendina">Alan R. Rendina</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Timothy+M.++Harper">Timothy M. Harper</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniel+L.++Cheney">Daniel L. Cheney</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joseph+M.++Luettgen">Joseph M. Luettgen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pancras+C.++Wong">Pancras C. Wong</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dietmar++Seiffert">Dietmar Seiffert</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ruth+R.++Wexler">Ruth R. Wexler</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=E.+Scott++Priestley">E. Scott Priestley</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Bristol-Myers Squibb R&D, 350 Carter Road, Hopewell, New Jersey 08540, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Bristol-Myers Squibb R&D, 311 Pennington-Rocky Hill Road, Pennington, New Jersey 08534-2130, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: 609-466-5104. Fax: 609-818-3460. E-mail: <a href="/cdn-cgi/l/email-protection#9de5f4fcf2f7e8f3b3e7f5fcf3faddfff0eeb3fef2f0"><span class="__cf_email__" data-cfemail="91e9f8f0fefbe4ffbfebf9f0fff6d1f3fce2bff2fefc">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00469&amp;href=/doi/10.1021%2Facs.jmedchem.6b00469" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 15</span><span class="cit-pageRange">, 7125–7137</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 25, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>30 March 2016</li><li><span class="item_label"><b>Published</b> online</span>2 August 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 11 August 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b00469" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00469</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7125%26pageCount%3D13%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DXiaojun%2BZhang%252C%2BPeter%2BW.%2BGlunz%252C%2BJames%2BA.%2BJohnson%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D59%26issueNum%3D15%26contentID%3Dacs.jmedchem.6b00469%26title%3DDiscovery%2Bof%2Ba%2BHighly%2BPotent%252C%2BSelective%252C%2Band%2BOrally%2BBioavailable%2BMacrocyclic%2BInhibitor%2Bof%2BBlood%2BCoagulation%2BFactor%2BVIIa%25E2%2580%2593Tissue%2BFactor%2BComplex%26numPages%3D13%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7137%26publicationDate%3DAugust%2B2016">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b00469"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1463</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">11</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b00469" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of a Highly Potent, Selective, and Orally Bioavailable Macrocyclic Inhibitor of Blood Coagulation Factor VIIa–Tissue Factor Complex&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Xiaojun&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;W. Glunz&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;A. Johnson&quot;},{&quot;first_name&quot;:&quot;Wen&quot;,&quot;last_name&quot;:&quot;Jiang&quot;},{&quot;first_name&quot;:&quot;Swanee&quot;,&quot;last_name&quot;:&quot;Jacutin-Porte&quot;},{&quot;first_name&quot;:&quot;Vladimir&quot;,&quot;last_name&quot;:&quot;Ladziata&quot;},{&quot;first_name&quot;:&quot;Yan&quot;,&quot;last_name&quot;:&quot;Zou&quot;},{&quot;first_name&quot;:&quot;Monique&quot;,&quot;last_name&quot;:&quot;S. Phillips&quot;},{&quot;first_name&quot;:&quot;Nicholas&quot;,&quot;last_name&quot;:&quot;R. Wurtz&quot;},{&quot;first_name&quot;:&quot;Brandon&quot;,&quot;last_name&quot;:&quot;Parkhurst&quot;},{&quot;first_name&quot;:&quot;Alan&quot;,&quot;last_name&quot;:&quot;R. Rendina&quot;},{&quot;first_name&quot;:&quot;Timothy&quot;,&quot;last_name&quot;:&quot;M. Harper&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;L. Cheney&quot;},{&quot;first_name&quot;:&quot;Joseph&quot;,&quot;last_name&quot;:&quot;M. Luettgen&quot;},{&quot;first_name&quot;:&quot;Pancras&quot;,&quot;last_name&quot;:&quot;C. Wong&quot;},{&quot;first_name&quot;:&quot;Dietmar&quot;,&quot;last_name&quot;:&quot;Seiffert&quot;},{&quot;first_name&quot;:&quot;Ruth&quot;,&quot;last_name&quot;:&quot;R. Wexler&quot;},{&quot;first_name&quot;:&quot;E.&quot;,&quot;last_name&quot;:&quot;Scott Priestley&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;08&quot;,&quot;day&quot;:&quot;02&quot;,&quot;issue&quot;:&quot;15&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;7125-7137&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b00469&quot;},&quot;abstract&quot;:&quot;Inhibitors of the tissue factor (TF)/factor VIIa complex (TF-FVIIa) are promising novel anticoagulants which show excellent efficacy and minimal bleeding in preclinical models. Starting with an aminoisoquinoline P1-based macrocyclic inhibitor, optimization of the P′ groups led to a series of highly potent and selective TF-FVIIa inhibitors which displayed poor permeability. Fluorination of the aminoisoquinoline reduced the basicity of the P1 group and significantly improved permeability. The resulting lead compound was highly potent, selective, and achieved good pharmacokinetics in dogs with oral dosing. Moreover, it demonstrated robust antithrombotic activity in a rabbit model of arterial thrombosis.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00469&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00469" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00469&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00469" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00469&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00469" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00469&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00469&amp;href=/doi/10.1021/acs.jmedchem.6b00469" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b00469" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b00469" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00469&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b00469%26sid%3Dliteratum%253Aachs%26pmid%3D27455395%26genre%3Darticle%26aulast%3DZhang%26date%3D2016%26atitle%3DDiscovery%2Bof%2Ba%2BHighly%2BPotent%252C%2BSelective%252C%2Band%2BOrally%2BBioavailable%2BMacrocyclic%2BInhibitor%2Bof%2BBlood%2BCoagulation%2BFactor%2BVIIa%25E2%2580%2593Tissue%2BFactor%2BComplex%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D15%26spage%3D7125%26epage%3D7137%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a>,</li><li><a href="/action/doSearch?ConceptID=291352" title="Screening assays">Screening assays</a>,</li><li><a href="/action/doSearch?ConceptID=292504" title="Permeability">Permeability</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/15" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/jmcmar.2016.59.issue-15/20160811-01/jmcmar.2016.59.issue-15.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00469/20160811/images/medium/jm-2016-004697_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00469/20160811/images/large/jm-2016-004697_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00469&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Inhibitors of the tissue factor (TF)/factor VIIa complex (TF-FVIIa) are promising novel anticoagulants which show excellent efficacy and minimal bleeding in preclinical models. Starting with an aminoisoquinoline P1-based macrocyclic inhibitor, optimization of the P′ groups led to a series of highly potent and selective TF-FVIIa inhibitors which displayed poor permeability. Fluorination of the aminoisoquinoline reduced the basicity of the P1 group and significantly improved permeability. The resulting lead compound was highly potent, selective, and achieved good pharmacokinetics in dogs with oral dosing. Moreover, it demonstrated robust antithrombotic activity in a rabbit model of arterial thrombosis.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10486" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10486" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Pathological blood clotting initiated by tissue factor (TF) leads to thromboembolic cardiovascular diseases such as ischemic stroke, myocardial infarction, and deep venous thrombosis.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Atherosclerotic plaque rupture or vascular injury exposes TF to circulating coagulation factor VIIa (FVIIa), a serine protease. Binding of TF to FVIIa and formation of the TF-FVIIa complex leads to a large increase in its catalytic activity and subsequently initiates the extrinsic coagulation pathway by activating factor IX to IXa and factor X to Xa. Factor Xa then activates prothrombin to thrombin.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Thrombin plays an essential role in the pathogenesis of thrombosis by cleaving fibrinogen to fibrin and activating platelets through proteolytic activation of thrombin receptors, enabling clot formation.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3, 4)</a> It has been shown that selective inhibition of the TF-FVIIa complex provides antithrombotic efficacy with a low risk of bleeding in preclinical models.<a onclick="showRef(event, 'ref5 ref6 ref7 ref8 ref9 ref10 ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7 ref8 ref9 ref10 ref11 ref12 ref13">(5-13)</a> In addition, recombinant nematode anticoagulant protein c2, a biological agent that inhibits TF-VIIa complex, demonstrated the antithrombotic efficacy and safety in patients with acute coronary syndrome.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Accordingly, direct-acting, orally bioavailable TF-FVIIa inhibitors could be effective and safe in the treatment and prevention of venous and arterial thrombosis. Despite strong target validation and substantial efforts to discover orally active TF-FVIIa inhibitors,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> there are no reports of small molecule TF-FVIIa inhibitors advancing to antithrombotic clinical trials. The most significant unsolved issue for small molecule drugs targeting TF-FVIIa is oral bioavailability; the vast majority of known TF-FVIIa inhibitors contain benzamidine or a similar highly basic P1 group (p<i>K</i><sub>a</sub> ∼ 12).<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> The basic group engages in a strong interaction with Asp189 in the active site of FVIIa, resulting in inhibitors that are potent, but poorly permeable/orally bioavailable. Alternatively, several groups have attempted to replace the benzamidine moiety with less basic groups, although with limited success.<a onclick="showRef(event, 'ref17 ref18 ref19 ref20 ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19 ref20 ref21 ref22 ref23">(17-23)</a></div><div class="NLM_p">Our group reported a series of aminoisoquinoline-based phenylpyrrolidine phenylglycineamides as potent and selective TF-FVIIa inhibitors displaying promising oral bioavailabilty.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> On the basis of a crystal structure of a phenylpyrrolidine lead bound in the active site of FVIIa and subsequent molecular modeling studies, Priestley et al. recently reported a novel series of macrocyclic TF-FVIIa inhibitors with improved potency relative to the acyclic analogues.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Further potency optimization and structure guided atropisomer control by incorporation of P2 methyls provided a macrocyclic compound <b>1</b> with TF-FVIIa <i>K</i><sub>i</sub> (37 °C) of 20 nM and measurable PAMPA permeability of 13 nm/s (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>).<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Discovery of the conformationally constrained macrocyclic scaffold represented a significant advance in the search for potent TF-FVIIa inhibitors and opened new possibilities for orally bioavailable TF-FVIIa inhibitor development. Compound <b>1</b>, although equally potent against human tissue kallikrein (HK-1, <i>K</i><sub>i</sub> = 21 nM), served as an attractive starting point for further improvement. Herein we report optimization of the P′ groups and fluorination of the aminoisoquinoline P1 group in <b>1</b> that led to the discovery of the lead compound <b>13</b>, a highly potent, selective macrocyclic inhibitor of TF-FVIIa with good pharmacokinetics in dogs from oral dosing and robust antithrombotic activity in a rabbit model of arterial thrombosis.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00469/20160811/images/medium/jm-2016-004697_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00469/20160811/images/large/jm-2016-004697_0002.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Optimization of P′ and fluorination of P1 in <b>1</b> led to the discovery of lead compound <b>13</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00469/20160811/images/large/jm-2016-004697_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00469&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec1_1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65148" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65148" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The syntheses of the macrocyclic inhibitors <b>1</b> and <b>8</b>–<b>10</b> are outlined in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. A three-component Petasis reaction<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> of di-Boc protected 6-aminoisoqunoline <b>15</b>,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> (<i>R</i>)-(4-(1-hydroxypropan-2-yl)-3-methylphenyl)boronic acid <b>16</b>,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> and glyoxylate <b>17</b> gave rise to the phenylglycine derivative <b>18</b>. Coupling of intermediate <b>18</b> with substituted <i>N</i>-methylbenzylamines <b>19a</b>–<b>c</b> afforded the corresponding phenylglycinamides <b>20a</b>–<b>c</b>. The Petasis reaction and amide coupling could be conveniently carried out in a two-step, one-pot procedure without isolation of the acid <b>18</b>. Macrocylization to form the upper carbamate bond was accomplished by the treatment of compounds <b>20a</b>–<b>c</b>, first with phosgene to generate a transient chloroformate, followed by a slow addition of the chloroformate to triethylamine in dichloromethane to finish the lactamization.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> At this stage, the two diastereoisomers were separated by chiral HPLC to yield the desired enantiomer. Deprotection of the di-Boc group with acid and a final HPLC purification afforded the macrocyclic inhibitors <b>1</b>, <b>8</b>, and <b>10</b>. Macrocyclic inhibitor <b>9</b> was obtained by a monohydrolysis of the diethylphosphonate <b>8</b> with LiOH. The Petasis reaction/amide coupling provided an efficient and modular synthetic route to macrocyclic TF-VIIa inhibitors.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00469/20160811/images/medium/jm-2016-004697_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00469/20160811/images/large/jm-2016-004697_0005.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Macrocyclic Inhibitors <b>1</b> and <b>8</b>–<b>10</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00469/20160811/images/large/jm-2016-004697_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00469&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) DMF/CH<sub>3</sub>CN (1:2), 80 °C; (b) BOP, DIEA, DMF/CH<sub>3</sub>CN (1:2), 51–77% for 2 steps; (c) phosgene, CH<sub>3</sub>CN/CH<sub>2</sub>Cl<sub>2</sub> (1:1), then TEA; (d) chiral HPLC, 37–49% for 2 steps; (e) TFA/CH<sub>2</sub>Cl<sub>2</sub> or 4.0 N HCl in dioxane/EtOAc, 36–60%; (f) LiOH, THF, 40 °C, 51%.</p></p></figure><div class="NLM_p">Syntheses of macrocyclic inhibitors <b>2</b> and <b>7</b> are shown in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. Nitro substituted <i>N</i>-methylbenzylamines <b>21a</b>,<b>b</b> were coupled with intermediate <b>18</b>. After amide coupling, the nitro group was readily reduced to give anilines <b>20d</b>,<b>e</b>. Macrocyclization, chiral separation, and deprotection of the di-Boc group as exemplified in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> yielded macrocyclic inhibitors <b>2</b> and <b>7</b>.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00469/20160811/images/medium/jm-2016-004697_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00469/20160811/images/large/jm-2016-004697_0006.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Macrocyclic Inhibitors <b>2</b> and <b>7</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00469/20160811/images/large/jm-2016-004697_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00469&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) BOP, DIEA, DMF/CH<sub>3</sub>CN (1:2), 54–59%; (b) Pd/C, H<sub>2</sub> balloon, MeOH, 82–89%; (c) phosgene, CH<sub>3</sub>CN/CH<sub>2</sub>Cl<sub>2</sub> (1:1), then TEA; (d) chiral HPLC, 12–32% for 2 steps; (e) TFA/CH<sub>2</sub>Cl<sub>2</sub>, 44–90%.</p></p></figure><div class="NLM_p">Syntheses of macrocyclic inhibitors <b>3</b>–<b>6</b> were achieved by late stage functionalization of an advanced intermediate, as shown in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. The macrocyclic bromide <b>22</b> was subjected to a Pd-catalyzed carbonylation to give rise to the methyl ester <b>23</b>. Deprotection of the di-Boc group in <b>23</b> yielded inhibitor <b>3</b>. Methyl ester <b>23</b> was hydrolyzed to the corresponding acid <b>24</b>. Amide coupling of the acid <b>24</b> with amines, followed by deprotection of the di-Boc group, afforded macrocyclic inhibitors <b>4</b>-<b>6</b>.</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00469/20160811/images/medium/jm-2016-004697_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00469/20160811/images/large/jm-2016-004697_0007.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Macrocyclic Inhibitors <b>3</b>–<b>6</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00469/20160811/images/large/jm-2016-004697_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00469&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Pd(OAc)<sub>2</sub>, dppp, CO (25 psi), TEA, DMSO/MeOH (2:1), 80 °C, 83%; (b) LiOH, THF/H<sub>2</sub>O (2:1), 57%; (c) EDC/HOBt, NH<sub>4</sub>Cl, DIEA, 97% for <b>4</b>; HATU, <i>N</i>-methylmorpholine, DMF, 29–39% for <b>5</b>–<b>6</b>; (d) TFA, 80–90%.</p></p></figure><div class="NLM_p">Syntheses of macrocyclic inhibitors <b>11</b>–<b>13</b> are shown in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>. Petasis reaction of a fluoro-substituted aminoisoquinoline <b>25a</b>–<b>c</b>, boronic acid <b>16</b>, and glyoxylate <b>17</b> gave rise to the phenylglycine derivatives <b>26a</b>–<b>c</b>. Coupling of <b>26a</b>–<b>c</b> with 4-(cyclopropylsulfonyl)-3-((methylamino)methyl)aniline <b>19c</b> afforded phenylglycinamides <b>27a</b>–<b>c</b>. It is advantageous to carry out the petasis reaction/amide coupling in a two-step, one-pot procedure without isolation of the acid <b>26</b>. Macrocylization, chiral separation, and di-Boc deprotection, as described for the synthesis of compounds <b>1</b>–<b>10</b>, yielded macrocyclic inhibitors <b>11</b>–<b>13</b>.</div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00469/20160811/images/medium/jm-2016-004697_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00469/20160811/images/large/jm-2016-004697_0008.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Macrocyclic Inhibitors <b>11</b>–<b>13</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00469/20160811/images/large/jm-2016-004697_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00469&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) DMF/CH<sub>3</sub>CN (1:2), 80 °C; (b) BOP, TEA, DMF/CH<sub>3</sub>CN (1:2), 38–54% for two steps; (c) phosgene, CH<sub>3</sub>CN/CH<sub>2</sub>Cl<sub>2</sub> (1:1), then TEA; (d) chiral HPLC, 34–43% for 2 steps; (e) TFA/CH<sub>2</sub>Cl<sub>2</sub> or 4.0 N HCl in dioxane/EtOAc, 17–90%.</p></p></figure><div class="NLM_p">Syntheses of fluoro-substituted aminoisoquinolines <b>25a</b>–<b>c</b> are summarized in <a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>. 8- or 7-Fluoro substituted 6-(dibenzylamino)isoquinolin-1(2<i>H</i>)-one <b>28</b><a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> was treated with POCl<sub>3</sub> to generate the corresponding chloride, which was reacted with ammonia in ethylene glycol to yield 8- or 7-fluoro <i>N</i>,<i>N</i>-dibenzylisoquinoline-1,6-diamine <b>29</b>. The displacement of the chloride by ammonia had to be carried out at high temperature in an autoclave to obtain moderate yields of the aminoisoquinolines <b>29a</b>,<b>b</b>. Protection of the free amines <b>29a</b> and <b>29b</b> with Boc anhydride, followed by Pd-catalyzed hydrogenation with Pearlman’s catalyst in ethanol, gave rise to the corresponding 8- and 7-fluoroaminoisoquinolines <b>25a</b> and <b>25b</b> in good yield.</div><figure id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00469/20160811/images/medium/jm-2016-004697_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00469/20160811/images/large/jm-2016-004697_0009.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Fluoro-Substituted Aminoisoquinolines <b>25a</b>–<b>c</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00469/20160811/images/large/jm-2016-004697_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00469&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) POCl<sub>3</sub>, 100 °C, >95%; (b) NH<sub>3</sub>, HO(CH<sub>2</sub>)<sub>2</sub>OH, 130 °C, 50–64%; (c) (Boc)<sub>2</sub>O, DMAP (cat.), CH<sub>3</sub>CN, 66–77%; (d) Pd(OH)<sub>2</sub>, H<sub>2</sub> (55 psi), EtOH, 90–96%; (e) Selectfluor, MeOH/CH<sub>3</sub>CN (1:1), 82 °C, 99%; (f) 4.0 HCl, dioxane/CH<sub>3</sub>CN (1:1), 65 °C, 98%; (g) Pd(OAc)<sub>2</sub>, benzophenone imine, BINAP, Cs<sub>2</sub>CO<sub>3</sub>, toluene, 90 °C, then HCl, THF/H<sub>2</sub>O, 79%; (h) Pd/C, H<sub>2</sub> (balloon), HCl (cat.), MeOH, 99%.</p></p></figure><div class="NLM_p last">A different strategy was devised to prepare the 4-fluoroaminoisoquinoline <b>25c</b>. Compound <b>30</b>, prepared in high yield as previously described,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> reacted with Selectfluor in methanol to generate methanol-trapped fluorine adduct <b>31</b> in a nearly quantitative yield. Treatment of hemiaminal <b>31</b> with HCl in acetonitrile resulted in elimination of methanol and aromatization to afford 4-fluoro-6-nitroisoquinolin-1(2<i>H</i>)-one <b>32</b> in 98% yield. Compound <b>32</b> was converted to the corresponding chloride <b>33</b> with POCl<sub>3</sub>. Displacement of the chloride <b>33</b> by ammonia to give amine <b>34</b> proved to be problematic because of partial displacement of fluoride. Consequently, Pd-catalyzed amination of the chloride <b>33</b> with benzophenone imine, followed by treatment with acid, yielded the 4-fluoro-6-nitroisoquinolin-1-amine <b>34</b> in good yield. Boc protection of <b>34</b> and reduction of the nitro group afforded 4-fluoroaminoisoquinoline <b>25c</b>. The optimized sequence enabled a high yielding and scalable synthesis of the key intermediate <b>25c</b>.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68716" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68716" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Our strategy to improve the potency of macrocyclic inhibitor <b>1</b> was to optimize the molecular interactions of the inhibitors with the S′ site of FVIIa, in an analogy to that of the phenylpyrrolidine phenylglycineamide series,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> by substitution at the ortho position (to the benzyl amide) of the P′ phenyl ring (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). The in vitro activity was expressed as the inhibition constant <i>K</i><sub>i</sub> against human TF-FVIIa at 37 °C with physiologically relevant factor X (FX) as the substrate.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> The selectivity of the compounds was first evaluated against a panel of serine proteases including coagulation factor Xa (FXa), factor XIa (FXIa), thrombin, trypsin, and human tissue kallikrein (HK-1). For compounds of interest, selectivity was evaluated with a broader range of serine proteases.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> The anticlotting activity of the compounds was evaluated with a FVII deficient prothrombin time (FVII def PT) assay in human plasma, expressed as the concentration required to prolong clotting time by 2-fold (EC<sub>2<i>x</i></sub>).<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> The permeability of the macrocyclic compounds was evaluated in a parallel artificial membrane permeability assay (PAMPA).<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Summary of P′ SAR of the Macrocyclic TF-FVIIa Inhibitors</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00469/20160811/images/medium/jm-2016-004697_0010.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00469/20160811/images/medium/jm-2016-004697_0011.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">TF-FVIIa assays were performed at 37 °C (<i>n</i> ≥ 2).</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last"><i>K</i><sub>i</sub>s for the indicated enzymes were determined at 25 °C, except HK-1, which was run at 37 °C (<i>n</i> = 2).</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">See ref <a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">11</a> for a detailed description of the FVII deficient prothrombin time assay.</p></div><div class="footnote" id="t1fn4"><sup>Table d</sup><p class="last">Not determined</p></div></div><div></div></div><div class="NLM_p">Compound <b>1</b> showed a promising overall profile. It exhibited good potency and anticlotting activity (<i>K</i><sub>i</sub> = 20 nM, EC<sub>2<i>x</i></sub> = 5.3 μM). It displayed excellent selectivity against FXa, FXIa, thrombin, and trypsin. However, it retained an equal potency against HK-1 (<i>K</i><sub>i</sub> = 21 nM) and displayed low but measurable PAMPA permeability (Pc = 13 nm/s). As shown in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>, the trifluoromethoxy group in compound <b>2</b> improved the binding affinity for TF-FVIIa by 4-fold and maintained good overall selectivity except for HK-1. The anticlotting activity of compound <b>2</b> (EC<sub>2<i>x</i></sub> = 10 μM) was 2-fold less potent than that of compound <b>1</b> despite its improved binding affinity. This is most likely due to its decreased free fraction in human plasma as a result of increased lipophilicity compared to compound <b>1</b>. The trifluoromethoxy moiety significantly improved the PAMPA permeability (Pc = 230 nm/s) in compound <b>2</b>. Although methyl ester <b>3</b> and primary amide <b>4</b> only slightly improved the TF-FVIIa binding affinity, the selectivity against HK-1 of the two compounds was significantly improved while the excellent selectivity profile against other coagulation serine proteases was maintained. <i>N</i>,<i>N</i>-Dimethyl and <i>N</i>,<i>N</i>-diethyl amide <b>5</b> and <b>6</b> further improved the selectivity against HK-1 by concomitantly improving the binding affinity to TF-FVIIa and reducing the binding affinity to HK-1. Compound <b>6</b> proved to be a highly potent (<i>K</i><sub>i</sub> = 0.57 nM) and selective (>1000-fold) TF-VIIa inhibitor with good anticlotting activity (EC<sub>2<i>x</i></sub> = 2.2 μM). Unfortunately, the PAMPA permeability of compound <b>6</b> (Pc = 33 nm/s) was only modest compared to <b>1</b>.</div><div class="NLM_p">Small heterocycles such as pyrazole <b>7</b> improved the TF-FVIIa activity as well as the anticlotting activity with moderate permeability compared to compound <b>1</b>. Diethyl phosphate <b>8</b> and ethyl phosphonic acid <b>9</b> also significantly improved the TF-VIIa binding affinity and anticlotting activity. Compound <b>9</b> displayed an exceptional selectivity profile including against HK-1, suggesting a polar group in the P′ site is beneficial for achieving good HK-1 selectivity. Not surprisingly, the high polarity of compound <b>9</b> significantly limited its permeability (Pc = 3 nm/s). The most profound improvement in potency originated from the substitution of cyclopropyl sulfone in the P′ site, affording compound <b>10</b> with an excellent TF-FVIIa binding affinity and anticlotting activity (<i>K</i><sub>i</sub> = 0.16 nM, EC<sub>2<i>x</i></sub> = 1.1 μM) while still maintaining an excellent selectivity profile (>1600-fold) and moderate permeability (Pc = 50 nm/s). This interaction, which yielded more than 120-fold potency improvement relative to compound <b>1</b>, was observed earlier in the acylsulfonamide and phenylpyrrolidine phenylglycinamide series.<a onclick="showRef(event, 'ref24 ref31'); return false;" href="javascript:void(0);" class="ref ref24 ref31">(24, 31)</a> It is believed that the cyclopropylsulfone engages in hydrophobic interaction with Cys42–Cys58 disulfide bridge in the active site of TF-FVIIa complex. <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a> depicts a binding model of <b>13</b> bound in FVIIa based on crystallographic structures of analogous molecules.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> In this model, the fluoro-aminoisoquinoline forms a salt bridge with Asp189 side chain and a hydrogen bond with a water molecule above Tyr228 side chain. In the S1′ pocket, the amide carbonyl forms a pair of hydrogen bonds to the catalytic Ser195 and H57 side chains. The phenyl sulfone directs the cyclopropyl ring toward the Cys42–Cys58 disulfide bridge.</div><figure id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00469/20160811/images/medium/jm-2016-004697_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00469/20160811/images/large/jm-2016-004697_0003.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Model of <b>13</b> bound in FVIIa. Graphics were generated with the program PyMOL.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00469/20160811/images/large/jm-2016-004697_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00469&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>10</b> showed good metabolic stability in human and dog liver microsomes with <i>t</i><sub>1/2</sub> > 100 min but limited metabolic stability in rat liver microsomes with <i>t</i><sub>1/2</sub> = 12 min (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). Given its excellent potency and selectivity, good anticlotting activity, and moderate PAMPA permeability, compound <b>10</b> was progressed to dog pharmacokinetic studies. To our disappointment, it demonstrated very low oral exposure with only 1% absolute oral bioavailability. We believe its limited oral bioavailability is most likely attributed to its insufficient permeability. Despite modest potency, compound <b>2</b> possessed significantly improved PAMPA permeability and good metabolic stability in human and dog liver microsomes. Accordingly, it achieved much higher oral exposure than compound <b>10</b> with a 22% oral bioavailability in dogs. These results strongly suggested that good oral exposure of compound <b>10</b> could be achieved by improvement of its PAMPA permeability.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Metabolic Stability, Permeability, and Oral Bioavailability of Compounds <b>10</b> and <b>2</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" colspan="3" align="center" char=".">microsomal stability <i>t</i><sub>1/2</sub> (min)</th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">human</th><th class="colsep0 rowsep0" align="center" char=".">dog</th><th class="colsep0 rowsep0" align="center" char=".">rat</th><th class="colsep0 rowsep0" align="center" char=".">PAMPA <i>Pc</i> (nm/s)</th><th class="colsep0 rowsep0" align="center" char=".">oral bioavailability in dogs (<i>F</i>%)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="char" char=".">>120</td><td class="colsep0 rowsep0" align="char" char=".">110</td><td class="colsep0 rowsep0" align="char" char=".">12</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="char" char=".">130</td><td class="colsep0 rowsep0" align="char" char=".">140</td><td class="colsep0 rowsep0" align="char" char=".">37</td><td class="colsep0 rowsep0" align="char" char=".">230</td><td class="colsep0 rowsep0" align="char" char=".">22</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Dogs (<i>n</i> = 3) were dosed with 0.2 mg/kg iv and 1.0 mg/kg po.</p></div></div></div><div class="NLM_p">It is well established that the strong electron withdrawing nature of fluorine can exert significant effects on the basicity of neighboring functional groups.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> We decided to investigate fluoro substitution on the aminoisoquinoline P1 in macrocyclic inhibitor <b>10</b> as a strategy to reduce the basicity and thus improve permeability (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). The unsubstituted aminoisoquinoline <b>10</b> has an experimentally determined p<i>K</i><sub>a</sub> of 8.7 and calculated p<i>K</i><sub>a</sub> of 8.8.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Compound <b>11</b>, with fluoro substitution at the 8-position, has a measured p<i>K</i><sub>a</sub> of 8.0 relative to 8.7 for compound <b>10</b>. As expected, the reduced basicity translated into improved PAMPA permeability (from 50 nm/s in compound <b>10</b> to 200 nm/s in compound <b>11</b>). The reduction of basicity in <b>11</b> by fluorination resulted in 6-fold loss of binding affinity to TF-FVIIa and about 3-fold loss of anticlotting activity compared to <b>10</b>. On the other hand, compound <b>11</b> improved binding affinity to HK-1 by nearly 3-fold, resulting in a less selective profile. Compound <b>12</b>, with fluoro substitution at the 7-position, has a calculated p<i>K</i><sub>a</sub> of 8.5, marginally reduced relative to 8.8 in compound <b>10</b>.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> It resulted in a compound of comparable inhibitory potency relative to <b>10</b> but still with improved PAMPA permeability (Pc = 180 nm/s). Fluoro substitution at the 4-position had the most profound impact on p<i>K</i><sub>a</sub> and permeability. Compound <b>13</b> achieved nearly two log units reduction of the measured p<i>K</i><sub>a</sub> (from 8.7 to 7.1) and 18-fold improvement of PAMPA permeability (from 50 to 900 nm/s) relative to <b>10</b> while maintaining excellent TF-FVIIa inhibitory activity and good anticlotting activity (<i>K</i><sub>i</sub> = 0.43 nM, EC<sub>2<i>x</i></sub> = 6.1 μM). The data suggests that 4-fluoroaminoisoquinoline is still capable of strong binding in the S1 specificity pocket of TF-FVIIa via ionic interaction with Asp189 despite its significantly reduced basicity.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Effects of Fluorine Substitution on P1</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00469/20160811/images/medium/jm-2016-004697_0012.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="right" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">F position on P1</th><th class="colsep0 rowsep0" align="center">p<i>K</i><sub>a</sub><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">FVIIa <i>K</i><sub>i</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char=".">HK-1 <i>K</i><sub>i</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char=".">FVII def PT EC<sub>2<i>x</i></sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">PAMPA <i>Pc</i> (nm/s)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="center">NA<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="right">8.7 (8.8)</td><td class="colsep0 rowsep0" align="char" char=".">0.16</td><td class="colsep0 rowsep0" align="char" char=".">270</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td><td class="colsep0 rowsep0" align="char" char=".">50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="center">8-F</td><td class="colsep0 rowsep0" align="right">8.0 (8.2)</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">2.8</td><td class="colsep0 rowsep0" align="char" char=".">200</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="center">7-F</td><td class="colsep0 rowsep0" align="right">(8.5)</td><td class="colsep0 rowsep0" align="char" char=".">0.23</td><td class="colsep0 rowsep0" align="char" char=".">790</td><td class="colsep0 rowsep0" align="char" char=".">4.2</td><td class="colsep0 rowsep0" align="char" char=".">180</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="center">4-F</td><td class="colsep0 rowsep0" align="right">7.1 (7.5)</td><td class="colsep0 rowsep0" align="char" char=".">0.43</td><td class="colsep0 rowsep0" align="char" char=".">650</td><td class="colsep0 rowsep0" align="char" char=".">6.1</td><td class="colsep0 rowsep0" align="char" char=".">900</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Data in parentheses refers to QM calculated p<i>K</i><sub>a</sub>. See ref <a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">33</a> for details.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">Not applicable.</p></div></div></div><div class="NLM_p">The fluorinated macrocyclic inhibitors <b>11</b>–<b>13</b> showed good metabolic stability in human liver microsomes but poor metabolic stability in rat as observed in compound <b>10</b> (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). Further pharmacokinetic studies were performed in dogs because of the good metabolic stability achieved with compounds <b>11</b> and <b>13</b>.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Compound <b>11</b>, with a <i>t</i><sub>1/2</sub> = 39 min in dog liver microsomes and permeability Pc = 200 nm/s, displayed a moderate clearance and volume of distribution (CL = 13 mL/min/kg, <i>V</i><sub>dss</sub> = 8 L/kg) with <i>t</i><sub>1/2</sub> = 8 h and <i>F</i>% = 24. Compound <b>12</b>, with <i>t</i><sub>1/2</sub> = 7 min in dog liver microsomes, showed a moderate clearance and low oral exposure, most likely due to combination of poor metabolic stability and insufficient permeability. Compound <b>13</b>, with <i>t</i><sub>1/2</sub> = 26 min in dog liver microsomes and significantly improved PAMPA permeability (Pc = 900 nm/s), demonstrated a low clearance and moderate volume of distribution (CL = 8 mL/min/kg, <i>V</i><sub>dss</sub> = 5 L/kg) with <i>t</i><sub>1/2</sub> = 8 h and <i>F</i>% = 40. Thus, the 4-fluoroaminoisoquinoline had the most profound impact on p<i>K</i><sub>a</sub>, permeability, and oral bioavailability in this series of macrocyclic TF-FVIIa inhibitors. Because of its poor metabolic stability in rat and mouse liver microsomes (<i>t</i><sub>1/2</sub> = 1.9 and 3.1 min, respectively), compound <b>13</b> showed poor oral exposure in both species with absolute oral bioavailability <5%.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Dog Pharmacokinetic Parameters of Macrocyclic Inhibitors <b>11</b>–<b>13</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="char" char="." /></col><col align="center" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">microsomal stability <i>t</i><sub>1/2</sub> (min)</th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="rowsep1 colsep0" colspan="4" align="center">dog PK<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">human</th><th class="colsep0 rowsep0" align="center">dog</th><th class="colsep0 rowsep0" align="center">rat</th><th class="colsep0 rowsep0" align="center" char=".">PAMPA Pc (nm/s)</th><th class="colsep0 rowsep0" align="center">CL (mL/min/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub>dss</sub> (L/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="center">120</td><td class="colsep0 rowsep0" align="center">39</td><td class="colsep0 rowsep0" align="center">3.3</td><td class="colsep0 rowsep0" align="char" char=".">200</td><td class="colsep0 rowsep0" align="center">13</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="center">95</td><td class="colsep0 rowsep0" align="center">7</td><td class="colsep0 rowsep0" align="center">10</td><td class="colsep0 rowsep0" align="char" char=".">180</td><td class="colsep0 rowsep0" align="center">11</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="char" char="."><1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="center">45</td><td class="colsep0 rowsep0" align="center">26</td><td class="colsep0 rowsep0" align="center">1.9</td><td class="colsep0 rowsep0" align="char" char=".">900</td><td class="colsep0 rowsep0" align="center">8</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">40</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Dogs (<i>n</i> = 3) were dosed with 0.2 mg/kg iv and 1.0 mg/kg po.</p></div></div></div><div class="NLM_p">Because of its superior pharmacokinetic properties in dogs, compound <b>13</b> was selected for further in vitro and in vivo characterization. In addition to its excellent TF-FVIIa inhibitory activity, it displayed excellent selectivity toward other proteases important to hemostasis and thrombolysis (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>). It showed no significant inhibition in cytochrome P450 enzymes and ion channels (Na, Ca, and hERG). Free fraction of compound <b>13</b> in human and dog plasma was measured to be 2.3% and 1.4% respectively. Compound <b>13</b> exhibited good binding affinity to rabbit TF-VIIa (<i>K</i><sub>i</sub> = 1.9 nM) with a free fraction of 2.6% in rabbit plasma. In a rabbit model of electrically induced carotid arterial thrombosis (ECAT),<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> compound <b>13</b> inhibited thrombus formation in a concentration-dependent manner with an EC<sub>50</sub> of 360 nM (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>).</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Selectivity Profile of Macrocyclic Inhibitor <b>13</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">human enzyme</th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub> (nM)<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">selectivity (fold)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TF-FVIIa</td><td class="colsep0 rowsep0" align="center">0.43</td><td class="colsep0 rowsep0" align="center">NA<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FIXa<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="center">1600</td><td class="colsep0 rowsep0" align="center">>3700</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FXa</td><td class="colsep0 rowsep0" align="center">4000</td><td class="colsep0 rowsep0" align="center">>9300</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FXIa</td><td class="colsep0 rowsep0" align="center">3400</td><td class="colsep0 rowsep0" align="center">>7900</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FXIIa<a class="ref internalNav" href="#t5fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="center">7500</td><td class="colsep0 rowsep0" align="center">>17000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">thrombin</td><td class="colsep0 rowsep0" align="center">11000</td><td class="colsep0 rowsep0" align="center">>26000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">trypsin</td><td class="colsep0 rowsep0" align="center">3000</td><td class="colsep0 rowsep0" align="center">>7000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">plasma kallikrein</td><td class="colsep0 rowsep0" align="center">520</td><td class="colsep0 rowsep0" align="center">>1200</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">aPC<a class="ref internalNav" href="#t5fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="center">190</td><td class="colsep0 rowsep0" align="center">440</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HK-1</td><td class="colsep0 rowsep0" align="center">650</td><td class="colsep0 rowsep0" align="center">>1500</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">chymotrypsin</td><td class="colsep0 rowsep0" align="center">17000</td><td class="colsep0 rowsep0" align="center">>39000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">plasmin</td><td class="colsep0 rowsep0" align="center">1500</td><td class="colsep0 rowsep0" align="center">>3500</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">tPA<a class="ref internalNav" href="#t5fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="center">9100</td><td class="colsep0 rowsep0" align="center">>21000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">urokinase</td><td class="colsep0 rowsep0" align="center">15000</td><td class="colsep0 rowsep0" align="center">>35000</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">TF-FVIIa assays were performed at 37 °C (<i>n</i> > 2). <i>K</i><sub>i</sub>s for other indicated enzymes were determined at 25 °C, except aPC and HK-1, which were run at 37 °C (<i>n</i> = 2).</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">Not applicable.</p></div><div class="footnote" id="t5fn3"><sup>c</sup><p class="last">Factor IXa.</p></div><div class="footnote" id="t5fn4"><sup>d</sup><p class="last">Factor XIIa.</p></div><div class="footnote" id="t5fn5"><sup>e</sup><p class="last">Active protein C.</p></div><div class="footnote" id="t5fn6"><sup>f</sup><p class="last">Tissue plasminogen activator.</p></div></div></div><figure id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00469/20160811/images/medium/jm-2016-004697_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00469/20160811/images/large/jm-2016-004697_0004.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Antithrombotic effects of compound <b>13</b> in the rabbit ECAT model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00469/20160811/images/large/jm-2016-004697_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00469&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08853" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08853" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, starting from macrocyclic TF-FVIIa inhibitor <b>1</b> and optimizing the interactions with the S′ site, we have significantly improved potency and selectivity. The cyclopropyl sulfone <b>10</b> showed optimal TF-FVIIa binding affinity and overall selectivity against a panel of serine proteases. To address poor permeability and improve oral bioavailability in the series, we have resorted to fluorination of the aminoisoquinoline P1 group to reduce its basicity. The novel 4-fluoroaminoisoquinoline had a profound impact on p<i>K</i><sub>a</sub> and thus permeability and oral exposure. The resulting lead compound <b>13</b> achieved clinical candidate level potency, selectivity, anticlotting activity, and in vivo efficacy. It also achieved acceptable oral bioavailability and half-life in dogs. The key limitation is poor rodent metabolic stability and pharmacokinetics, preventing further advancement.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44084" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44084" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> General Methods for Chemistry</h3><div class="NLM_p">All experiments were carried out under an inert atmosphere and at room temperature unless otherwise stated. Reactions were monitored using thin-layer chromatography on 250 μm plates or using HPLC and LCMS with UV detection at 220 or 254 nm. Purification was accomplished by medium pressure liquid chromatography on a CombiFlash Companion (Teledyne Isco) with RediSep normal phase silica gel or by reverse phase preparative HPLC. All compounds for biological testing were purified by preparative HPLC. Purity of all final compounds was 95% or higher, determined with two orthogonal HPLC conditions (see <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a> for details). Reverse phase analytical and preparative HPLC were carried out using Shimadzu HPLC system running Discovery VP software. LCMS chromatograms were obtained on a Shimadzu HPLC system running Discovery VP software, coupled with a Waters ZQ mass spectrometer running MassLynx version 3.5 software. <sup>1</sup>H NMR spectra were recorded on a Bruker spectrometer (400 or 500 MHz) at ambient temperature.</div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> (2<i>R</i>,15<i>R</i>)-2-[(1-Aminoisoquinolin-6-yl)amino]-4,15,17-trimethyl-13-oxa-4,11-diazatricyclo[14.2.2.1<sup>6,10</sup>]henicosa-1(18),6,8,10(21),16,19-hexaene-3,12-dione (<b>1</b>)</h4><div class="NLM_p">Phosgene (0.12 mL, 0.19 mmol, 20% in toluene) was added dropwise to a solution of <b>20a</b> (115 mg, 0.17 mmol) in MeCN (1.5 mL)/CH<sub>2</sub>Cl<sub>2</sub> (1.5 mL) at 0 °C. The bath was removed, and the mixture was stirred at room temperature for 30 min. Argon was bubbled through the solution to remove excess phosgene, then the mixture was added to a solution of TEA (0.11 mL, 0.79 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (25 mL) at 40 °C over 5 h. The reaction was stirred at room temperature overnight, quenched with H<sub>2</sub>O (1 mL) and MeOH (5 mL), and concentrated. The crude product was purified by flash chromatography (0–100% EtOAc/hexanes) to give a mixture of diastereoisomers. The diastereoisomers were separated by a prep chiral HPLC (Whelk-01 25 cm × 21.1 mm, 50% (1:1 MeOH/EtOH) in heptanes) to give the desired enantiomer (30 mg, 0.083 mmol, 49% yield). MS (ESI) <i>m</i>/<i>z</i> 710.5 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Trifluoroacetic acid (2 mL) was added to the above desired enantiomer (30 mg, 0.083 mmol), and the reaction was stirred at room temperature for 1 h. The mixture was concentrated and purified by prep HPLC to yield <b>1</b> (19.0 mg, 36% yield) as a white solid. MS (ESI) <i>m</i>/<i>z</i> 510.2 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, MeOH-<i>d</i><sub>4</sub>) δ 8.05 (d, <i>J</i> = 9.35 Hz, 1H), 7.63 (dd, <i>J</i> = 1.79, 7.84 Hz, 1H), 7.43 (d, <i>J</i> = 7.98 Hz, 1H), 7.31 (d, <i>J</i> = 7.15 Hz, 1H), 7.23 (d, <i>J</i> = 1.38 Hz, 1H), 7.21 (dd, <i>J</i> = 2.48, 9.35 Hz, 1H), 7.18 (t, <i>J</i> = 7.84 Hz, 1H), 6.91 (d, <i>J</i> = 6.88 Hz, 2H), 6.84 (d, <i>J</i> = 2.20 Hz, 1H), 6.69 (dd, <i>J</i> = 0.96, 7.84 Hz, 1H), 5.93 (s, 1H), 5.74 (s, 1H), 5.45 (d, <i>J</i> = 16.51 Hz, 1H), 4.61- 4.69 (m, 1H), 3.96–4.03 (m, 1H), 3.91 (d, <i>J</i> = 16.51 Hz, 1H), 3.46–3.55 (m, 1H), 3.29 (s, 3H), 2.34 (s, 3H), 1.31 (d, <i>J</i> = 6.88 Hz, 3H). HPLC purity 100%.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> (2<i>R</i>,15<i>R</i>)-2-[(1-Aminoisoquinolin-6-yl)amino]-4,15,17-trimethyl-7-(trifluoromethoxy)-13-oxa-4,11-diazatricyclo[14.2.2.1<sup>6,10</sup>]henicosa-1(18),6,8,10(21),16,19-hexaene-3,12-dione (<b>2</b>)</h4><div class="NLM_p last">In a procedure similar to that described for <b>1</b>, <b>20d</b> (1.21 g, 1.58 mmol) reacted with phosgene/TEA, diastereoisomers were chirally separated (Chiral OD 10 μm 4.6 × 250 mm, 40% EtOH/MeOH(50/50) with 0.1%DEA in heptanes), and the desired enantiomer was deprotected with TFA to give <b>2</b> (240 mg, 41% yield) as a white solid. MS (ESI) <i>m</i>/<i>z</i> 594.7 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, MeOH-<i>d</i><sub>4</sub>) δ ppm 9.00 (s, 1H), 7.95 (d, <i>J</i> = 8.79 Hz, 1H), 7.54–7.59 (m, 1H), 7.36 (d, <i>J</i> = 7.70 Hz, 1H), 7.22 (d, <i>J</i> = 7.15 Hz, 1H), 7.09–7.14 (m, 2H), 7.06 (d, <i>J</i> = 7.15 Hz, 1H), 6.82 (d, <i>J</i> = 7.15 Hz, 1H), 6.75 (d, <i>J</i> = 2.20 Hz, 1H), 6.68 (dd, <i>J</i> = 8.79, 2.20 Hz, 1H), 5.94 (d, <i>J</i> = 2.20 Hz, 1H), 5.66 (s, 1H), 5.34 (d, <i>J</i> = 17.59 Hz, 1H), 4.56 (t, <i>J</i> = 10.99 Hz, 1H), 3.80–3.91 (m, 2H), 3.44 (s, 3H), 2.24 (s, 3H), 1.22 (d, <i>J</i> = 7.15 Hz, 3H). <sup>19</sup>F NMR (376 MHz, MeOH-<i>d</i><sub>4</sub>) δ ppm −59.11 (s, 3F). HPLC purity 96%.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> Methyl (2<i>R</i>,15<i>R</i>)-2-[(1-Aminoisoquinolin-6-yl)amino]-4,15,17-trimethyl-3,12-dioxo-13-oxa-4,11-diazatricyclo[14.2.2.1<sup>6,10</sup>]henicosa-1(18),6,8,10(21),16,19-hexaene-7-carboxylate (<b>3</b>)</h4><div class="NLM_p last"><b>23</b> (15 mg, 0.02 mmol) was dissolved in TFA (1 mL) and stirred for 1 h. The mixture was concentrated and purified by prep HPLC to yield <b>3</b> (11.2 mg, 80% yield). MS (ESI) <i>m</i>/<i>z</i> 568.2 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, MeOH-<i>d</i><sub>4</sub>) δ ppm 9.32 (s, 1H), 8.04 (d, <i>J</i> = 9.34 Hz, 1H), 7.92 (m, 1H), 7.63–7.71 (m, 1H), 7.47 (m, 1H), 7.31 (m, 1H), 7.20 (dd, <i>J</i> = 9.34, 2.20 Hz, 1H), 6.92 (m, 1H), 6.85 (d, <i>J</i> = 2.20 Hz, 1H), 6.74 (dd, <i>J</i> = 8.79, 2.20 Hz, 1H), 6.21 (br s, 1H), 5.68–5.74 (m, 2H), 4.63 (t, <i>J</i> = 10.99 Hz, 1H), 3.96 (dd, <i>J</i> = 10.99, 4.40 Hz, 1H), 3.79–3.88 (m, 3H), 3.61–3.74 (m, 5H), 2.31 (s, 3H), 1.32 (d, <i>J</i> = 7.15 Hz, 3H). HPLC purity 95%.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> (2<i>R</i>,15<i>R</i>)-2-[(1-Aminoisoquinolin-6-yl)amino]-4,15,17-trimethyl-3,12-dioxo-13-oxa-4,11- diazatricyclo[14.2.2.1<sup>6,10</sup>]henicosa-1(18),6,8,10(21),16,19-hexaene-7-carboxamide (<b>4</b>)</h4><div class="NLM_p last"><b>24</b> (12 mg, 0.016 mmol), EDC (6.1 mg, 0.032 mmol), HOBt (4.9 mg, 0.032 mmol), NH<sub>4</sub>Cl (1.7 mg, 0.032 mmol), and DIEA (0.011 mL, 0.064 mmol) were added into a vial. To this mixture was added DMF (0.5 mL) and stirred at room temperature under argon overnight. Water was added, and the reaction mixture was extracted with EtOAc. The combined organic layers were washed with brine, dried over MgSO<sub>4</sub>, and concentrated. The crude product was treated with TFA (1.0 mL) for 15 min to deprotect the di-Boc group. The mixture was concentrated and purified by prep HPLC to yield <b>4</b> (3.1 mg, 97% yield) as a white solid. MS (ESI) <i>m</i>/<i>z</i> 553.1 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, MeOH-<i>d</i><sub>4</sub>) δ ppm 8.04 (d, <i>J</i> = 9.03 Hz, 1H), 7.66 (d, <i>J</i> = 7.53 Hz, 1H), 7.46 (t, <i>J</i> = 7.28 Hz, 2H), 7.31 (d, <i>J</i> = 7.28 Hz, 1H), 7.20 (dd, <i>J</i> = 9.16, 2.13 Hz, 1H), 7.16 (s, 1H), 6.91 (d, <i>J</i> = 7.03 Hz, 1H), 6.84 (s, 1H), 6.68–6.78 (m, 1H), 6.17 (br s, 1H), 5.72 (s, 1H), 5.43–5.62 (m, 1H), 4.63 (t, <i>J</i> = 11.04 Hz, 1H), 4.21 (d, <i>J</i> = 17.57 Hz, 1H), 3.98 (dd, <i>J</i> = 10.54, 4.27 Hz, 1H), 3.58–3.41 (m, 1H), 3.28 (s, 3H), 2.32 (s, 3H), 1.32 (d, <i>J</i> = 7.03 Hz, 3H). HPLC purity 97%.</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> (2<i>R</i>,15<i>R</i>)-2-[(1-Aminoisoquinolin-6-yl)amino]-<i>N</i>,<i>N</i>,4,15,17-pentamethyl-3,12-dioxo-13-oxa-4,11-diazatricyclo[14.2.2.1<sup>6,10</sup>]henicosa-1(18),6,8,10(21),16,19-hexaene-7-carboxamide (<b>5</b>)</h4><div class="NLM_p last">To a solution of <b>24</b> (8 mg, 10.6 μmol) at 0 °C in DMF (0.3 mL) and MeCN (0.3 mL) was added HATU (4.8 mg, 0.013 mmol) and <i>N</i>-methylmorpholine (1.75 μL, 0.016 mmol). The reaction was stirred for 5 min. Then 2 M dimethylamine in THF (6.4 μL, 0.013 mmol) was added and the reaction was allowed to warm to room temperature and stirred for 4 h. The reaction mixture was diluted with water and extracted with EtOAc. The combined organic layer was washed with water, brine, dried over MgSO<sub>4</sub>, and concentrated. The di-Boc intermediate was treated with TFA (1.5 mL) for 30 min. The reaction mixture was then concentrated and purified by prep HPLC to give <b>5</b> (2.9 mg, 39% yield). MS (ESI) <i>m</i>/<i>z</i> 581.2 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, MeOH-<i>d</i><sub>4</sub>) δ ppm 8.06 (d, <i>J</i> = 9.29 Hz, 1H), 7.61–7.71 (m, 1H), 7.47 (d, <i>J</i> = 8.03 Hz, 2H), 7.33 (d, <i>J</i> = 7.03 Hz, 1H), 7.18–7.26 (m, 1H), 7.13 (d, <i>J</i> = 8.03 Hz, 1H), 6.93 (d, <i>J</i> = 7.03 Hz, 1H), 6.84 (d, <i>J</i> = 2.26 Hz, 1H), 6.77 (dd, <i>J</i> = 8.03, 2.01 Hz, 1H), 6.14 (s, 1H), 5.75 (s, 1H), 5.27 (s, 1H), 4.60–4.73 (m, 1H), 4.01 (dd, <i>J</i> = 10.67, 4.39 Hz, 1H), 3.88 (d, <i>J</i> = 16.56 Hz, 1H), 3.44–3.58 (m, 1H), 3.27 (s, 3H), 3.11 (s, 3H), 2.94 (s, 3H), 2.35 (s, 3H), 1.33 (d, <i>J</i> = 7.03 Hz, 3H). HPLC purity 98%.</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> (2<i>R</i>,15<i>R</i>)-2-[(1-Aminoisoquinolin-6-yl)amino]-<i>N</i>,<i>N</i>-diethyl-4,15,17-trimethyl-3,12-dioxo-13-oxa-4,11-diazatricyclo[14.2.2.1<sup>6,10</sup>]henicosa-1(18),6,8,10(21),16,19-hexaene-7-carboxamide (<b>6</b>)</h4><div class="NLM_p last">In a procedure similar to that described for <b>5</b>, replacing dimethylamine with diethylamine, <b>6</b> (3.4 mg, 29% yield) was obtained as a white solid. MS (ESI) <i>m</i>/<i>z</i> 609.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, MeOH-<i>d</i><sub>4</sub>) δ ppm 7.99–8.11 (m, 1H), 7.65 (dd, <i>J</i> = 7.78, 1.76 Hz, 1H), 7.46 (d, <i>J</i> = 8.03 Hz, 1H), 7.31 (d, <i>J</i> = 7.03 Hz, 1H), 7.15–7.26 (m, 2H), 7.10 (d, <i>J</i> = 8.03 Hz, 1H), 6.91 (d, <i>J</i> = 7.03 Hz, 1H), 6.83 (d, <i>J</i> = 2.26 Hz, 1H), 6.76 (dd, <i>J</i> = 8.03, 1.76 Hz, 1H), 6.10 (s, 1H), 5.73 (s, 1H), 5.25 (br s, 1H), 4.65 (t, <i>J</i> = 11.04 Hz, 1H), 3.99 (dd, <i>J</i> = 10.79, 4.27 Hz, 1H), 3.87 (br s, 2H), 3.59 (d, <i>J</i> = 1.00 Hz, 1H), 3.42–3.56 (m, 2H), 3.27 (s, 3H), 2.33 (s, 3H), 1.27–1.37 (m, 3H), 1.25 (t, <i>J</i> = 7.15 Hz, 3H), 1.10 (t, <i>J</i> = 7.03 Hz, 3H). HPLC purity 99%.</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> (2<i>R</i>,15<i>R</i>)-2-[(1-Aminoisoquinolin-6-yl)amino]-4,15,20-trimethyl-7-(1-methyl-1<i>H</i>-pyrazol-5-yl)-13-oxa-4,11-diazatricyclo[14.2.2.1<sup>6,10</sup>]henicosa-1(18),6,8,10(21),16,19-hexaene-3,12-dione (<b>7</b>)</h4><div class="NLM_p last">In a procedure similar to that described for <b>1</b>, <b>20e</b> (200 mg, 0.26 mmol) reacted with phosgene/TEA, diastereoisomers were chirally separated (R,R-Whelk-01 column 21.1 mm × 250 mm; isocratic 45% MeOH/EtOH (1:1)/65% heptanes), and the desired enantiomer was deprotected with TFA to give <b>7</b> (8.5 mg, 5% yield). MS (ESI) <i>m</i>/<i>z</i> 590.4 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, MeOH-<i>d</i><sub>4</sub>) δ ppm 8.02 (d, <i>J</i> = 9.23 Hz, 1H), 7.55–7.79 (m, 2H), 7.39–7.56 (m, 2H), 7.29 (d, <i>J</i> = 7.03 Hz, 1H), 7.15–7.22 (m, 2H), 7.12 (d, <i>J</i> = 8.35 Hz, 1H), 6.88 (d, <i>J</i> = 7.03 Hz, 1H), 6.80 (br s, 2H), 6.29 (d, <i>J</i> = 1.76 Hz, 1H), 6.17 (s, 1H), 5.70 (s, 1H), 4.98–5.14 (m, 2H), 4.16–4.25 (m, 2H), 3.98 (dd, <i>J</i> = 10.55, 4.39 Hz, 1H), 3.67–3.70 (m, 3H), 3.67 (s, 3H), 3.49–3.54 (m, 3H), 2.33 (s, 3H). HPLC purity 96%.</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> Diethyl [(2<i>R</i>,15<i>R</i>)-2-[(1-Aminoisoquinolin-6-yl)amino]-4,15,17-trimethyl-3,12-dioxo-13-oxa-4,11-diazatricyclo[14.2.2.1<sup>6,10</sup>]henicosa-1(18),6,8,10(21),16,19-hexaen-7-yl]phosphonate (<b>8</b>)</h4><div class="NLM_p last">In a procedure similar to that described for <b>1</b>, <b>20b</b> (130 mg, 0.16 mmol) reacted with phosgene/TEA, diastereoisomers were chirally separated (Chiralcel AD-H, 2.0 cm × 25 cm), and the desired enantiomer was deprotected with 4.0 N HCl in dioxane to give <b>8</b> (24 mg, 22% yield) as a white solid. MS (ESI) <i>m</i>/<i>z</i> 646.1 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, MeOH-<i>d</i><sub>4</sub>) δ ppm 9.39 (s, 1H), 8.04 (d, <i>J</i> = 9.23 Hz, 1H), 7.74 (dd, <i>J</i> = 14.06, 8.35 Hz, 1H), 7.67 (dd, <i>J</i> = 7.91, 1.32 Hz, 1H), 7.47 (d, <i>J</i> = 7.91 Hz, 1H), 7.31 (d, <i>J</i> = 7.03 Hz, 1H), 7.19 (dd, <i>J</i> = 9.23, 2.20 Hz, 1H), 7.16 (s, 1H), 6.92 (d, <i>J</i> = 7.03 Hz, 1H), 6.84 (m, 1H), 6.76–6.82 (m, 1H), 6.22–6.29 (m, 1H), 5.74 (s, 1H), 5.67 (d, <i>J</i> = 17.14 Hz, 1H), 4.63 (t, <i>J</i> = 10.99 Hz, 1H), 4.06–4.14 (m, 4H), 3.96–4.02 (m, 1H), 3.43–3.55 (m, 1H), 3.35 (s, 3H), 2.30 (s, 3H), 1.29–1.38 (m, 9H). HPLC purity 95%.</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> [(2<i>R</i>,15<i>R</i>)-2-[(1-Aminoisoquinolin-6-yl)amino]-4,15,20-trimethyl-3,12-dioxo-13-oxa-4,11-diazatricyclo[14.2.2.1<sup>6,10</sup>]henicosa-1(18),6,8,10(21),16,19-hexaen-7-yl](ethoxy)phosphinic Acid (<b>9</b>)</h4><div class="NLM_p last">One M LiOH (10 drops) was added to a solution of <b>8</b> (8 mg, 0.012 mmol) in DMSO (4 drops) and THF (0.1 mL), and the mixture was stirred at 40 °C overnight. The reaction mixture was neutralized with 1.0 M HCl (15 drops) and concentrated. The crude product was purified by prep HPLC to yield <b>9</b> (4.0 mg, 51% yield) as a white solid. MS (ESI) <i>m</i>/<i>z</i> 618.5 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, MeOH-<i>d</i><sub>4</sub>) δ ppm 8.05 (d, <i>J</i> = 9.23 Hz, 1H), 7.75 (dd, <i>J</i> = 13.84, 8.13 Hz, 1H), 7.67 (dd, <i>J</i> = 7.91, 1.76 Hz, 1H), 7.47 (d, <i>J</i> = 8.35 Hz, 1H), 7.31 (d, <i>J</i> = 7.03 Hz, 1H), 7.17–7.24 (m, 2H), 6.92 (d, <i>J</i> = 7.03 Hz, 1H), 6.84 (d, <i>J</i> = 2.20 Hz, 1H), 6.76 (d, <i>J</i> = 7.91 Hz, 1H), 6.15–6.22 (m, 1H), 5.66–5.75 (m, 2H), 4.63 (t, <i>J</i> = 10.99 Hz, 1H), 4.21 (d, <i>J</i> = 17.14 Hz, 1H), 3.92–4.03 (m, 4H), 3.41–3.55 (m, 1H), 3.33 (br s, 3H), 2.33 (s, 3H), 1.24–1.38 (m, 6H). HPLC purity 99%.</div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> (2<i>R</i>,15<i>R</i>)-2-[(1-Aminoisoquinolin-6-yl)amino]-7-(cyclopropanesulfonyl)-4,15,20-trimethyl-13-oxa-4,11-diazatricyclo[14.2.2.1<sup>6,10</sup>]henicosa-1(18),6,8,10(21),16,19-hexaene-3,12-dione (<b>10</b>)</h4><div class="NLM_p last">In a procedure similar to that described for <b>1</b>, <b>20c</b> (0.66 g, 0.83 mmol) reacted with phosgene/TEA, diastereoisomers were chirally separated (R,R-Whelk-01 column 21.1 mm × 250 mm), and the desired enantiomer was deprotected with TFA to give <b>10</b> (115.8 mg, 38% yield) as white solid. MS (ESI) <i>m</i>/<i>z</i> 614.1 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, MeOH-<i>d</i><sub>4</sub>) δ ppm 9.50 (s, 1H), 8.05 (d, <i>J</i> = 9.29 Hz, 1H), 7.73 (d, <i>J</i> = 8.53 Hz, 1H), 7.68 (dd, <i>J</i> = 7.91, 1.63 Hz, 1H), 7.48 (d, <i>J</i> = 8.03 Hz, 1H), 7.32 (d, <i>J</i> = 7.03 Hz, 1H), 7.20 (dd, <i>J</i> = 9.16, 2.38 Hz, 1H), 7.11 (s, 1H), 6.92 (d, <i>J</i> = 7.03 Hz, 1H), 6.80–6.86 (m, 2H), 6.42 (t, <i>J</i> = 2.38 Hz, 1H), 5.78 (d, <i>J</i> = 17.57 Hz, 1H), 5.74 (s, 1H), 4.64 (t, <i>J</i> = 11.04 Hz, 1H), 4.30 (d, <i>J</i> = 17.57 Hz, 1H), 3.99 (dd, <i>J</i> = 10.79, 4.27 Hz, 1H), 3.46–3.55 (m, 1H), 3.40 (s, 3H), 2.81–2.92 (m, 1H), 2.31 (s, 3H), 1.34 (d, <i>J</i> = 7.03 Hz, 3H), 1.22–1.30 (m, 1H), 1.01–1.17 (m, 3H). HPLC purity 98%.</div></div><div id="sec4_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> (2<i>R</i>,15<i>R</i>)-2-[(1-Amino-8-fluoroisoquinolin-6-yl)amino]-7-(cyclopropanesulfonyl)-4,15,17- trimethyl-13-oxa-4,11-diazatricyclo[14.2.2.1<sup>6,10</sup>]henicosa-1(18),6,8,10(21),16,19-hexaene-3,12-dione (<b>11</b>)</h4><div class="NLM_p last">In a procedure similar to that described for <b>1</b>, <b>27a</b> (0.2 g, 0.25 mmol) reacted with phosgene/TEA, diastereoisomers were chirally separated (Chiral OD 10 um 4.6 mm × 250 mm; isocratic 35% 1:1 MeOH:EtOH/heptanes with 0.1% DEA), and the desired enantiomer was deprotected with 4 N HCl in dioxane to give the <b>11</b> (7.7 mg, 10% yield). MS (ESI) <i>m</i>/<i>z</i> 632.4 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, MeOH-<i>d</i><sub>4</sub>) δ ppm 7.71 (d, <i>J</i> = 8.34 Hz, 1H), 7.63 (dd, <i>J</i> = 7.83, 1.77 Hz, 1H), 7.54–7.41 (m, 2H), 7.10 (d, <i>J</i> = 1.52 Hz, 1H), 6.81 (dd, <i>J</i> = 8.46, 2.15 Hz, 1H), 6.78–6.64 (m, 2H), 6.51 (d, <i>J</i> = 2.27 Hz, 1H), 6.41 (d, <i>J</i> = 2.02 Hz, 1H), 5.75 (d, <i>J</i> = 17.43 Hz, 1H), 5.63 (s, 1H), 4.62 (t, <i>J</i> = 10.99 Hz, 1H), 4.28 (d, <i>J</i> = 17.68 Hz, 1H), 3.97 (dd, <i>J</i> = 10.86, 4.29 Hz, 1H), 3.55–3.44 (m, 1H), 3.40–3.36 (m, 4H), 2.29 (s, 3H), 1.32 (t, <i>J</i> = 7.33 Hz, 3H), 1.27–1.14 (m, 2H), 1.15–0.95 (m, 2H) <sup>19</sup>F NMR (376 MHz, MeOH-<i>d</i><sub>4</sub>) δ ppm −115.25 (s, 1F). HPLC purity 98%.</div></div><div id="sec4_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> (2<i>R</i>,15<i>R</i>)-2-[(1-Amino-7-fluoroisoquinolin-6-yl)amino]-7-(cyclopropanesulfonyl)-4,15,17-trimethyl-13-oxa-4,11-diazatricyclo[14.2.2.1<sup>6,10</sup>]henicosa-1(18),6,8,10(21),16,19-hexaene-3,12-dione (<b>12</b>)</h4><div class="NLM_p last">In a procedure similar to that described for <b>1</b>, <b>27b</b> (80 mg, 0.1 mmol) reacted with phosgene/TEA, diastereoisomers were chirally separated (R,R-Whelk-01 column 21.1 mm × 250 mm), and the desired enantiomer was deprotected with 4 N HCl in dioxane to give the <b>12</b> (19 mg, 24% yield). MS (ESI) <i>m</i>/<i>z</i> 632.4 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, MeCN-<i>d</i><sub>3</sub>) δ ppm 7.92 (d, <i>J</i> = 12.64 Hz, 1H), 7.64–7.73 (m, 2H), 7.44 (d, <i>J</i> = 7.70 Hz, 1H), 7.29 (d, <i>J</i> = 7.15 Hz, 1H), 6.93–6.99 (m, 2H), 6.90 (d, <i>J</i> = 7.15 Hz, 1H), 6.69–6.84 (m, 1H), 6.34 (s, 1H), 5.69–5.77 (m, 2H), 4.54–4.58 (m, 1H), 4.23 (d, <i>J</i> = 17.59 Hz, 1H), 3.91 (dd, <i>J</i> = 10.44, 4.40 Hz, 1H), 3.38–3.49 (m, 1H), 3.31 (s, 3H), 2.74–2.88 (m, 1H), 2.21 (s, 3H), 1.25 (d, <i>J</i> = 6.60 Hz, 3H), 0.97–1.13 (m, 4H). <sup>19</sup>F NMR (376 MHz, MeCN-<i>d</i><sub>3</sub>) δ ppm −131.68 (s, 1F). HPLC purity 99%.</div></div><div id="sec4_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> (2<i>R</i>,15<i>R</i>)-2-[(1-Amino-4-fluoroisoquinolin-6-yl)amino]-7-(cyclopropanesulfonyl)-4,15,17-trimethyl-13-oxa-4,11-diazatricyclo[14.2.2.1<sup>6,10</sup>]henicosa-1(18),6,8,10(21),16,19-hexaene-3,12-dione (<b>13</b>)</h4><div class="NLM_p last">In a procedure similar to that described for <b>1</b>, <b>27c</b> (135 mg, 0.17 mmol) reacted with phosgene/TEA, diastereoisomers were chirally separated (R,R-Whelk-01 column 21.1 mm × 250 mm), and the desired enantiomer was deprotected with 4 N HCl in dioxane to give the <b>13</b> (39 mg, 31% yield). MS (ESI) <i>m</i>/<i>z</i> 632.1 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, MeCN-<i>d</i><sub>3</sub>) δ ppm 7.74–7.81 (m, 2H), 7.71 (d, <i>J</i> = 8.35 Hz, 1H), 7.64–7.69 (m, 1H), 7.45 (d, <i>J</i> = 7.91 Hz, 1H), 7.21 (d, <i>J</i> = 4.83 Hz, 1H), 7.13 (dd, <i>J</i> = 9.23, 2.20 Hz, 1H), 6.98 (s, 1H), 6.88 (s, 1H), 6.81 (dd, <i>J</i> = 8.35, 1.76 Hz, 1H), 6.30 (d, <i>J</i> = 1.76 Hz, 1H), 5.70 (d, <i>J</i> = 17.14 Hz, 1H), 5.65 (d, <i>J</i> = 3.95 Hz, 1H), 4.56 (t, <i>J</i> = 10.99 Hz, 1H), 4.18 (d, <i>J</i> = 17.58 Hz, 1H), 3.91 (dd, <i>J</i> = 10.55, 4.39 Hz, 1H), 3.39 (ddd, <i>J</i> = 11.32, 7.14, 4.39 Hz, 1H), 3.27 (s, 3H), 2.63–2.72 (m, 1H), 2.17 (s, 3H), 1.25 (d, <i>J</i> = 7.03 Hz, 3H), 1.05–1.20 (m, 2H), 0.93–1.04 (m, 2H). <sup>13</sup>C NMR (125.66 MHz, MeOH-<i>d</i><sub>4</sub>) δ ppm 171.60, 154.81, 153.62, 152.98, 149.39, 145.12, 143.87, 139.51, 139.18, 134.39, 133.66, 133.08, 133.00, 129.10, 128.31, 128.10, 120.16, 119.80, 119.18, 113.35, 109.38, 99.33, 72.08, 58.15, 51.87, 37.81, 36.17, 33.56, 20.28, 15.72, 6.60, 6.18. <sup>19</sup>F NMR (376 MHz, MeCN-<i>d</i><sub>3</sub>) δ ppm −154.37 (s, 1F). e.e. 99.8%. Anal. Calcd for C<sub>33</sub>H<sub>34</sub>N<sub>5</sub>O<sub>5</sub>SF·HCl: C, 55.60; H, 5.70; N, 9.64; S, 4.41; Cl, 5.30. Found: C, 56.79; H, 5.49; N, 9.50; S, 4.39; Cl, 5.20. HPLC purity 98%.</div></div><div id="sec4_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> <i>tert</i>-Butyl <i>N</i>-{6-[({[(3-Aminophenyl)methyl](methyl)carbamoyl}({4-[(2<i>R</i>)-1-hydroxypropan-2-yl]-3-methylphenyl})methyl)amino]isoquinolin-1-yl}-<i>N</i>-[(<i>tert</i>-butoxy)carbonyl]carbamate (<b>20a</b>)</h4><div class="NLM_p last">To a mixture of <b>15</b> (120 mg, 0.33 mmol), <b>16</b> (64.8 mg, 0.33 mmol), and glyoxylic acid monohydrate <b>17</b> (31 mg, 0.33 mmol) were added DMF (1 mL) and MeCN (2 mL). The heterogeneous mixture was stirred at 80 °C for 3 h to give an orange solution of <b>18</b>, which was cooled to room temperature. To this mixture were added <b>19a</b> (50.0 mg, 0.37 mmol), BOP (162 mg, 0.37 mmol), and TEA (0.23 mL, 1.7 mmol). The mixture was stirred at room temperature for 1 h, diluted with EtOAc, washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The crude product was purified by flash chromatography (1–10% MeOH/CH<sub>2</sub>Cl<sub>2</sub>) to afford <b>20a</b> (117 mg, 51% yield) as off-white solid. MS (ESI) <i>m</i>/<i>z</i> 684.5 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, MeOH-<i>d</i><sub>4</sub>) δ 8.03 (dd, <i>J</i> = 18.0, 5.9 Hz, 1H), 7.65–7.53 (m, 1H), 7.49–7.35 (m, 2H), 7.35–7.13 (m, 3H), 7.13–6.94 (m, 1H), 6.80–6.44 (m, 4H), 5.64–5.48 (m, 1H), 4.65–4.45 (m, 2H), 3.69–3.64 (m, 1H), 3.58–3.53 (m, 1H), 3.22–3.15 (m, 1H), 3.05 (s, 3H), 2.39–2.34 (m, 3H), 1.30–1.25 (m, 18H), 1.24–1.20 (m, 3H). <sup>1</sup>H NMR was complicated by a pair of diastereomers and rotamers.</div></div><div id="sec4_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> <i>tert</i>-Butyl <i>N</i>-(6-{[({[5-Amino-2-diethoxyphosphoryl)phenyl]methyl}(methyl)carbamoyl)({4-[(2<i>R</i>)-1-hydroxypropan-2-yl]-3-methylphenyl})methyl]amino}isoquinolin-1-yl)-<i>N</i>-[(<i>tert</i>-butoxy)carbonyl]carbamate (<b>20b</b>)</h4><div class="NLM_p last">In a procedure similar to that described for <b>20a</b>, replacing <b>19a</b> with <b>19b</b>, <b>20b</b> (135 mg, 71% yield) was obtained as a yellow solid. MS (ESI) <i>m</i>/<i>z</i> 820.1 [M + H]<sup>+</sup>. <sup>1</sup>H NMR was complicated by a pair of diastereomers and rotamers.</div></div><div id="sec4_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> <i>tert</i>-Butyl <i>N</i>-(6-{[({[5-Amino-2-(cyclopropanesulfonyl)phenyl]methyl}(methyl)carbamoyl)({4-[(2<i>R</i>)-1-hydroxypropan-2-yl]-3-methylphenyl})methyl]amino}isoquinolin-1-yl)-<i>N</i>-[(<i>tert</i>-butoxy)carbonyl]carbamate (<b>20c</b>)</h4><div class="NLM_p last">In a procedure similar to that described for <b>20a</b>, replacing <b>19a</b> with <b>19c</b>, <b>20c</b> (0.66 g, 77% yield) was obtained as an orange glass, which was lyophilized to give a white powder. MS (ESI) <i>m</i>/<i>z</i> 788.2 [M + H]<sup>+</sup>. <sup>1</sup>H NMR was complicated by a pair of diastereomers and rotamers.</div></div><div id="sec4_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> <i>tert</i>-Butyl <i>N</i>-(6-{[({[5-Amino-2-(trifluoromethoxy)phenyl]methyl}(methyl)carbamoyl)({4-[(2<i>R</i>)-1-hydroxypropan-2-yl]-3-methylphenyl})methyl]amino}isoquinolin-1-yl)-<i>N</i>-[(<i>tert</i>-butoxy)carbonyl]carbamate (<b>20d</b>)</h4><div class="NLM_p">To a mixture of <b>15</b> (1.0 g, 2.8 mmol), <b>16</b> (0.54 g, 2.8 mmol), and glyoxylic acid monohydrate <b>17</b> (0.21 g, 2.8 mmol) were added DMF (6 mL) and MeCN (12 mL). The heterogeneous mixture was stirred at 80 °C for 3 h to give an orange solution of <b>18</b>, which was cooled to room temperature. To this mixture were added <b>21a</b> (0.77 g, 2.7 mmol), BOP (1.49 g, 3.4 mmol), and DIEA (1.2 mL, 6.8 mmol). The reaction was stirred at room temperature overnight, diluted with EtOAc, washed with water and brine, dried with Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The crude product was purified by flash chromatography (1–10% MeOH/CH<sub>2</sub>Cl<sub>2</sub>) to afford the nitro intermediate (1.35 g, 63% yield) as a solid. MS (ESI) <i>m</i>/<i>z</i> 798.8 [M + H]<sup>+</sup>.</div><div class="NLM_p last">A mixture of the above nitro intermediate (1.34 g, 1.68 mmol), 4.0N HCl in dioxane (0.42 mL, 1.68 mmol), and 10% Pd/C (600 mg) in MeOH (50 mL) was hydrogenated with a hydrogen balloon for 1.5 h. Pd/C was removed by filtration. The filtrate was concentrated and redissolved in CH<sub>2</sub>Cl<sub>2</sub> and washed with satd NaHCO<sub>3</sub> and half-saturated brine. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated to give <b>20d</b> (1.2 g, 94% yield) as a yellow solid. MS (ESI) <i>m</i>/<i>z</i> 768.4 [M + H]<sup>+</sup>. <sup>1</sup>H NMR was complicated by a pair of diastereomers and rotamers.</div></div><div id="sec4_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> <i>tert</i>-Butyl-<i>N</i>-(6-{[({[5-amino-2-(1-methyl-1<i>H</i>-pyrazol-5-yl)phenyl]methyl}(methyl)carbamoyl)({4-[(2<i>R</i>)-1-hydroxypropan-2-yl]-3-methylphenyl})methyl]amino}isoquinolin-1-yl)-<i>N</i>-[(<i>tert</i>-butoxy)carbonyl]carbamate (<b>20e</b>)</h4><div class="NLM_p last">In a procedure similar to that described for <b>20d</b>, replacing <b>21a</b> with <b>21b</b>, <b>20e</b> (210 mg, 82% yield) was obtained as a solid. MS (ESI) <i>m</i>/<i>z</i> 764.5 [M + H]<sup>+</sup>. <sup>1</sup>H NMR was complicated by a pair of diastereomers and rotamers.</div></div><div id="sec4_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> <i>tert</i>-Butyl <i>N</i>-(6-{[(2<i>R</i>,15<i>R</i>)-7-Bromo-4,15,20-trimethyl-3,12-dioxo-13-oxa-4,11-diazatricyclo[14.2.2.1<sup>6,10</sup>]henicosa-1(18),6,8,10(21),16,19-hexaen-2-yl]amino}isoquinolin-1-yl)-<i>N</i>-[(<i>tert</i>-butoxy)carbonyl]carbamate (<b>22</b>)</h4><div class="NLM_p">A solution of <b>15</b> (0.7 g, 1.9 mmol), glyoxylic acid monohydrate <b>17</b> (0.18 g, 1.9 mmol), and <b>16</b> (0.38 g, 1.9 mmol) in DMF (3 mL) and MeCN (3 mL) was stirred at 80 °C for 1.5 h. The mixture was cooled to room temperature and diluted with DMF (2 mL). To this mixture were added sequentially 4-bromo-3-((methylamino)methyl)aniline (0.67 g, 2.3 mmol), BOP (0.94 g, 2.1 mmol), and TEA (1.6 mL, 11 mmol). The mixture was stirred at room temperature for 30 min, then diluted with EtOAc, washed with water and brine, and dried (Na<sub>2</sub>SO<sub>4</sub>). The solvent was removed under reduced pressure. The residue was redissolved in CH<sub>2</sub>Cl<sub>2</sub> with 3% MeOH and purified by flash chromatography (1–10% MeOH/CH<sub>2</sub>Cl<sub>2</sub>) to give the intermediate amide (1.2 g, 79% yield) as an orange glass. MS (ESI) <i>m</i>/<i>z</i> 762.5 and 764.5 [M + H]<sup>+</sup>. <sup>1</sup>H NMR was complicated by a pair of diastereomers and rotamers.</div><div class="NLM_p last">A solution of the above amide (1.17 g, 1.53 mmol) in MeCN (8 mL), CH<sub>2</sub>Cl<sub>2</sub> (8 mL), and DMPU (0.6 mL) was cooled to 0 °C. To this solution was added phosgene (20% in toluene, 0.84 mL, 1.69 mmol). The mixture was stirred at 0 °C for 15 min and then bubbled with Ar for 10 min to remove excess phosgene. The resulting solution was added dropwise over 3 h (via a syringe pump) into a solution of TEA (2.1 mL, 15.4 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (400 mL) at 40 °C. The solution was stirred for an additional 30 min. Reaction mixture was concentrated, suspended in EtOAc (250 mL), washed with water and brine, and dried (Na<sub>2</sub>SO<sub>4</sub>). EtOAc was removed under reduced pressure, and the residue was purified by flash chromatography (50–100% EtOAc/hexanes) to give product as a mixture of diastereomers. The diastereoisomers were separated by chiral HPLC (Chiral OD 10 μm 4.6 mm × 250 mm; solvent A heptanes; solvent B 50% MeOH–50% EtOH) to give <b>22</b> (0.2 g, 33% yield). MS (ESI) <i>m</i>/<i>z</i> 788.1 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, MeOH-<i>d</i><sub>4</sub>) δ ppm 8.04 (d, <i>J</i> = 5.50 Hz, 1H), 7.68 (d, <i>J</i> = 6.05 Hz, 1H), 7.60 (d, <i>J</i> = 9.34 Hz, 1H), 7.51 (d, <i>J</i> = 6.05 Hz, 1H), 7.46 (d, <i>J</i> = 7.70 Hz, 1H), 7.40 (d, <i>J</i> = 8.24 Hz, 1H), 7.27 (dd, <i>J</i> = 8.79, 2.20 Hz, 1H), 7.22 (s, 1H), 6.87 (d, <i>J</i> = 2.20 Hz, 1H), 6.63 (dd, <i>J</i> = 8.52, 2.47 Hz, 1H), 5.99 (d, <i>J</i> = 2.20 Hz, 1H), 5.71 (s, 1H), 5.35 (d, <i>J</i> = 17.04 Hz, 1H), 4.65 (t, <i>J</i> = 11.27 Hz, 1H), 3.95 (dd, <i>J</i> = 10.99, 4.40 Hz, 1H), 3.65 (s, 1H), 3.44–3.53 (m, 1H), 3.34 (s, 3H), 2.31 (s, 3H), 1.31 (d, <i>J</i> = 7.15 Hz, 3H), 1.27 (s, 18H). HPLC purity 95%.</div></div><div id="sec4_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> Methyl (2<i>R</i>,15<i>R</i>)-2-[(1-{Bis[(<i>tert</i>-butoxy)carbonyl]amino}isoquinolin-6-yl)amino]-4,15,17-trimethyl-3,12-dioxo-13-oxa-4,11-diazatricyclo[14.2.2.1<sup>6,10</sup>]henicosa-1(18),6,8,10(21),16,19-hexaene-7-carboxylate (<b>23</b>)</h4><div class="NLM_p last">To a pressure flask charged with <b>22</b> (250 mg, 0.32 mmol), Pd(OAc)<sub>2</sub> (35.6 mg, 0.16 mmol), TEA (0.13 mL, 0.95 mmol), and 1,3-bis(diphenylphosphino)propane (dppp, 65.4 mg, 0.16 mmol) were added DMSO (2 mL)/MeOH (1 mL). The resulting mixture was charged with CO at 25 psi and then stirred at 80 °C under an atmosphere of CO overnight. Reaction mixture was cooled to room temperature, filtered, and concentrated. The resulting residue was dissolved in EtOAc and washed with water. The organic layer was washed with brine and dried (Na<sub>2</sub>SO<sub>4</sub>). The crude was purified flash chromatography (1% MeOH/CH<sub>2</sub>Cl<sub>2</sub>) to give <b>23</b> (203 mg, 83% yield). MS (ESI) <i>m</i>/<i>z</i> 768.4 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, MeOH-<i>d</i><sub>4</sub>) δ ppm 7.94 (d, <i>J</i> = 5.77 Hz, 1H), 7.81 (d, <i>J</i> = 8.28 Hz, 1H), 7.58 (d, <i>J</i> = 7.03 Hz, 1H), 7.49 (d, <i>J</i> = 9.03 Hz, 1H), 7.41 (d, <i>J</i> = 5.77 Hz, 1H), 7.36 (d, <i>J</i> = 7.78 Hz, 1H), 7.16 (dd, <i>J</i> = 9.16, 2.13 Hz, 1H), 7.08 (s, 1H), 6.78 (d, <i>J</i> = 1.76 Hz, 1H), 6.64 (dd, <i>J</i> = 8.28, 1.76 Hz, 1H), 6.14 (s, 1H), 5.54–5.66 (m, 2H), 4.52 (t, <i>J</i> = 10.92 Hz, 1H), 3.85 (dd, <i>J</i> = 10.54, 4.27 Hz, 1H), 3.74 (s, 3H), 3.21 (d, <i>J</i> = 1.51 Hz, 2H), 3.20 (br s, 3H), 2.18 (s, 3H), 1.21 (d, <i>J</i> = 7.03 Hz, 3H), 1.15 (s, 18H).</div></div><div id="sec4_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> (2<i>R</i>,15<i>R</i>)-2-[(1-{Bis[(<i>tert</i>-butoxy)carbonyl]amino}isoquinolin-6-yl)amino]-4,15,17-trimethyl-3,12-dioxo-13-oxa-4,11-diazatricyclo[14.2.2.1<sup>6,10</sup>]henicosa-1(18),6,8,10(21),16,19-hexaene-7-carboxylic acid (<b>24</b>)</h4><div class="NLM_p last">To a solution of <b>23</b> (25 mg, 0.03 mmol) in THF (1 mL) was added 1.0 N LiOH (0.5 mL), and the reaction mixture was stirred overnight. It was quenched with saturated NH<sub>4</sub>Cl, extracted with EtOAC, washed with brine, and concentrated. The crude was purified by prep HPLC to give <b>24</b> (14 mg, 57% yield). MS (ESI) <i>m</i>/<i>z</i> 754.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 6-Amino-1-(di-<i>tert</i>-butoxycarbonylamino)-8-fluoroisoquinoline (<b>25a</b>)</h4><div class="NLM_p">To a solution of <b>29a</b> (21 mg, 0.06 mmol) in MeCN (2 mL) was added BOC<sub>2</sub>O (58 mg, 0.27 mmol) followed by DMAP (5 mg, 0.04 mmol), then the suspension was stirred overnight at room temperature. Solvent was removed under vacuum and the residue purified by silica gel chromatography (0–30% MeOH/CH<sub>2</sub>Cl<sub>2</sub>) to give the di-Boc intermediate (23 mg, 70% yield). MS (ESI) <i>m</i>/<i>z</i> 558.3 [M + H]<sup>+</sup>.</div><div class="NLM_p last">To the above di-Boc intermediate (77 mg, 0.14 mmol) in ethanol (20 mL) was added 20% palladium hydroxide on carbon (94 mg). The reaction mixture was hydrogenated (55 psi) for 4 h. The mixture was filtered and volatiles removed under reduced pressure to give <b>25a</b> (47 mg, 90% yield) as a yellow solid. MS (ESI) <i>m</i>/<i>z</i> 378.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.05 (d, <i>J</i> = 6.0 Hz, 1H), 7.41 (dd, <i>J</i> = 6.0, 2.8 Hz, 1H), 6.79 (dd, <i>J</i> = 15.0, 2.0 Hz, 1H), 6.65 (d, <i>J</i> = 2.0 Hz, 1H), 6.26 (s, 2H), 1.30 (s, 18H).</div></div><div id="sec4_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 6-Amino-1-(di-<i>tert</i>-butoxycarbonylamino)-7-fluoroisoquinoline (<b>25b</b>)</h4><div class="NLM_p last">Using a procedure similar to that described for <b>25a</b>, <b>29b</b> (50 mg, 0.14 mmol) was Boc-protected and then hydrogenated to give <b>25b</b> (80 mg, 74% yield) as a white solid. MS (ESI) <i>m</i>/<i>z</i> 378.1 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ ppm 8.25 (d, <i>J</i> = 5.77 Hz, 1H), 7.49 (d, <i>J</i> = 11.80 Hz, 1H), 7.37 (d, <i>J</i> = 5.77 Hz, 1H), 7.01 (d, <i>J</i> = 8.53 Hz, 1H), 4.34 (s, 2H), 1.35 (s, 18H).</div></div><div id="sec4_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> <i>tert</i>-Butyl <i>N</i>-(6-Amino-4-fluoroisoquinolin-1-yl)-<i>N</i>-[(<i>tert</i>-butoxy)carbonyl]carbamate (<b>25c</b>)</h4><div class="NLM_p">To <b>34</b> (205 mg, 1.0 mmol) suspended in MeCN (8.0 mL) were added TEA (0.55 mL, 4.0 mmol), DMAP (30 mg, 0.25 mmol), and Boc<sub>2</sub>O (1.0 M in THF, 3.0 mL, 3.0 mmol). The cloudy mixture turned clear in 20 min. The reaction was continued at room temperature for 6 h. It was then diluted with EtOAc, washed with 0.5 N HCl, satd sodium carbonate, and brine, and dried over Na<sub>2</sub>SO<sub>4</sub>. After evaporation of solvent, the residue was purified on silica gel cartridge eluting with 0–30% EtOAc in hexanes to give the di-Boc intermediate (266 mg, 66% yield) as a yellow solid. <sup>1</sup>H NMR (400 MHz, MeOH-<i>d</i><sub>4</sub>) δ ppm 9.06 (d, <i>J</i> = 2.20 Hz, 1H), 8.58 (dd, <i>J</i> = 9.23, 2.20 Hz, 1H), 8.51 (s, 1H), 8.27 (d, <i>J</i> = 9.23 Hz, 1H), 1.30 (s, 18H). <sup>19</sup>F NMR (376 MHz, MeOH-<i>d</i><sub>4</sub>) δ ppm −136.64 (s, 1F).</div><div class="NLM_p last">To the above di-Boc intermediate (266 mg, 0.65 mmol) in MeOH (8 mL) was added 10% Pd/C (150 mg) and 1.0 N HCl (0.075 mL, 0.075 mmol). The mixture was placed under a hydrogen balloon and stirred for 30 min. Pd/C was removed by filtration. and the filtrate was concentrated to give <b>25c</b> (245 mg, 99% yield) as a yellow solid. MS (ESI) <i>m</i>/<i>z</i> 378.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, MeCN-<i>d</i><sub>3</sub>) δ ppm 7.96 (d, <i>J</i> = 3.08 Hz, 1H), 7.65 (dd, <i>J</i> = 9.23, 2.20 Hz, 1H), 7.13 (dd, <i>J</i> = 9.23, 2.20 Hz, 1H), 6.95 (d, <i>J</i> = 2.20 Hz, 1H), 1.27 (s, 18H). <sup>19</sup>F NMR (376 MHz, MeCN-<i>d</i><sub>3</sub>) δ ppm −142.33 (s, 1F).</div></div><div id="sec4_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> <i>tert</i>-Butyl <i>N</i>-(6-{[({[5-Amino-2-(cyclopropanesulfonyl)phenyl]methyl}(methyl)carbamoyl)({4-[(2<i>R</i>)-1-hydroxypropan-2-yl]-3-methylphenyl})methyl]amino}-8-fluoroisoquinolin-1- yl)-<i>N</i>-[(<i>tert</i>-butoxy)carbonyl]carbamate (<b>27a</b>)</h4><div class="NLM_p last"><b>25a</b> (400 mg, 1.06 mmol), <b>16</b> (247 mg, 1.27 mmol), and glyoxylic acid monohydrate <b>17</b> (98 mg, 1.06 mmol) were dissolved in DMF (2 mL) and MeCN (4 mL). The reaction mixture was heated at 100 °C in the microwave for 10 min to generate a solution of <b>26a</b>, then allowed to cool to room temperature. To this solution were added sequentially <b>19c</b> (398 mg, 1.27 mmol), BOP (563 mg, 1.27 mmol), and TEA (1.48 mL, 10.6 mmol). The mixture was stirred at room temperature for 18 h. The reaction mixture was quenched with water (0.5 mL), diluted with EtOAc (150 mL), washed with water and brine, and dried (Na<sub>2</sub>SO<sub>4</sub>). The solvent was removed under reduced pressure. The crude product was purified by flash chromatography (0–100% EtOAc/hexanes) to give <b>27a</b> (460 mg, 54% yield) as an orange glass, which was lyophilized to give a powder. MS (ESI) <i>m</i>/<i>z</i> 806.7 [M + H]<sup>+</sup>. <sup>1</sup>H NMR was complicated by a pair of diastereomers and rotamers.</div></div><div id="sec4_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> <i>tert</i>-Butyl <i>N</i>-(6-{[({[5-Amino-2-(cyclopropanesulfonyl)phenyl]methyl}(methyl)carbamoyl)({4-[(2<i>R</i>)-1-hydroxypropan-2-yl]-3-methylphenyl})methyl]amino}-7-fluoroisoquinolin-1-yl)-<i>N</i>-[(<i>tert</i>-butoxy)carbonyl]carbamate (<b>27b</b>)</h4><div class="NLM_p last">In a procedure similar to that described for <b>27a</b>, replacing <b>25a</b> with <b>25b</b>, <b>27b</b> (288 mg, 38% yield) was obtained as a solid. MS (ESI) <i>m</i>/<i>z</i> 806.7 [M + H]<sup>+</sup>. <sup>1</sup>H NMR was complicated by a pair of diastereomers and rotamers. <sup>19</sup>F NMR (376 MHz, MeCN-<i>d</i><sub>3</sub>) δ ppm −130.36 (s, 1F).</div></div><div id="sec4_1_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> <i>tert</i>-Butyl <i>N</i>-(6-{[({[5-Amino-2-(cyclopropanesulfonyl)phenyl]methyl}(methyl)carbamoyl)({4-[(2<i>R</i>)-1-hydroxypropan-2-yl]-3-methylphenyl})methyl]amino}-4-fluoroisoquinolin-1-yl)-<i>N</i>-[(<i>tert</i>-butoxy)carbonyl]carbamate (<b>27c</b>)</h4><div class="NLM_p last">In a procedure similar to that described for <b>27a</b>, replacing <b>25a</b> with <b>25c</b>, <b>27c</b> (135 mg, 53% yield) was obtained as a white solid. MS (ESI) <i>m</i>/<i>z</i> 806.6 [M + H]<sup>+</sup>. <sup>1</sup>H NMR was complicated by a pair of diastereomers and rotamers.</div></div><div id="sec4_1_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> <i>N</i><sup>6</sup>,<i>N</i><sup>6</sup>-Dibenzyl-8-fluoroisoquinoline-1,6-diamine (<b>29a</b>)</h4><div class="NLM_p last">A mixture of <b>28a</b> (0.28 g, 0.79 mmol) and phosphorus oxychloride (3 mL) was heated at 100 °C for 1 h. The reaction mixture was concentrated under reduced pressure, then ice was added followed by 1.0 N sodium hydroxide until the pH was basic. The resulting solid was collected by filtration, washed with water, and dried in vacuo to give a chloride intermediate (0.33 g) as a yellow solid. A portion of this solid (0.1 g) was treated with a saturated solution of ammonia in ethylene glycol (4 mL) at 130 °C in an autoclave overnight. The mixture was concentrated under reduced pressure, and the residue was purified by silica gel chromatography (5% MeOH/CH<sub>2</sub>Cl<sub>2</sub>) to give <b>29a</b> (55 mg, 64% yield) as a brown solid. MS (ESI) <i>m</i>/<i>z</i> 358.4 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.65 (d, <i>J</i> = 6.0 Hz, 1H), 7.38–7.32 (m, 4H), 7.31–7.20 (m, 6H), 6.68–6.60 (m, 2H), 6.55 (d, <i>J</i> = 2.7 Hz, 1H), 4.71 (s, 4H).</div></div><div id="sec4_1_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> <i>N</i><sup>6</sup>,<i>N</i><sup>6</sup>-Dibenzyl-7-fluoroisoquinoline-1,6-diamine (<b>29b</b>)</h4><div class="NLM_p last">Using a procedure similar to that described for <b>29a</b>, <b>28b</b> (0.22 g, 0.61 mmol) was chlorinated and then reacted with ammonia to give <b>29b</b> (109 mg, 50% yield). MS (ESI) <i>m</i>/<i>z</i> 358.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 4-Fluoro-3-methoxy-6-nitro-3,4-dihydroisoquinolin-1(2<i>H</i>)-one (<b>31</b>)</h4><div class="NLM_p last">To <b>30</b> (6.5 g, 34 mmol) in MeCN (180 mL) and MeOH (180 mL) was added Selectfluor (15.4 g, 44 mmol). The mixture was heated at 82 °C for 1.5 h. Solvent was removed under vacuum. The crude was suspended in EtOAc, stirred with 160 mL of 0.5 N HCl, and the organic layer was collected. The aqueous layer was further extracted with EtOAc, and the combined organic layers were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated to yield <b>31</b> (8.1 g, 99% yield) as a brown solid. MS (ESI) <i>m</i>/<i>z</i> 241.4 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ ppm 8.56 (br, 1H), 8.11–8.38 (m, 3H), 5.83–5.99 (dd, <i>J</i> = 47.8, 3.85 Hz, 1H) and 5.38–5.54 (dd, <i>J</i> = 48.37, 2.2 Hz,1H), 4.89–4.97 (m, 2H) 3.39 and 3.38 (s, 3H). <sup>19</sup>F NMR (376 MHz, chloroform-<i>d</i>) δ −168.64 (d, <i>J</i> = 46.24 Hz) and −201.6 (d, <i>J</i> = 52.00 Hz). <sup>1</sup>H and <sup>19</sup>F NMR indicated a mixture of two diastereoisomers.</div></div><div id="sec4_1_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 4-Fluoro-6-nitroisoquinolin-1(2<i>H</i>)-one (<b>32</b>)</h4><div class="NLM_p last">To a solution of <b>31</b> (8.1 g, 33.7 mmol) in MeCN (100 mL) was added 4.0 N HCl in dioxane (25.3 mL, 101 mmol). The mixture was stirred at 65 °C for 1.5 h. Solvent was removed under reduced pressure to yield <b>32</b> (8.1 g, 98% yield) as a yellow solid. MS (ESI) <i>m</i>/<i>z</i> 209.2 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.38–8.46 (m, 2H), 8.31 (dd, <i>J</i> = 8.79, 2.20 Hz, 1H), 7.61 (d, <i>J</i> = 2.20 Hz, 1H). <sup>19</sup>F NMR (376 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm −160.17 (s, 1F).</div></div><div id="sec4_1_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 1-Chloro-4-fluoro-6-nitroisoquinoline (<b>33</b>)</h4><div class="NLM_p last">To <b>32</b> (8.8 g, 36.0 mmol) was added phosphoryl trichloride (59.3 mL, 648 mmol). The suspension was heated at 115 °C for 1.0 h. Solvent was removed under high vacuum. The residue was diluted with EtOAc, washed with satd NaHCO<sub>3</sub> and brine, and dried over Na<sub>2</sub>SO<sub>4</sub>. After evaporation of solvent, the residue was purified on silica gel cartridge which was eluted with EtOAc in hexanes using 15 min gradient from 2% to 25% to give <b>33</b> (8.5 g, 100% yield) as a slightly yellow solid. MS (ESI) <i>m</i>/<i>z</i> 227.1 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ ppm 9.01 (s, 1H), 8.46–8.56 (m, 2H), 8.34 (s, 1H). <sup>19</sup>F NMR (376 MHz, chloroform-<i>d</i>) δ ppm −136.54 (s, 1F).</div></div><div id="sec4_1_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 4-Fluoro-6-nitroisoquinolin-1-amine (<b>34</b>)</h4><div class="NLM_p last">A mixture of <b>33</b> (0.57 g, 2.5 mmol), BINAP (0.16 g, 0.25 mmol), and Pd(OAc)<sub>2</sub> (0.028 g, 0.13 mmol) in toluene (12 mL) was degassed with Ar for 10 min. To this mixture was added benzophenone imine (0.54 mL, 3.2 mmol) and Cs<sub>2</sub>CO<sub>3</sub> (312 mg, 3.2 mmol). The mixture was heated at 90 °C overnight. After cooling to room temperature, it was diluted with EtOAc/water/brine and filtered through a pad of wet Celite. The organic layer was collected and washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated to give the crude imine. The crude imine was dissolved in THF (15 mL) and treated with 4.0 N HCl (9.6 mL, 38 mmol) for 30 min. The mixture was diluted with EtOAc, the aqueous was collected, and the organic was further extracted with 4.0 N HCl (2 × 10 mL). The aqueous layers were combined and treated at 0 °C with 5.0 N NaOH to adjust the pH to 12–13. The precipitate formed was then collected by filtration and dried under a vacuum oven. It was then redissolved in MeOH/CH<sub>2</sub>Cl<sub>2</sub> and evaporated to dryness to give <b>34</b> (0.41 g, 79% yield) as a brown solid. (ESI) <i>m</i>/<i>z</i> 208.1 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.59 (d, <i>J</i> = 2.20 Hz, 1H), 8.51 (dd, <i>J</i> = 9.34, 2.20 Hz, 1H), 8.29 (dd, <i>J</i> = 9.34, 2.20 Hz, 1H), 7.99 (d, <i>J</i> = 2.20 Hz, 1H), 7.16 (s, 2H). <sup>19</sup>F NMR (376 MHz, MeOH-<i>d</i><sub>4</sub>) δ −156.53 (s, 1F).</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> Enzyme Affinity Assays</h3><div class="NLM_p">Factors IXa, Xa, XIa, and activated protein C (aPC) were purchased from Haematologic Technologies. Factor XIIa, plasmin, and recombinant single chain tissue-type plasminogen activator (tPA) were purchased from American Diagnostica. Plasma kallikrein and α-thrombin were purchased from Enzyme Research Laboratories. Urokinase was purchased from Abbott Laboratories. Tissue kallikrein-1 (HK-1) was purchased from Dr. Julie Chao, Medical University of South Carolina. Trypsin and chymotrypsin were purchased from Sigma-Aldrich. Recombinant factor VIIa was purchased from Novo Nordisk. Recombinant soluble tissue factor residues 1–219 were produced at Bristol-Myers Squibb.</div><div class="NLM_p">Factor XIa, factor XIIa, chymotrypsin, tPA, plasmin, and urokinase assays were conducted in 50 mM HEPES, pH 7.4, 145 mM sodium chloride, 5 mM potassium chloride, and 0.1% PEG 8000. Factor Xa, thrombin, trypsin, plasma kallikrein, HK-1, and aPC assays were conducted in 100 mM sodium phosphate, pH 7.4, 200 mM sodium chloride, and 0.5% PEG 8000. Factor VIIa assays were conducted in 50 mM HEPES, pH 7.4, 150 mM sodium chloride, 5 mM calcium chloride, and 0.1% PEG 8000. Factor IXa assays were conducted in 50 mM TRIS, pH 7.4, 100 mM sodium chloride, 5 mM calcium chloride, 0.5% PEG 8000, and 2% DMSO. The peptide substrates were: pyro-Glu-Pro-Arg-pNA(<i>para</i>-nitroaniline) (Diapharma) for factor XIa, thrombin, and aPC; <i>N</i>-benzoyl-Ile-Glu-(OH,OMe)-Gly-Arg-pNA (Diapharma) for factor Xa and trypsin; methylsulfonyl-<span class="smallcaps smallerCapital">d</span>-cyclohexylglycyl-Gly-Arg-AMC(7-amino-4-methylcoumarin) (Pentapharm) for factor IXa; H-(<span class="smallcaps smallerCapital">d</span>)-Ile-Pro-Arg-pNA (Diapharma) for factor VIIa; H-(<span class="smallcaps smallerCapital">d</span>)-CHT-Gly-Arg-pNA (American Diagnostica) for factor XIIa; H-(<span class="smallcaps smallerCapital">d</span>)-Pro-Phe-Arg-pNA (Diapharma) for plasma kallikrein; MeO-Suc-Arg-Pro-Tyr-pNA (Diapharma) for chymotrypsin; H-(<span class="smallcaps smallerCapital">d</span>)-Val-Leu-Lys-pNA (Diapharma) for plasmin; Methylsulfonyl-<span class="smallcaps smallerCapital">d</span>-cyclohexylalanyl-Gly-Arg-pNA (American Diagnostica) for tPA; pyro-Glu-Gly-Arg-pNA (Diapharma) for urokinase; H-<span class="smallcaps smallerCapital">d</span>-Val-Leu-Arg-AFC(7-amino-4-trifluoromethylcoumarin) (Calbiochem) for tissue kallikrein-1.</div><div class="NLM_p">All assays were conducted at room temperature except where noted in 96-well microtiter plate spectrophotometers or spectrofluorimeters (Molecular Devices) with simultaneous measurement of enzyme activities in control and inhibitor containing solutions. Compounds were dissolved and diluted in DMSO and analyzed at a final concentration of 1% DMSO except where noted. Assays were initiated by adding enzyme to buffered solutions containing substrate in the presence or absence of inhibitor. Hydrolysis of the substrate resulted in the release of pNA (<i>para</i>-nitroaniline), which was monitored spectrophotometrically by measuring the increase in absorbance at 405 nm, or the release of AMC (7-amino-4-methylcoumarin), which was monitored spectrofluorometrically by measuring the increase in emission at 460 nm with excitation at 380 nm, or the release of AFC (7-amino-4-trifluoromethylcoumarin), which was monitored spectrofluorometrically by measuring the increase in emission at 505 nm with excitation at 400 nm. The rate of absorbance or fluorescence change is proportional to enzyme activity. A decrease in the rate of absorbance or fluorescence change in the presence of inhibitor is indicative of enzyme inhibition. Assays were conducted under conditions of excess substrate and inhibitor over enzyme. The Michaelis constant, <i>K</i><sub>m</sub>, for substrate hydrolysis by each protease was determined by fitting data from independent measurements at several substrate concentrations to the Michaelis–Menten equation: <i>v</i> = (<i>V</i><sub>max</sub>*[S])/(K<sub>m</sub> + [S]) where <i>v</i> is the observed velocity of the reaction, <i>V</i><sub>max</sub> is the maximal velocity, [S] is the concentration of substrate, and <i>K</i><sub>m</sub> is the Michaelis constant for the substrate.</div><div class="NLM_p">Values of IC<sub>50</sub> were determined by allowing the protease to react with the substrate in the presence of the inhibitor. Reactions were allowed to go for periods of 10–120 min (depending on the protease) and the velocities (rate of absorbance or fluorescence change versus time) were measured.</div><div class="NLM_p">The following relationships were used to calculate IC<sub>50</sub> values: <i>v</i><sub>s</sub>/<i>v</i><sub>o</sub> = <i>A</i> + ((<i>B</i> – <i>A</i>)/(1 + (IC<sub>50</sub>/<i>I</i>)<sup><i>n</i></sup>)), where <i>v</i><sub>o</sub> is the velocity of the control in the absence of inhibitor, <i>v</i><sub>s</sub> is the velocity in the presence of inhibitor, <i>I</i> is the concentration of inhibitor, <i>A</i> is the minimum activity remaining (usually locked at zero), <i>B</i> is the maximum activity remaining (usually locked at 1.0), <i>n</i> is the Hill coefficient, a measure of the number and cooperativity of potential inhibitor binding sites, and IC<sub>50</sub> is the concentration of inhibitor that produces 50% inhibition.</div><div class="NLM_p">When negligible enzyme inhibition was observed at the highest inhibitor concentration tested, the value assigned as a lower limit for IC<sub>50</sub> is the value that would be obtained with either 25% or 50% inhibition at the highest inhibitor concentration. In all other cases, IC<sub>50</sub> values represent the average of duplicate determinations obtained over 8–11 concentrations. The intraassay and interassay variabilities are 5% and 20%, respectively. Competitive inhibition was assumed for all proteases. IC<sub>50</sub> values were converted to <i>K</i><sub>i</sub> values by the relationship:</div><span class="NLM_disp-formula" id="eq1"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00469/20160811/images/jm-2016-004697_m001.gif" alt="" /></img><span class="labelSpan">(1)</span></span></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> FVIIa-Xase <i>K</i><sub>i</sub> (37 °C) Determination</h3><div class="NLM_p last">S2765 (0.5 mM), PCPS (phosphatidylcholine phosphatidylserine, 25 μM), calcium chloride (5 mM), full-length human TF (3 nM), human FVIIa (5 pM), and FVIIa inhibitor were incubated for 15 min at 37 °C. Reactions were initiated by the addition of human FX (range of concentrations). Preliminary experiments revealed that the plasma purified FX contains a residual amount of human FVIIa which could not be removed by affinity chromatography. The residual FVIIa is sufficient when combined with PCPS, calcium, and TF to catalyze the conversion of FX to Xa and was increased by the addition of 5 pM human FVIIa. FXa in turn hydrolyses S2765, which was monitored for 60 min at 405 nm. FXase activity was derived from the parabolic change in absorbance over time according to <a class="ref internalNav" href="#eq2" aria-label="eq 2">eq 2</a>:<span class="NLM_disp-formula" id="eq2"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00469/20160811/images/jm-2016-004697_m002.gif" alt="" /></img><span class="labelSpan">(2)</span></span>where <i>a</i> is proportional to the rate of FX activation ≡ product ≡ <i>v</i><sub>s</sub>, <i>b</i> is proportional to the hydrolysis of S2765 in the absence of FXa, and <i>c</i> is the absorbance at <i>t</i> = 0. Steady-state reaction velocity data (<i>v</i><sub>s</sub>) was globally fit to <a class="ref internalNav" href="#eq3" aria-label="eq 3">eq 3</a> for noncompetitive inhibition modified for contaminating enzyme (FVIIa) in the substrate (FX) as<span class="NLM_disp-formula" id="eq3"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00469/20160811/images/jm-2016-004697_m003.gif" alt="" /></img><span class="labelSpan">(3)</span></span>where <i>k</i><sub>cat</sub> is the enzyme turnover rate, <i>E</i> is the concentration of enzyme added, <i>f</i> is the molar fraction of enzyme contained in the substrate, and the rest as defined above.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> Anticlotting Assays</h3><div class="NLM_p last">Anticlotting assays were performed in a temperature-controlled automated coagulation device (Sysmex CA-6000 or CA-1500, Dade-Behring). Blood was obtained from healthy volunteers by venipuncture and anticoagulated with one-tenth volume 0.11 M buffered sodium citrate (Vacutainer, Becton Dickinson). Plasma was obtained after centrifugation at 2000<i>g</i> for 10 min and kept on ice prior to use. An initial stock solution of the inhibitor at 10 mM was prepared in DMSO. Subsequent dilutions were done in plasma. Clotting time was determined on control plasma and plasma containing up to seven different concentrations of inhibitor. FVIIa deficient PT (FVII def PT) was performed by mixing human FVII immunodepleted plasma with normal pooled plasma from different species to produce a clotting time of about 40 seconds (s). Plasma (50 μL) was warmed to 37 °C for 3 min before adding thromboplastin (100 μL, Thromboplastin C Plus, Dade-Behring, Illinois) to initiate coagulation. Determinations were performed in duplicate and expressed as a mean ratio of treated vs baseline control. The concentrations required to prolong clotting time by 2-fold (EC<sub>2<i>x</i></sub>) were calculated by linear interpolation (Microsoft Excel, Redmond, WA, USA) and are expressed as total plasma concentrations, not final assay concentrations after addition of clotting assay reagents.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> In Vivo Electrically Induced Carotid Artery Thrombosis (ECAT) Model</h3><div class="NLM_p">The in vivo studies in rabbit ECAT model and the calculation of % thrombus reduction were performed according to the published protocols.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Male New Zealand White rabbits were anesthetized with ketamine (50 mg/kg + 50 mg/kg/h IM) and xylazine (10 mg/kg + 10 mg/kg/h IM). These anesthetics were supplemented as needed. An electromagnetic flow probe was placed on a segment of an isolated carotid artery to monitor blood flow. Test agents or vehicle was administered by intravenous (IV) infusion prior to or after the initiation of thrombosis. Drug treatment prior to initiation of thrombosis was used to model the ability of test agents to prevent and reduce the risk of thrombus formation, whereas dosing after initiation was used to model the ability to treat existing thrombotic disease. Thrombus formation was induced by electrical stimulation of the carotid artery for 3 min at 4 mA using an external stainless steel bipolar electrode. Carotid blood flow was measured continuously over a 90 min period to monitor thrombus-induced occlusion. Total carotid blood flow over 90 min is calculated by the trapezoidal rule. Average carotid flow over 90 min is then determined by converting total carotid blood flow over 90 min to percent of total control carotid blood flow, which would result if control blood flow had been maintained continuously for 90 min. The EC<sub>50</sub> (dose that increased average carotid blood flow over 90 min to 50% of the control) of compounds are estimated by a nonlinear least-squares regression program using the Hill sigmoid <i>E</i><sub>max</sub> equation (DeltaGraph; SPSS Inc., Chicago, IL).<span class="NLM_disp-formula" id="eq4"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00469/20160811/images/jm-2016-004697_m004.gif" alt="" /></img><span class="labelSpan">(4)</span></span></div><div class="NLM_p last">EC<sub>50</sub> was determined using the four-parameter logistic equation <i>y</i> = <i>A</i> + ((<i>B</i> – <i>A</i>)/(1 + ((<i>C</i>/<i>x</i>)<i>D</i>))), where <i>A</i> = minimum <i>y</i> value, <i>B</i> = maximum, <i>C</i> = Log IC<sub>50</sub>, and <i>D</i> = slope factor. The logistic fit was analyzed by Prism-5 for Windows (GraphPad Software, San Diego, CA).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i54"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00469">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46482" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46482" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b00469" class="ext-link">10.1021/acs.jmedchem.6b00469</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Descriptions of biological assays, syntheses and characterization data for <b>19b</b>,<b>c</b> and <b>21a</b>,<b>b</b>, key compound characterization of <b>13</b>. (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00469/suppl_file/jm6b00469_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00469/suppl_file/jm6b00469_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00469/suppl_file/jm6b00469_si_001.pdf">jm6b00469_si_001.pdf (1.5 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00469/suppl_file/jm6b00469_si_002.csv">jm6b00469_si_002.csv (1.86 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.6b00469" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12786" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12786" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaojun Zhang</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb R&D, 350 Carter
Road, Hopewell, New Jersey 08540, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#245c4d454b4e514a0a5e4c454a43644649570a474b49"><span class="__cf_email__" data-cfemail="0b73626a64617e652571636a656c4b69667825686466">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter W. Glunz</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb R&D, 350 Carter
Road, Hopewell, New Jersey 08540, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James A. Johnson</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb R&D, 350 Carter
Road, Hopewell, New Jersey 08540, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wen Jiang</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb R&D, 350 Carter
Road, Hopewell, New Jersey 08540, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Swanee Jacutin-Porte</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb R&D, 350 Carter
Road, Hopewell, New Jersey 08540, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vladimir Ladziata</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb R&D, 350 Carter
Road, Hopewell, New Jersey 08540, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yan Zou</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb R&D, 350 Carter
Road, Hopewell, New Jersey 08540, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Monique S. Phillips</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb R&D, 350 Carter
Road, Hopewell, New Jersey 08540, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nicholas R. Wurtz</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb R&D, 350 Carter
Road, Hopewell, New Jersey 08540, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brandon Parkhurst</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb R&D, 350 Carter
Road, Hopewell, New Jersey 08540, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alan R. Rendina</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb R&D, 311 Pennington-Rocky
Hill Road, Pennington, New
Jersey 08534-2130, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Timothy M. Harper</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb R&D, 311 Pennington-Rocky
Hill Road, Pennington, New
Jersey 08534-2130, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel L. Cheney</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb R&D, 350 Carter
Road, Hopewell, New Jersey 08540, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joseph M. Luettgen</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb R&D, 311 Pennington-Rocky
Hill Road, Pennington, New
Jersey 08534-2130, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pancras C. Wong</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb R&D, 311 Pennington-Rocky
Hill Road, Pennington, New
Jersey 08534-2130, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dietmar Seiffert</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb R&D, 311 Pennington-Rocky
Hill Road, Pennington, New
Jersey 08534-2130, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ruth R. Wexler</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb R&D, 350 Carter
Road, Hopewell, New Jersey 08540, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">E. Scott Priestley</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb R&D, 350 Carter
Road, Hopewell, New Jersey 08540, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br><sup>§</sup>Yan Zou was deceased on March 21, 2014<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e4942-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i56">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38384" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38384" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Jeff Bozarth, Randi Brown, Sara Peterson, and Mojgan Abousleiman for obtaining the enzyme inhibition data, and Frank Barbera and Yiming Wu for obtaining the clotting assay data. We also thank Atsu Apedo, Gottfried Wenke, and the SPS group for carrying out chiral separation and p<i>K</i><sub>a</sub> measurement. We thank colleagues at the BMS-Biocon Research Center for synthesis of several intermediates.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i57" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i57"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i58" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i58"> Abbreviations Used</h2><tr><td class="NLM_term">TF-FVIIa</td><td class="NLM_def"><p class="first last">tissue factor–factor VIIa</p></td></tr><tr><td class="NLM_term">FIXa</td><td class="NLM_def"><p class="first last">factor IXa</p></td></tr><tr><td class="NLM_term">FXa</td><td class="NLM_def"><p class="first last">factor Xa</p></td></tr><tr><td class="NLM_term">FXIa</td><td class="NLM_def"><p class="first last">factor XIa</p></td></tr><tr><td class="NLM_term">FXIIa</td><td class="NLM_def"><p class="first last">factor XIIa</p></td></tr><tr><td class="NLM_term">aPC</td><td class="NLM_def"><p class="first last">active protein C</p></td></tr><tr><td class="NLM_term">HK-1</td><td class="NLM_def"><p class="first last">human tissue kallikrein 1</p></td></tr><tr><td class="NLM_term">tPA</td><td class="NLM_def"><p class="first last">tissue plasminogen activator</p></td></tr><tr><td class="NLM_term">ECAT</td><td class="NLM_def"><p class="first last">electrically induced carotid arterial thrombosis</p></td></tr><tr><td class="NLM_term">dppp</td><td class="NLM_def"><p class="first last">1,3-bis(diphenylphosphino)propane</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last">1-[bis(dimethylamino)methylene]-1<i>H</i>-1,2,3-triazolo[4,5-<i>b</i>]pyridinium 3-oxid hexafluorophosphate</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i59">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00336" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00336" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 36 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Henry, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, R. U.</span><span> </span><span class="NLM_article-title">Recent research developments in the direct inhibition of coagulation proteinases - inhibitors of the initiation phase</span> <span class="citation_source-journal">Cardiovasc. Hematol. Agents Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">323</span><span class="NLM_x">–</span> <span class="NLM_lpage">336</span><span class="refDoi"> DOI: 10.2174/187152508785909519</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=10.2174%2F187152508785909519" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2008&pages=323-336&author=L.+B.+Henryauthor=R.+U.+Desai&title=Recent+research+developments+in+the+direct+inhibition+of+coagulation+proteinases+-+inhibitors+of+the+initiation+phase&doi=10.2174%2F187152508785909519"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.2174%2F187152508785909519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152508785909519%26sid%3Dliteratum%253Aachs%26aulast%3DHenry%26aufirst%3DL.%2BB.%26aulast%3DDesai%26aufirst%3DR.%2BU.%26atitle%3DRecent%2520research%2520developments%2520in%2520the%2520direct%2520inhibition%2520of%2520coagulation%2520proteinases%2520-%2520inhibitors%2520of%2520the%2520initiation%2520phase%26jtitle%3DCardiovasc.%2520Hematol.%2520Agents%2520Med.%2520Chem.%26date%3D2008%26volume%3D6%26spage%3D323%26epage%3D336%26doi%3D10.2174%2F187152508785909519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Soejima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuguchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuguchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwanaga, S.</span><span> </span><span class="NLM_article-title">Factor VIIa modified in the 170 loop shows enhanced catalytic activity but does not change the zymogen-like property</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">17229</span><span class="NLM_x">–</span> <span class="NLM_lpage">17235</span><span class="refDoi"> DOI: 10.1074/jbc.M009206200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=10.1074%2Fjbc.M009206200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=17229-17235&author=K.+Soejimaauthor=J.+Mizuguchiauthor=M.+Yuguchiauthor=T.+Nakagakiauthor=S.+Higashiauthor=S.+Iwanaga&title=Factor+VIIa+modified+in+the+170+loop+shows+enhanced+catalytic+activity+but+does+not+change+the+zymogen-like+property&doi=10.1074%2Fjbc.M009206200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M009206200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M009206200%26sid%3Dliteratum%253Aachs%26aulast%3DSoejima%26aufirst%3DK.%26aulast%3DMizuguchi%26aufirst%3DJ.%26aulast%3DYuguchi%26aufirst%3DM.%26aulast%3DNakagaki%26aufirst%3DT.%26aulast%3DHigashi%26aufirst%3DS.%26aulast%3DIwanaga%26aufirst%3DS.%26atitle%3DFactor%2520VIIa%2520modified%2520in%2520the%2520170%2520loop%2520shows%2520enhanced%2520catalytic%2520activity%2520but%2520does%2520not%2520change%2520the%2520zymogen-like%2520property%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D17229%26epage%3D17235%26doi%3D10.1074%2Fjbc.M009206200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Golino, P.</span><span> </span><span class="NLM_article-title">The inhibitors of the tissue factor:factor VII pathway</span> <span class="citation_source-journal">Thromb. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">V257</span><span class="NLM_x">–</span> <span class="NLM_lpage">V265</span><span class="refDoi"> DOI: 10.1016/S0049-3848(02)00079-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=10.1016%2FS0049-3848%2802%2900079-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2002&pages=V257-V265&author=P.+Golino&title=The+inhibitors+of+the+tissue+factor%3Afactor+VII+pathway&doi=10.1016%2FS0049-3848%2802%2900079-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS0049-3848%2802%2900079-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0049-3848%252802%252900079-8%26sid%3Dliteratum%253Aachs%26aulast%3DGolino%26aufirst%3DP.%26atitle%3DThe%2520inhibitors%2520of%2520the%2520tissue%2520factor%253Afactor%2520VII%2520pathway%26jtitle%3DThromb.%2520Res.%26date%3D2002%26volume%3D106%26spage%3DV257%26epage%3DV265%26doi%3D10.1016%2FS0049-3848%2802%2900079-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Houston, D. S.</span><span> </span><span class="NLM_article-title">Tissue factor - a therapeutic target for thrombotic disorders</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">174</span><span class="refDoi"> DOI: 10.1517/14728222.6.2.159</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=10.1517%2F14728222.6.2.159" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=12223078" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=1%3ACAS%3A528%3ADC%252BD38Xjs1KhtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2002&pages=159-174&author=D.+S.+Houston&title=Tissue+factor+-+a+therapeutic+target+for+thrombotic+disorders&doi=10.1517%2F14728222.6.2.159"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Tissue factor - a therapeutic target for thrombotic disorders</span></div><div class="casAuthors">Houston, Donald S.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">159-174</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Exposure of blood to tissue factor (TF) sets off the coagulation cascade.  TF is a transmembrane protein that serves as an essential cofactor for activated coagulation factor VII (FVIIa).  TF may be exposed locally by vascular injury (such as balloon angioplasty) or by spontaneous rupture of an atherosclerotic plaque.  Expression of TF may also be induced on monocytes and endothelial cells in conditions like sepsis and cancer, causing a more generalized activation of clotting.  TF may thus play a central role in thrombosis in a no. of settings, and attention has turned to blocking TF as a means to prevent thrombosis.  Inhibiting the inducible expression of TF by monocytes can be achieved by "deactivating" cytokines, such as interleukin (IL)-4, -10 and -13, or by certain prostanoids; by drugs that modify signal transduction, such as pentoxifylline, retinoic acid or vitamin D3, or by antisense oligonucleotides.  Such approaches are for the most part at a preclin. stage.  The function of TF can be blocked by antibodies that prevent the binding of FVIIa to TF; by active site-inhibited FVIIa, which competes with native FVIIa for binding; by antibodies or small mols. that block the function of the TF/FVIIa complex; and by mols., such as TF pathway inhibitor or nematode anticoagulant peptide C2, which inhibit the active site of FVIIa in the TF/FVIIa complex after first binding to activated factor X.  The latter two agents have entered Phase II clin. trials.  Perhaps most intriguing is the use of anti-TF agents locally, which holds the promise of stopping thrombosis at a specific site of injury without the bleeding risk assocd. with systemic anticoagulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwePXJMpIGx7Vg90H21EOLACvtfcHk0lgaMIIo7yT5ZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xjs1KhtLs%253D&md5=eff403c5cf411f1d4e006fd253126b43</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1517%2F14728222.6.2.159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.6.2.159%26sid%3Dliteratum%253Aachs%26aulast%3DHouston%26aufirst%3DD.%2BS.%26atitle%3DTissue%2520factor%2520-%2520a%2520therapeutic%2520target%2520for%2520thrombotic%2520disorders%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2002%26volume%3D6%26spage%3D159%26epage%3D174%26doi%3D10.1517%2F14728222.6.2.159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Arnold, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Upshaw, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prydz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chand, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotian, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bantia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu, Y. S.</span><span> </span><span class="NLM_article-title">The antithrombotic and anti-inflammatory effects of BCX-3607, a small molecule tissue factor/factor VIIa inhibitor</span> <span class="citation_source-journal">Thromb. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">343</span><span class="NLM_x">–</span> <span class="NLM_lpage">349</span><span class="refDoi"> DOI: 10.1016/j.thromres.2005.03.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=10.1016%2Fj.thromres.2005.03.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=16378835" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=1%3ACAS%3A528%3ADC%252BD28XksVyj" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2006&pages=343-349&author=C.+S.+Arnoldauthor=C.+Parkerauthor=R.+Upshawauthor=H.+Prydzauthor=P.+Chandauthor=P.+Kotianauthor=S.+Bantiaauthor=Y.+S.+Babu&title=The+antithrombotic+and+anti-inflammatory+effects+of+BCX-3607%2C+a+small+molecule+tissue+factor%2Ffactor+VIIa+inhibitor&doi=10.1016%2Fj.thromres.2005.03.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The antithrombotic and anti-inflammatory effects of BCX-3607, a small molecule tissue factor/factor VIIa inhibitor</span></div><div class="casAuthors">Arnold, C. Shane; Parker, Cynthia; Upshaw, Ramanda; Prydz, Hans; Chand, Pooran; Kotian, Pravin; Bantia, Shanta; Babu, Y. Sudhakar</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">343-349</span>CODEN:
                <span class="NLM_cas:coden">THBRAA</span>;
        ISSN:<span class="NLM_cas:issn">0049-3848</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Tissue factor (TF) is a transmembrane glycoprotein that binds its zymogen cofactor, Factor VIIa (FVIIa) on the cell surface.  Together (TF/FVIIa) they activate Factor X (FX) and Factor IX (FIX) and start the extrinsic pathway of blood coagulation.  As such, the TF/FVIIa complex plays an important role in normal physiol. as well as in thrombotic diseases such as unstable angina (UA), disseminated intravascular coagulation (DIC), and deep vein thrombosis (DVT).  In addn. to its function as an initiator of coagulation, TF/FVIIa plays an important role in inflammation.  Expression of TF on the cell surface and its appearance as a sol. mol. are characteristic features of acute and chronic inflammation in conditions such as sepsis and atherosclerosis.  Here we demonstrate that BCX-3607, a small mol. potent inhibitor of TF/FVIIa, reduces thrombus wt. in an animal model of DVT.  BCX-3607 also decreases the level of interleukin-6 (IL-6) in a LPS-stimulated mouse model of endotoxemia.  Addnl., in vitro studies indicate that BCX-3607 blocks the generation of TF/FVIIa-induced IL-8 mRNA in human keratinocytes and reduces the TF/FVIIa-mediated generation of IL-6 and IL-8 in human umbilical vein endothelial cells (HUVEC).  Therefore, BCX-3607 might block the TF/FVIIa-mediated coagulation and inflammation assocd. with pathol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPjwtCzXOm2LVg90H21EOLACvtfcHk0lgaMIIo7yT5ZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XksVyj&md5=4252b9eb75f303c34b111a0db12a62d3</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.thromres.2005.03.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.thromres.2005.03.015%26sid%3Dliteratum%253Aachs%26aulast%3DArnold%26aufirst%3DC.%2BS.%26aulast%3DParker%26aufirst%3DC.%26aulast%3DUpshaw%26aufirst%3DR.%26aulast%3DPrydz%26aufirst%3DH.%26aulast%3DChand%26aufirst%3DP.%26aulast%3DKotian%26aufirst%3DP.%26aulast%3DBantia%26aufirst%3DS.%26aulast%3DBabu%26aufirst%3DY.%2BS.%26atitle%3DThe%2520antithrombotic%2520and%2520anti-inflammatory%2520effects%2520of%2520BCX-3607%252C%2520a%2520small%2520molecule%2520tissue%2520factor%252Ffactor%2520VIIa%2520inhibitor%26jtitle%3DThromb.%2520Res.%26date%3D2006%26volume%3D117%26spage%3D343%26epage%3D349%26doi%3D10.1016%2Fj.thromres.2005.03.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Olivero, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eigenbrot, C. G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldsmith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robarge, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artis, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flygare, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rawson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutherlin, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadkhodayan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beresini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, L. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeGuzman, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banner, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ultsch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marzec, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanson, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Refino, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunting, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirchhofer, D.</span><span> </span><span class="NLM_article-title">A selective, slow binding inhibitor of factor VIIa binds to a nonstandard active site conformation and attenuates thrombus formation in vivo</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">9160</span><span class="NLM_x">–</span> <span class="NLM_lpage">9169</span><span class="refDoi"> DOI: 10.1074/jbc.M409068200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=10.1074%2Fjbc.M409068200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=15632123" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitVCitLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=9160-9169&author=A.+G.+Oliveroauthor=C.+G.+R.+Eigenbrotauthor=R.+Goldsmithauthor=K.+Robargeauthor=D.+R.+Artisauthor=J.+Flygareauthor=T.+Rawsonauthor=D.+P.+Sutherlinauthor=S.+Kadkhodayanauthor=M.+Beresiniauthor=L.+O.+Elliottauthor=G.+G.+DeGuzmanauthor=D.+W.+Bannerauthor=M.+Ultschauthor=U.+Marzecauthor=S.+R.+Hansonauthor=C.+Refinoauthor=S.+Buntingauthor=D.+Kirchhofer&title=A+selective%2C+slow+binding+inhibitor+of+factor+VIIa+binds+to+a+nonstandard+active+site+conformation+and+attenuates+thrombus+formation+in+vivo&doi=10.1074%2Fjbc.M409068200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">A Selective, Slow Binding Inhibitor of Factor VIIa Binds to a Nonstandard Active Site Conformation and Attenuates Thrombus Formation in Vivo</span></div><div class="casAuthors">Olivero, Alan G.; Eigenbrot, Charles; Goldsmith, Richard; Robarge, Kirk; Artis, Dean R.; Flygare, John; Rawson, Thomas; Sutherlin, Daniel P.; Kadkhodayan, Saloumeh; Beresini, Maureen; Elliott, Linda O.; DeGuzman, Geralyn G.; Banner, David W.; Ultsch, Mark; Marzec, Ulla; Hanson, Stephen R.; Refino, Canio; Bunting, Stuart; Kirchhofer, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">9160-9169</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The serine protease factor VIIa (FVIIa) in complex with its cellular cofactor tissue factor (TF) initiates the blood coagulation reactions.  TF·FVIIa is also implicated in thrombosis-related disorders and constitutes an appealing therapeutic target for treatment of cardiovascular diseases.  To this end, we generated the FVIIa active site inhibitor G17905, which displayed great potency toward TF·FVIIa (Ki = 0.35 ± 0.11 nM).  G17905 did not appreciably inhibit 12 of the 14 examd. trypsin-like serine proteases, consistent with its TF·FVIIa-specific activity in clotting assays.  The crystal structure of the FVIIa·G17905 complex provides insight into the mol. basis of the high selectivity.  It shows that compared with other serine proteases, FVIIa is uniquely equipped to accommodate conformational disturbances in the Gln217-Gly219 region caused by the ortho-hydroxy group of the inhibitor's aminobenzamidine moiety located in the S1 recognition pocket.  Moreover, the structure revealed a novel, nonstandard conformation of FVIIa active site in the region of the oxyanion hole, a "flipped" Lys192-Gly193 peptide bond.  Macromol. substrate activation assays demonstrated that G17905 is a noncompetitive, slow-binding inhibitor.  Nevertheless, G17905 effectively inhibited thrombus formation in a baboon arterio-venous shunt model, reducing platelet and fibrin deposition by ∼70% at 0.4 mg/kg + 0.1 mg/kg/min infusion.  Therefore, the in vitro potency of G17905, characterized by slow binding kinetics, correlated with efficacious antithrombotic activity in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqBsqLvuUrX7Vg90H21EOLACvtfcHk0lgaMIIo7yT5ZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitVCitLc%253D&md5=55ce1fbbe36808a4c495f9c6768e2397</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M409068200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M409068200%26sid%3Dliteratum%253Aachs%26aulast%3DOlivero%26aufirst%3DA.%2BG.%26aulast%3DEigenbrot%26aufirst%3DC.%2BG.%2BR.%26aulast%3DGoldsmith%26aufirst%3DR.%26aulast%3DRobarge%26aufirst%3DK.%26aulast%3DArtis%26aufirst%3DD.%2BR.%26aulast%3DFlygare%26aufirst%3DJ.%26aulast%3DRawson%26aufirst%3DT.%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26aulast%3DKadkhodayan%26aufirst%3DS.%26aulast%3DBeresini%26aufirst%3DM.%26aulast%3DElliott%26aufirst%3DL.%2BO.%26aulast%3DDeGuzman%26aufirst%3DG.%2BG.%26aulast%3DBanner%26aufirst%3DD.%2BW.%26aulast%3DUltsch%26aufirst%3DM.%26aulast%3DMarzec%26aufirst%3DU.%26aulast%3DHanson%26aufirst%3DS.%2BR.%26aulast%3DRefino%26aufirst%3DC.%26aulast%3DBunting%26aufirst%3DS.%26aulast%3DKirchhofer%26aufirst%3DD.%26atitle%3DA%2520selective%252C%2520slow%2520binding%2520inhibitor%2520of%2520factor%2520VIIa%2520binds%2520to%2520a%2520nonstandard%2520active%2520site%2520conformation%2520and%2520attenuates%2520thrombus%2520formation%2520in%2520vivo%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D9160%26epage%3D9169%26doi%3D10.1074%2Fjbc.M409068200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Salyers, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szalony, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suleymanov, O. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parlow, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">South, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholson, N. S.</span><span> </span><span class="NLM_article-title">Assessment of bleeding propensity in non-human primates by combination of selective tissue factor/VIIa inhibition and aspirin compared to warfarin and aspirin treatment</span> <span class="citation_source-journal">Pharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">100</span><span class="NLM_x">–</span> <span class="NLM_lpage">106</span><span class="refDoi"> DOI: 10.1159/000074674</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=10.1159%2F000074674" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2004&pages=100-106&author=A.+K.+Salyersauthor=J.+A.+Szalonyauthor=O.+D.+Suleymanovauthor=J.+J.+Parlowauthor=R.+S.+Woodauthor=M.+S.+Southauthor=N.+S.+Nicholson&title=Assessment+of+bleeding+propensity+in+non-human+primates+by+combination+of+selective+tissue+factor%2FVIIa+inhibition+and+aspirin+compared+to+warfarin+and+aspirin+treatment&doi=10.1159%2F000074674"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1159%2F000074674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000074674%26sid%3Dliteratum%253Aachs%26aulast%3DSalyers%26aufirst%3DA.%2BK.%26aulast%3DSzalony%26aufirst%3DJ.%2BA.%26aulast%3DSuleymanov%26aufirst%3DO.%2BD.%26aulast%3DParlow%26aufirst%3DJ.%2BJ.%26aulast%3DWood%26aufirst%3DR.%2BS.%26aulast%3DSouth%26aufirst%3DM.%2BS.%26aulast%3DNicholson%26aufirst%3DN.%2BS.%26atitle%3DAssessment%2520of%2520bleeding%2520propensity%2520in%2520non-human%2520primates%2520by%2520combination%2520of%2520selective%2520tissue%2520factor%252FVIIa%2520inhibition%2520and%2520aspirin%2520compared%2520to%2520warfarin%2520and%2520aspirin%2520treatment%26jtitle%3DPharmacology%26date%3D2004%26volume%3D70%26spage%3D100%26epage%3D106%26doi%3D10.1159%2F000074674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Suleymanov, O. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szalony, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salyers, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lachance, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parlow, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">South, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholson, N. S.</span><span> </span><span class="NLM_article-title">Pharmacological interruption of acute thrombus formation with minimal hemorrhagic complications by a small molecule tissue factor/factor VIIa inhibitor: Comparison to factor Xa and thrombin inhibition in a nonhuman primate thrombosis model</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">306</span><span class="NLM_x">, </span> <span class="NLM_fpage">1115</span><span class="NLM_x">–</span> <span class="NLM_lpage">1121</span><span class="refDoi"> DOI: 10.1124/jpet.103.052779</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=10.1124%2Fjpet.103.052779" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=12829728" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmvVehtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=306&publication_year=2003&pages=1115-1121&author=O.+D.+Suleymanovauthor=J.+A.+Szalonyauthor=A.+K.+Salyersauthor=R.+M.+Lachanceauthor=J.+J.+Parlowauthor=M.+S.+Southauthor=R.+S.+Woodauthor=N.+S.+Nicholson&title=Pharmacological+interruption+of+acute+thrombus+formation+with+minimal+hemorrhagic+complications+by+a+small+molecule+tissue+factor%2Ffactor+VIIa+inhibitor%3A+Comparison+to+factor+Xa+and+thrombin+inhibition+in+a+nonhuman+primate+thrombosis+model&doi=10.1124%2Fjpet.103.052779"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological interruption of acute thrombus formation with minimal hemorrhagic complications by a small molecule tissue factor/factor VIIa inhibitor: Comparison to factor Xa and thrombin inhibition in a nonhuman primate thrombosis model</span></div><div class="casAuthors">Suleymanov, Osman D.; Szalony, James A.; Salyers, Anita K.; Lachance, Rhonda M.; Parlow, John J.; South, Michael S.; Wood, Rhonda S.; Nicholson, Nancy S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">306</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1115-1121</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">This study was designed to evaluate the antithrombotic efficacy and bleeding propensity of a selective, small-mol. inhibitor of tissue factor/factor VIIa (TF/VIIa) in comparison to small-mol., selective inhibitors of factor Xa and thrombin in a nonhuman primate model of thrombosis.  Acute, spontaneous thrombus formation was induced by electrolytic injury to the intimal surface of a femoral blood vessel, which results in thrombus propagation at the injured site.  The TF/FVIIa inhibitor 3-amino-5-[1-[2-({4-[amino(imino)methyl]benzyl}amino)-2-oxo-ethyl]-3-chloro-5-(isopropylamino)-6-oxo-1,6-dihydropyrazin-2-yl]benzoic acid dihydrochloride (PHA-927F) was fully effective in prevention of thrombosis-induced vessel occlusion at a dose of 400 μg/kg/min, i.v., in the arterial vasculature (femoral artery).  Neither the ED nor multiples up to 4.4-fold the effective arterial plasma concn. elicited any significant effect on bleeding time or blood loss from either the bleeding time site or the surgical (femoral isolation) site.  Small-mol. inhibitors of factor Xa or thrombin were effective arterial antithrombotic agents; however, in contrast to the TF/FVIIa inhibitor, they both elicited substantial increases in bleeding propensity at the ED and at multiples of the effective plasma concn.  These data indicate that TF/VIIa inhibition effectively prevented arterial thrombosis with less impact on bleeding parameters than equiv. doses of factor Xa and thrombin inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9P761Xvt4yLVg90H21EOLACvtfcHk0liM4sHOSV89gA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmvVehtLg%253D&md5=b2bb7c0a9d7cb160404d7848be9436f3</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1124%2Fjpet.103.052779&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.103.052779%26sid%3Dliteratum%253Aachs%26aulast%3DSuleymanov%26aufirst%3DO.%2BD.%26aulast%3DSzalony%26aufirst%3DJ.%2BA.%26aulast%3DSalyers%26aufirst%3DA.%2BK.%26aulast%3DLachance%26aufirst%3DR.%2BM.%26aulast%3DParlow%26aufirst%3DJ.%2BJ.%26aulast%3DSouth%26aufirst%3DM.%2BS.%26aulast%3DWood%26aufirst%3DR.%2BS.%26aulast%3DNicholson%26aufirst%3DN.%2BS.%26atitle%3DPharmacological%2520interruption%2520of%2520acute%2520thrombus%2520formation%2520with%2520minimal%2520hemorrhagic%2520complications%2520by%2520a%2520small%2520molecule%2520tissue%2520factor%252Ffactor%2520VIIa%2520inhibitor%253A%2520Comparison%2520to%2520factor%2520Xa%2520and%2520thrombin%2520inhibition%2520in%2520a%2520nonhuman%2520primate%2520thrombosis%2520model%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2003%26volume%3D306%26spage%3D1115%26epage%3D1121%26doi%3D10.1124%2Fjpet.103.052779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Szalony, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suleymanov, O. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salyers, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panzer-Knodle, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blom, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaChance, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Case, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parlow, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">South, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholson, N. S.</span><span> </span><span class="NLM_article-title">Administration of a small molecule tissue factor/Factor VIIa inhibitor in a non-human primate thrombosis model of venous thrombosis: effects on thrombus formation and bleeding time</span> <span class="citation_source-journal">Thromb. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">174</span><span class="refDoi"> DOI: 10.1016/j.thromres.2003.10.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=10.1016%2Fj.thromres.2003.10.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=14967414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=1%3ACAS%3A280%3ADC%252BD2c%252FnvVOktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2003&pages=167-174&author=J.+A.+Szalonyauthor=O.+D.+Suleymanovauthor=A.+K.+Salyersauthor=S.+G.+Panzer-Knodleauthor=J.+D.+Blomauthor=R.+M.+LaChanceauthor=B.+L.+Caseauthor=J.+J.+Parlowauthor=M.+S.+Southauthor=R.+S.+Woodauthor=N.+S.+Nicholson&title=Administration+of+a+small+molecule+tissue+factor%2FFactor+VIIa+inhibitor+in+a+non-human+primate+thrombosis+model+of+venous+thrombosis%3A+effects+on+thrombus+formation+and+bleeding+time&doi=10.1016%2Fj.thromres.2003.10.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Administration of a small molecule tissue factor/factor VIIa inhibitor in a non-human primate thrombosis model of venous thrombosis: effects on thrombus formation and bleeding time</span></div><div class="casAuthors">Szalony James A; Suleymanov Osman D; Salyers Anita K; Panzer-Knodle Susan G; Blom Jason D; LaChance Rhonda M; Case Brenda L; Parlow John J; South Michael S; Wood Rhonda S; Nicholson Nancy S</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">167-74</span>
        ISSN:<span class="NLM_cas:issn">0049-3848</span>.
    </div><div class="casAbstract">INTRODUCTION:  Pharmacological treatment of deep vein thrombosis (DVT) in the future may target inhibitors of specific procoagulant proteins.  This study used a non-human primate model to test the effect of PHA-798, a specific inhibitor of the tissue factor/Factor VIIa complex (TF/VIIa), on venous thrombus formation.  MATERIALS AND METHODS:  PHA inhibits the TF/VIIa complex with an IC(50) of 13.5 nM (K(i) 9 nM) and is more than 2000-fold selective for the TF/VIIa complex with respect to IC(50)s for factor Xa and thrombin.  In the model, a thrombogenic surface was introduced into the vena cava of a primate, and the amount of thrombus accumulated after 30 min was determined.  RESULTS:  PHA-798 reduced thrombus formation on the thrombogenic surface in a dose-dependent manner (56+/-1.9% and 85+/-0.3% inhibition with 100 and 200 microg/kg/min PHA-798, respectively) indicating that the model is sensitive to TF/VIIa inhibition.  Treatment with 1 mg/kg intravenous (IV) acetyl salicylic acid (ASA) resulted in only a slight (4-12%), non-significant inhibition of thrombus formation.  However, the combination of 100 microg/kg/min PHA-798 and 1 mg/kg ASA resulted in an 89% inhibition of thrombus formation.  Additionally, while ASA alone increased bleeding time (BT) from 3.3 min at baseline to 4.6 min following treatment, addition of PHA-798 (100 microg/kg/min) to ASA did not significantly increase the BT further (4.7 min).  CONCLUSIONS:  The results of this study indicate that inhibition of TF/VIIa may be safe and effective for the prevention of the proprogation of venous thrombosis and that the combination of ASA and PHA may provide increased efficacy with little change in safety.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQmXRQK21QlEJHZzFRCXxVKfW6udTcc2eYnGvcyeHg5qrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c%252FnvVOktA%253D%253D&md5=8bf40ca317c6f2a99976ecc2a6ee279c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.thromres.2003.10.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.thromres.2003.10.017%26sid%3Dliteratum%253Aachs%26aulast%3DSzalony%26aufirst%3DJ.%2BA.%26aulast%3DSuleymanov%26aufirst%3DO.%2BD.%26aulast%3DSalyers%26aufirst%3DA.%2BK.%26aulast%3DPanzer-Knodle%26aufirst%3DS.%2BG.%26aulast%3DBlom%26aufirst%3DJ.%2BD.%26aulast%3DLaChance%26aufirst%3DR.%2BM.%26aulast%3DCase%26aufirst%3DB.%2BL.%26aulast%3DParlow%26aufirst%3DJ.%2BJ.%26aulast%3DSouth%26aufirst%3DM.%2BS.%26aulast%3DWood%26aufirst%3DR.%2BS.%26aulast%3DNicholson%26aufirst%3DN.%2BS.%26atitle%3DAdministration%2520of%2520a%2520small%2520molecule%2520tissue%2520factor%252FFactor%2520VIIa%2520inhibitor%2520in%2520a%2520non-human%2520primate%2520thrombosis%2520model%2520of%2520venous%2520thrombosis%253A%2520effects%2520on%2520thrombus%2520formation%2520and%2520bleeding%2520time%26jtitle%3DThromb.%2520Res.%26date%3D2003%26volume%3D112%26spage%3D167%26epage%3D174%26doi%3D10.1016%2Fj.thromres.2003.10.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Szalony, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taite, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girard, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholson, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaChance, R. M.</span><span> </span><span class="NLM_article-title">Pharmacological intervention at disparate sites in the coagulation cascade: comparison of anti-thrombotic efficacy vs. bleeding propensity in a rat model of acute arterial thrombosis</span> <span class="citation_source-journal">J. Thromb. Thrombolysis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">113</span><span class="NLM_x">–</span> <span class="NLM_lpage">121</span><span class="refDoi"> DOI: 10.1023/A:1023228827733</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=10.1023%2FA%3A1023228827733" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=12714830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=1%3ACAS%3A528%3ADC%252BD3sXislyju7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2002&pages=113-121&author=J.+A.+Szalonyauthor=B.+B.+Taiteauthor=T.+J.+Girardauthor=N.+S.+Nicholsonauthor=R.+M.+LaChance&title=Pharmacological+intervention+at+disparate+sites+in+the+coagulation+cascade%3A+comparison+of+anti-thrombotic+efficacy+vs.+bleeding+propensity+in+a+rat+model+of+acute+arterial+thrombosis&doi=10.1023%2FA%3A1023228827733"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological Intervention at Disparate Sites in the Coagulation Cascade: Comparison of Anti-thrombotic Efficacy vs. Bleeding Propensity in a Rat Model of Acute Arterial Thrombosis</span></div><div class="casAuthors">Szalony, James A.; Taite, Beatrice B.; Girard, Thomas J.; Nicholson, Nancy S.; LaChance, Rhonda M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Thrombosis and Thrombolysis</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">113-121</span>CODEN:
                <span class="NLM_cas:coden">JTTHFF</span>;
        ISSN:<span class="NLM_cas:issn">0929-5305</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">The Tissue Factor/Factor VIIa (TF/FVIIa) complex is an attractive target for pharmacol. interruption of thrombin generation and hence blood coagulation, as this complex is the initiation point of the extrinsic pathway of coagulation.  TF is a cell membrane-assocd. protein that interacts with sol. FVIIa to activate factors IX and X resulting in a cascade of events that leads to thrombin generation and eventual fibrin deposition.  The goal of this non-randomized study was to evaluate XK1, a specific protein inhibitor of TF/FVIIa, and compare antithrombotic efficacy and bleeding propensity to a previously described Factor Xa (FXa) inhibitor (SC-83157/SN 429) and a direct-acting thrombin inhibitor (SC-79407/L-374087) in an acute rat model of arterial thrombosis.  All saline-treated animals experienced occlusion of the carotid artery due to acute thrombus formation within 20 min.  Rats treated with XK1 exhibited a dose-dependent inhibition of thrombus formation with full antithrombotic efficacy and no change in bleeding time or total blood loss at a dose of 4.5 mg/kg, i.v. administered over a 60 min period.  FXa inhibition with SC-83157 resulted in complete inhibition of thrombus formation at a dose of 1.2 mg/kg, i.v.; however, this effect was assocd. with substantial blood loss.  Thrombin inhibition with SC-79407 also afforded complete protection from thrombus formation and occlusion at a dose of 2.58 mg/kg, i.v., and like SC-83157, was assocd. with substantial blood loss.  These data imply that TF/FVIIa inhibition confers protection from acute thrombosis without concomitant changes in bleeding, indicating that this target (TF/FVIIa) may provide improved sepn. of efficacy vs. bleeding side-effects than interruption of coagulation by directly inhibiting either FXa or thrombin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHae8oWa6ph7Vg90H21EOLACvtfcHk0lh6m4mw00LCcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXislyju7w%253D&md5=20775c9852acbb3416f88e7abab360ed</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1023%2FA%3A1023228827733&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1023228827733%26sid%3Dliteratum%253Aachs%26aulast%3DSzalony%26aufirst%3DJ.%2BA.%26aulast%3DTaite%26aufirst%3DB.%2BB.%26aulast%3DGirard%26aufirst%3DT.%2BJ.%26aulast%3DNicholson%26aufirst%3DN.%2BS.%26aulast%3DLaChance%26aufirst%3DR.%2BM.%26atitle%3DPharmacological%2520intervention%2520at%2520disparate%2520sites%2520in%2520the%2520coagulation%2520cascade%253A%2520comparison%2520of%2520anti-thrombotic%2520efficacy%2520vs.%2520bleeding%2520propensity%2520in%2520a%2520rat%2520model%2520of%2520acute%2520arterial%2520thrombosis%26jtitle%3DJ.%2520Thromb.%2520Thrombolysis%26date%3D2002%26volume%3D14%26spage%3D113%26epage%3D121%26doi%3D10.1023%2FA%3A1023228827733" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Wong, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luettgen, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rendina, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kettner, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knabb, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wexler, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Priestley, E. S.</span><span> </span><span class="NLM_article-title">BMS-593214, an active site-directed factor VIIa inhibitor: Enzyme kinetics, antithrombotic and antihaemostatic studies</span> <span class="citation_source-journal">Thromb. Haemostasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">261</span><span class="NLM_x">–</span> <span class="NLM_lpage">269</span><span class="refDoi"> DOI: 10.1160/TH10-01-0025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=10.1160%2FTH10-01-0025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=20589312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFaju77M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2010&pages=261-269&author=P.+C.+Wongauthor=J.+M.+Luettgenauthor=A.+R.+Rendinaauthor=C.+A.+Kettnerauthor=B.+Xinauthor=R.+M.+Knabbauthor=R.+R.+Wexlerauthor=E.+S.+Priestley&title=BMS-593214%2C+an+active+site-directed+factor+VIIa+inhibitor%3A+Enzyme+kinetics%2C+antithrombotic+and+antihaemostatic+studies&doi=10.1160%2FTH10-01-0025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">BMS-593214, an active site-directed factor VIIa inhibitor: enzyme kinetics, antithrombotic and antihemostatic studies</span></div><div class="casAuthors">Wong, Pancras C.; Luettgen, Joseph M.; Rendina, Alan R.; Kettner, Charles A.; Xin, Baomin; Knabb, Robert M.; Wexler, Ruth R.; Priestley, E. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">261-269</span>CODEN:
                <span class="NLM_cas:coden">THHADQ</span>;
        ISSN:<span class="NLM_cas:issn">0340-6245</span>.
    
            (<span class="NLM_cas:orgname">Schattauer GmbH</span>)
        </div><div class="casAbstract">Factor (F) VIIa in assocn. with tissue factor (TF) is the primary in vivo initiator of blood coagulation and activates FX and FIX to generate thrombin, which plays a key role in the pathogenesis of thrombosis.  We evaluated the enzyme kinetics, antithrombotic and antihemostatic properties of BMS-593214, an active-site, direct FVIIa inhibitor.  Studies were conducted in enzymic assays, and in anesthetized rabbit models of elec.-induced carotid arterial thrombosis (AT), thread-induced vena cava venous thrombosis (VT) and cuticle bleeding time (BT).  Antithrombotic efficacy of BMS-593214 given i.v. was evaluated for both the prevention and treatment of AT and VT.  BMS-593214 displayed direct, competitive inhibition of human FVIIa in the hydrolysis of a tripeptide substrate with Ki of 5 nM.  However, it acted as a noncompetitive inhibitor of the activation of the physiol. substrate FX by TF/VIIa with Ki of 9.3 nM.  BMS-593214 showed selectivity for FVIIa and exhibited species differences in TF-FVIIa-dependent anticoagulation with similar potency in human and rabbit plasma.  BMS-593214 was efficacious in the prevention and treatment models of AT and VT with ED50 values of 1.1 to 3.1 mg/kg.  Furthermore, BMS-593214 exhibited a wide therapeutic window with respect to BT.  These results suggest that inhibition of FVIIa with small-mol. active-site inhibitors represents a promising antithrombotic approach for the development of new therapies for the prevention and treatment of AT and VT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqK14c5SoyEXLVg90H21EOLACvtfcHk0lh6m4mw00LCcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFaju77M&md5=5f7058b79c6fe0cd23ccbd632741a625</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1160%2FTH10-01-0025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1160%252FTH10-01-0025%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DP.%2BC.%26aulast%3DLuettgen%26aufirst%3DJ.%2BM.%26aulast%3DRendina%26aufirst%3DA.%2BR.%26aulast%3DKettner%26aufirst%3DC.%2BA.%26aulast%3DXin%26aufirst%3DB.%26aulast%3DKnabb%26aufirst%3DR.%2BM.%26aulast%3DWexler%26aufirst%3DR.%2BR.%26aulast%3DPriestley%26aufirst%3DE.%2BS.%26atitle%3DBMS-593214%252C%2520an%2520active%2520site-directed%2520factor%2520VIIa%2520inhibitor%253A%2520Enzyme%2520kinetics%252C%2520antithrombotic%2520and%2520antihaemostatic%2520studies%26jtitle%3DThromb.%2520Haemostasis%26date%3D2010%26volume%3D104%26spage%3D261%26epage%3D269%26doi%3D10.1160%2FTH10-01-0025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Young, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mordenti, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torkelson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shrader, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolesnikov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rai, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leahy, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sprengeler, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katz, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janc, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elrod, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marzec, U. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanson, S. R.</span><span> </span><span class="NLM_article-title">Factor VIIa inhibitors: Chemical optimization, preclinical pharmacokinetics, pharmacodynamics, and efficacy in an arterial baboon thrombosis model</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">2037</span><span class="NLM_x">–</span> <span class="NLM_lpage">2041</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2005.12.059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=10.1016%2Fj.bmcl.2005.12.059" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=2037-2041&author=W.+B.+Youngauthor=J.+Mordentiauthor=S.+Torkelsonauthor=W.+D.+Shraderauthor=A.+Kolesnikovauthor=R.+Raiauthor=L.+Liuauthor=H.+Huauthor=E.+M.+Leahyauthor=M.+J.+Greenauthor=P.+A.+Sprengelerauthor=B.+A.+Katzauthor=C.+Yuauthor=J.+W.+Jancauthor=K.+C.+Elrodauthor=U.+M.+Marzecauthor=S.+R.+Hanson&title=Factor+VIIa+inhibitors%3A+Chemical+optimization%2C+preclinical+pharmacokinetics%2C+pharmacodynamics%2C+and+efficacy+in+an+arterial+baboon+thrombosis+model&doi=10.1016%2Fj.bmcl.2005.12.059"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2005.12.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2005.12.059%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DW.%2BB.%26aulast%3DMordenti%26aufirst%3DJ.%26aulast%3DTorkelson%26aufirst%3DS.%26aulast%3DShrader%26aufirst%3DW.%2BD.%26aulast%3DKolesnikov%26aufirst%3DA.%26aulast%3DRai%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DHu%26aufirst%3DH.%26aulast%3DLeahy%26aufirst%3DE.%2BM.%26aulast%3DGreen%26aufirst%3DM.%2BJ.%26aulast%3DSprengeler%26aufirst%3DP.%2BA.%26aulast%3DKatz%26aufirst%3DB.%2BA.%26aulast%3DYu%26aufirst%3DC.%26aulast%3DJanc%26aufirst%3DJ.%2BW.%26aulast%3DElrod%26aufirst%3DK.%2BC.%26aulast%3DMarzec%26aufirst%3DU.%2BM.%26aulast%3DHanson%26aufirst%3DS.%2BR.%26atitle%3DFactor%2520VIIa%2520inhibitors%253A%2520Chemical%2520optimization%252C%2520preclinical%2520pharmacokinetics%252C%2520pharmacodynamics%252C%2520and%2520efficacy%2520in%2520an%2520arterial%2520baboon%2520thrombosis%2520model%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D2037%26epage%3D2041%26doi%3D10.1016%2Fj.bmcl.2005.12.059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Zbinden, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banner, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilpert, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Himber, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lave, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riederer, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tschopp, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obst-Sander, U.</span><span> </span><span class="NLM_article-title">Dose-dependent antithrombotic activity of an orally active tissue factor/factor VIIa inhibitor without concomitant enhancement of bleeding propensity</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">5357</span><span class="NLM_x">–</span> <span class="NLM_lpage">5369</span><span class="refDoi"> DOI: 10.1016/j.bmc.2006.03.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=10.1016%2Fj.bmc.2006.03.042" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=5357-5369&author=K.+G.+Zbindenauthor=D.+W.+Bannerauthor=K.+Hilpertauthor=J.+Himberauthor=T.+Laveauthor=M.+A.+Riedererauthor=M.+Stahlauthor=T.+B.+Tschoppauthor=U.+Obst-Sander&title=Dose-dependent+antithrombotic+activity+of+an+orally+active+tissue+factor%2Ffactor+VIIa+inhibitor+without+concomitant+enhancement+of+bleeding+propensity&doi=10.1016%2Fj.bmc.2006.03.042"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2006.03.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2006.03.042%26sid%3Dliteratum%253Aachs%26aulast%3DZbinden%26aufirst%3DK.%2BG.%26aulast%3DBanner%26aufirst%3DD.%2BW.%26aulast%3DHilpert%26aufirst%3DK.%26aulast%3DHimber%26aufirst%3DJ.%26aulast%3DLave%26aufirst%3DT.%26aulast%3DRiederer%26aufirst%3DM.%2BA.%26aulast%3DStahl%26aufirst%3DM.%26aulast%3DTschopp%26aufirst%3DT.%2BB.%26aulast%3DObst-Sander%26aufirst%3DU.%26atitle%3DDose-dependent%2520antithrombotic%2520activity%2520of%2520an%2520orally%2520active%2520tissue%2520factor%252Ffactor%2520VIIa%2520inhibitor%2520without%2520concomitant%2520enhancement%2520of%2520bleeding%2520propensity%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D5357%26epage%3D5369%26doi%3D10.1016%2Fj.bmc.2006.03.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Giugliano, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiviott, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stone, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweiger, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouchard, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leesar, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulder, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deitcher, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCabe, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braunwald, E.</span><span> </span><span class="NLM_article-title">Recombinant nematode anticoagulant protein c2 in patients with non-ST-segment elevation acute coronary syndrome: the ANTHEM-TIMI-32 trial</span> <span class="citation_source-journal">J. Am. Coll. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">2398</span><span class="NLM_x">–</span> <span class="NLM_lpage">2407</span><span class="refDoi"> DOI: 10.1016/j.jacc.2007.02.065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=10.1016%2Fj.jacc.2007.02.065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=17599602" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=1%3ACAS%3A528%3ADC%252BD2sXntFyhs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2007&pages=2398-2407&author=R.+P.+Giuglianoauthor=S.+D.+Wiviottauthor=P.+H.+Stoneauthor=D.+I.+Simonauthor=M.+J.+Schweigerauthor=A.+Bouchardauthor=M.+A.+Leesarauthor=M.+A.+Goulderauthor=S.+R.+Deitcherauthor=C.+H.+McCabeauthor=E.+Braunwald&title=Recombinant+nematode+anticoagulant+protein+c2+in+patients+with+non-ST-segment+elevation+acute+coronary+syndrome%3A+the+ANTHEM-TIMI-32+trial&doi=10.1016%2Fj.jacc.2007.02.065"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Recombinant Nematode Anticoagulant Protein c2 in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome: the ANTHEM-TIMI-32 Trial</span></div><div class="casAuthors">Giugliano, Robert P.; Wiviott, Stephen D.; Stone, Peter H.; Simon, Daniel I.; Schweiger, Marc J.; Bouchard, Alain; Leesar, Massoud A.; Goulder, Michael A.; Deitcher, Steven R.; McCabe, Carolyn H.; Braunwald, Eugene</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American College of Cardiology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">2398-2407</span>CODEN:
                <span class="NLM_cas:coden">JACCDI</span>;
        ISSN:<span class="NLM_cas:issn">0735-1097</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Objectives: We sought to evaluate the safety and efficacy of recombinant nematode anticoagulant protein c2 (rNAPc2) in patients with non-ST-segment elevation acute coronary syndrome (nSTE-ACS).  Background: Recombinant NAPc2 is a potent inhibitor of the tissue factor/factor VIIa complex that has the potential to reduce ischemic complications mediated by thrombin generation.  Methods: A total of 203 patients were randomized 4:1 to double-blinded i.v. rNAPc2 or placebo every 48 h for a total of 1 to 3 doses in 8 ascending panels (1.5 to 10 μg/kg).  All patients received aspirin, unfractionated heparin (UFH), or enoxaparin and early catheterization; clopidogrel and glycoprotein IIb/IIIa blockers were encouraged.  Two subsequent open-label panels evaluated 10 μg/kg rNAPc2 with half-dose UFH (n = 26) and no UFH (n = 26).  The primary end point was the rate of major plus minor bleeding.  Pharmacokinetics, pharmacodynamics, continuous electrocardiog., and clin. events were assessed.  Results: Recombinant NAPc2 did not significantly increase major plus minor bleeding (3.7% vs. 2.5%; p = NS) despite increasing the international normalized ratio in a dose-related fashion (trend p ≤ 0.0001).  Higher-dose rNAPc2 (≥7.5 μg/kg) suppressed prothrombin fragment F1.2 generation compared with placebo and reduced ischemia by >50% compared to placebo and lower-dose rNAPc2.  Thrombotic bailout requiring open-label anticoagulant occurred in 5 of 26 patients treated without UFH, but none in the half-dose UFH group (19% vs. 0%; p = 0.051).  Conclusions: In patients with nSTE-ACS managed with std. antithrombotics and an early invasive approach, addnl. proximal inhibition of the coagulation cascade with rNAPc2 was well tolerated. rNAPc2 doses ≥7.5 μg/kg suppressed F1.2 and reduced ischemia, though some heparin may be necessary to avoid procedure-related thrombus formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqr5uob7lm2DbVg90H21EOLACvtfcHk0lj9854keAI_yA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXntFyhs74%253D&md5=72d19940ea9410323c4f8e7c324d5347</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.jacc.2007.02.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jacc.2007.02.065%26sid%3Dliteratum%253Aachs%26aulast%3DGiugliano%26aufirst%3DR.%2BP.%26aulast%3DWiviott%26aufirst%3DS.%2BD.%26aulast%3DStone%26aufirst%3DP.%2BH.%26aulast%3DSimon%26aufirst%3DD.%2BI.%26aulast%3DSchweiger%26aufirst%3DM.%2BJ.%26aulast%3DBouchard%26aufirst%3DA.%26aulast%3DLeesar%26aufirst%3DM.%2BA.%26aulast%3DGoulder%26aufirst%3DM.%2BA.%26aulast%3DDeitcher%26aufirst%3DS.%2BR.%26aulast%3DMcCabe%26aufirst%3DC.%2BH.%26aulast%3DBraunwald%26aufirst%3DE.%26atitle%3DRecombinant%2520nematode%2520anticoagulant%2520protein%2520c2%2520in%2520patients%2520with%2520non-ST-segment%2520elevation%2520acute%2520coronary%2520syndrome%253A%2520the%2520ANTHEM-TIMI-32%2520trial%26jtitle%3DJ.%2520Am.%2520Coll.%2520Cardiol.%26date%3D2007%26volume%3D49%26spage%3D2398%26epage%3D2407%26doi%3D10.1016%2Fj.jacc.2007.02.065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Priestley, E. S.</span><span> </span><span class="NLM_article-title">Tissue factor-fVIIa inhibition: update on an unfinished quest for a novel oral antithrombotic</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1440</span><span class="NLM_x">–</span> <span class="NLM_lpage">1444</span><span class="refDoi"> DOI: 10.1016/j.drudis.2014.05.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=10.1016%2Fj.drudis.2014.05.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=24881783" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVShtL3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=1440-1444&author=E.+S.+Priestley&title=Tissue+factor-fVIIa+inhibition%3A+update+on+an+unfinished+quest+for+a+novel+oral+antithrombotic&doi=10.1016%2Fj.drudis.2014.05.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Tissue factor-fVIIa inhibition: update on an unfinished quest for a novel oral antithrombotic</span></div><div class="casAuthors">Priestley, E. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1440-1444</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The tissue factor-coagulation factor VIIa complex (TF-fVIIa) is a well-validated biol. target and has been the focus of extensive research directed toward the discovery of novel oral antithrombotics.  This review briefly summarizes the key antithrombotic target validation data and provides an update on recent advances in small mol. TF-fVIIa inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7zNpJzOd-MrVg90H21EOLACvtfcHk0lj9854keAI_yA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVShtL3K&md5=262318fbf25e17dd13dae0c323d699f5</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2014.05.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2014.05.023%26sid%3Dliteratum%253Aachs%26aulast%3DPriestley%26aufirst%3DE.%2BS.%26atitle%3DTissue%2520factor-fVIIa%2520inhibition%253A%2520update%2520on%2520an%2520unfinished%2520quest%2520for%2520a%2520novel%2520oral%2520antithrombotic%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2014%26volume%3D19%26spage%3D1440%26epage%3D1444%26doi%3D10.1016%2Fj.drudis.2014.05.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Talhout, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engberts, J.</span><span> </span><span class="NLM_article-title">Thermodynamic analysis of binding of p-substituted benzamidines to trypsin</span> <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">268</span><span class="NLM_x">, </span> <span class="NLM_fpage">1554</span><span class="NLM_x">–</span> <span class="NLM_lpage">1560</span><span class="refDoi"> DOI: 10.1046/j.1432-1327.2001.01991.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=10.1046%2Fj.1432-1327.2001.01991.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=11248672" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitlSktbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=268&publication_year=2001&pages=1554-1560&author=R.+Talhoutauthor=J.+Engberts&title=Thermodynamic+analysis+of+binding+of+p-substituted+benzamidines+to+trypsin&doi=10.1046%2Fj.1432-1327.2001.01991.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Thermodynamic analysis of binding of p-substituted benzamidines to trypsin</span></div><div class="casAuthors">Talhout, Reinskje; Engberts, Jan B. F. N.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">268</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1554-1560</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">Understanding the structural basis of inhibitor-enzyme interactions, important for the design of new drugs, requires a complete thermodn. characterization of the binding process as well as a description of the structure of the complex.  In this paper, the binding of p-substituted benzamidinium derivs. to the structurally well-characterized serine proteinase bovine pancreatic trypsin has been studied using isothermal titrn. calorimetry.  These expts. have permitted a complete characterization of the temp. dependence of the inhibitor-binding thermodn.  At 25°, both the enthalpy and entropy of binding are favorable for all studied derivs., but this is only true for a relatively narrow temp. range.  As binding is characterized by a neg. change in heat capacity, the process is characterized by enthalpy-entropy compensation, resulting in a change of the net thermodn. driving force for assocn. from entropic to enthalpic with increasing temp.  These phenomena are not unusual when hydrophobic forces play an important role.  The trend in the relative binding potencies can, to a significant extent, be attributed to the electron-donating/withdrawing character of the substituent at the para position, as shown by the Hammett σp+ plot for the different inhibitors; the more polar the p-substituted benzamidine, the less potent it will be as a trypsin inhibitor.  This behavior might result from a bulk solvation effect, meaning that the more polar, lower potency inhibitors will be more stabilized in water than the less polar, higher potency inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyMFBZp9jo8rVg90H21EOLACvtfcHk0lj9854keAI_yA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitlSktbc%253D&md5=f70ce474ada944add5d791244fe85c7d</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1046%2Fj.1432-1327.2001.01991.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1432-1327.2001.01991.x%26sid%3Dliteratum%253Aachs%26aulast%3DTalhout%26aufirst%3DR.%26aulast%3DEngberts%26aufirst%3DJ.%26atitle%3DThermodynamic%2520analysis%2520of%2520binding%2520of%2520p-substituted%2520benzamidines%2520to%2520trypsin%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D2001%26volume%3D268%26spage%3D1554%26epage%3D1560%26doi%3D10.1046%2Fj.1432-1327.2001.01991.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Hu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolesnikov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riggs, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesson, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephens, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leahy, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shrader, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sprengeler, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanford, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gjerstad, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cabuslay, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, W. B.</span><span> </span><span class="NLM_article-title">Potent 4-amino-5-azaindole factor VIIa inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">4567</span><span class="NLM_x">–</span> <span class="NLM_lpage">4570</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2006.06.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=10.1016%2Fj.bmcl.2006.06.016" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=4567-4570&author=H.+Huauthor=A.+Kolesnikovauthor=J.+R.+Riggsauthor=K.+E.+Wessonauthor=R.+Stephensauthor=E.+M.+Leahyauthor=W.+D.+Shraderauthor=P.+A.+Sprengelerauthor=M.+J.+Greenauthor=E.+Sanfordauthor=M.+Nguyenauthor=E.+Gjerstadauthor=R.+Cabuslayauthor=W.+B.+Young&title=Potent+4-amino-5-azaindole+factor+VIIa+inhibitors&doi=10.1016%2Fj.bmcl.2006.06.016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.06.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.06.016%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DH.%26aulast%3DKolesnikov%26aufirst%3DA.%26aulast%3DRiggs%26aufirst%3DJ.%2BR.%26aulast%3DWesson%26aufirst%3DK.%2BE.%26aulast%3DStephens%26aufirst%3DR.%26aulast%3DLeahy%26aufirst%3DE.%2BM.%26aulast%3DShrader%26aufirst%3DW.%2BD.%26aulast%3DSprengeler%26aufirst%3DP.%2BA.%26aulast%3DGreen%26aufirst%3DM.%2BJ.%26aulast%3DSanford%26aufirst%3DE.%26aulast%3DNguyen%26aufirst%3DM.%26aulast%3DGjerstad%26aufirst%3DE.%26aulast%3DCabuslay%26aufirst%3DR.%26aulast%3DYoung%26aufirst%3DW.%2BB.%26atitle%3DPotent%25204-amino-5-azaindole%2520factor%2520VIIa%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D4567%26epage%3D4570%26doi%3D10.1016%2Fj.bmcl.2006.06.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Miura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koike, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishihara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niimi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirayama, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shigenaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakai-Moritani, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tagawa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawasaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakamoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukamoto, S.-i.</span><span> </span><span class="NLM_article-title">Design, synthesis and biological activity of selective and orally available TF/FVIIa complex inhibitors containing non-amidine P1 ligands</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">160</span><span class="NLM_x">–</span> <span class="NLM_lpage">173</span><span class="refDoi"> DOI: 10.1016/j.bmc.2006.09.071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=10.1016%2Fj.bmc.2006.09.071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=17064913" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1CmtrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=160-173&author=M.+Miuraauthor=N.+Sekiauthor=T.+Koikeauthor=T.+Ishiharaauthor=T.+Niimiauthor=F.+Hirayamaauthor=T.+Shigenagaauthor=Y.+Sakai-Moritaniauthor=A.+Tagawaauthor=T.+Kawasakiauthor=S.+Sakamotoauthor=M.+Okadaauthor=M.+Ohtaauthor=S.-i.+Tsukamoto&title=Design%2C+synthesis+and+biological+activity+of+selective+and+orally+available+TF%2FFVIIa+complex+inhibitors+containing+non-amidine+P1+ligands&doi=10.1016%2Fj.bmc.2006.09.071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and biological activity of selective and orally available TF/FVIIa complex inhibitors containing non-amidine P1 ligands</span></div><div class="casAuthors">Miura, Masanori; Seki, Norio; Koike, Takanori; Ishihara, Tsukasa; Niimi, Tatsuya; Hirayama, Fukushi; Shigenaga, Takeshi; Sakai-Moritani, Yumiko; Tagawa, Ayako; Kawasaki, Tomihisa; Sakamoto, Shuichi; Okada, Minoru; Ohta, Mitsuaki; Tsukamoto, Shin-ichi</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">160-173</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">We found the novel selective and orally available non-amidine TF/FVIIa complex inhibitor 21e (I), 4-({[(1S)-(aminocarbonyl)-3-methylbutyl]amino}carbonyl)-2'-({[4- (aminomethyl)phenyl]amino}carbonyl)-4'-(methylamino)biphenyl-2-carboxylic acid.  The derivs. were synthesized by conversions of the iso-Bu moiety and the introduction of alkylamino groups to 4'-position of the central Ph ring of compds. 2a and 2b reported previously.  Some compds. show increased in vitro anti-TF/FVIIa and PT prolongation activities.  Among them, compd. 21e reached and sustained micromolar plasma concn. levels of up to 2 h after oral administration in mice.  Moreover, compd. 21e did not prolong the bleeding time even at the highest dose level in cynomolgus monkeys, while PT was prolonged 3.7-fold increases at this dose.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeyYBTGFY_DbVg90H21EOLACvtfcHk0lg0SUjJqCzg3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1CmtrbM&md5=5349b8f0727b66611a9fb43f04aa0365</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2006.09.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2006.09.071%26sid%3Dliteratum%253Aachs%26aulast%3DMiura%26aufirst%3DM.%26aulast%3DSeki%26aufirst%3DN.%26aulast%3DKoike%26aufirst%3DT.%26aulast%3DIshihara%26aufirst%3DT.%26aulast%3DNiimi%26aufirst%3DT.%26aulast%3DHirayama%26aufirst%3DF.%26aulast%3DShigenaga%26aufirst%3DT.%26aulast%3DSakai-Moritani%26aufirst%3DY.%26aulast%3DTagawa%26aufirst%3DA.%26aulast%3DKawasaki%26aufirst%3DT.%26aulast%3DSakamoto%26aufirst%3DS.%26aulast%3DOkada%26aufirst%3DM.%26aulast%3DOhta%26aufirst%3DM.%26aulast%3DTsukamoto%26aufirst%3DS.-i.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520activity%2520of%2520selective%2520and%2520orally%2520available%2520TF%252FFVIIa%2520complex%2520inhibitors%2520containing%2520non-amidine%2520P1%2520ligands%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D160%26epage%3D173%26doi%3D10.1016%2Fj.bmc.2006.09.071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Parlow, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurumbail, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stegeman, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stallings, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">South, M. S.</span><span> </span><span class="NLM_article-title">Design, synthesis, and crystal structure of selective 2-pyridone tissue factor VIIa inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">4696</span><span class="NLM_x">–</span> <span class="NLM_lpage">4701</span><span class="refDoi"> DOI: 10.1021/jm0301686</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0301686" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnt1Kktrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=4696-4701&author=J.+J.+Parlowauthor=R.+G.+Kurumbailauthor=R.+A.+Stegemanauthor=A.+M.+Stevensauthor=W.+C.+Stallingsauthor=M.+S.+South&title=Design%2C+synthesis%2C+and+crystal+structure+of+selective+2-pyridone+tissue+factor+VIIa+inhibitors&doi=10.1021%2Fjm0301686"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Crystal Structure of Selective 2-Pyridone Tissue Factor VIIa Inhibitors</span></div><div class="casAuthors">Parlow, John J.; Kurumbail, Ravi G.; Stegeman, Roderick A.; Stevens, Anna M.; Stallings, William C.; South, Michael S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">4696-4701</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Targeted 2-pyridones were selected as tissue factor VIIa inhibitors and prepd. from 2,6-dibromopyridine via a multistep synthesis.  A variety of chem. transformations, including regioselective nucleophilic addn., selective nitrogen alkylation, and a Suzuki coupling, afforded the targeted tissue factor VIIa inhibitors.  The pyridone core was selected as a replacement for the pyrazinone core of noncovalent tissue Factor VIIa inhibitors and designed such that their substitution pattern would occupy and interact with the S1, S2, and S3 pockets of the tissue factor VIIa enzyme.  These compds. were tested in several serine protease enzyme assays involved in the coagulation cascade exhibiting modest activity on tissue factor VIIa with excellent selectivity over thrombin and Factor Xa.  Finally, an X-ray crystal structure of one inhibitor bound to tissue factor VIIa was obtained and will be described.  Compds. thus prepd. and tested were 3-amino-5-[1-[2-[[[4-(aminoiminomethyl)phenyl]methyl]amino]-2-oxoethyl]-1,6-dihydro-5-[(1-methylethyl)amino]-6-oxo-2-pyridinyl]benzoic acid and N-[[4-(aminoiminomethyl)phenyl]methyl]-6-(3,5-diaminophenyl)-3-[(1-methylethyl)amino]-2-oxo-1(2H)-pyridineacetamide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrt-RHbO3bWK7Vg90H21EOLACvtfcHk0lg0SUjJqCzg3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnt1Kktrc%253D&md5=d463973a0ba48427f8131ae032c0637b</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm0301686&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0301686%26sid%3Dliteratum%253Aachs%26aulast%3DParlow%26aufirst%3DJ.%2BJ.%26aulast%3DKurumbail%26aufirst%3DR.%2BG.%26aulast%3DStegeman%26aufirst%3DR.%2BA.%26aulast%3DStevens%26aufirst%3DA.%2BM.%26aulast%3DStallings%26aufirst%3DW.%2BC.%26aulast%3DSouth%26aufirst%3DM.%2BS.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520crystal%2520structure%2520of%2520selective%25202-pyridone%2520tissue%2520factor%2520VIIa%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D4696%26epage%3D4701%26doi%3D10.1021%2Fjm0301686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Trujillo, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neumann, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahoney, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garland, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kusturin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbas, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">South, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reitz, D. B.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of pyrazinones containing novel P1 needles as inhibitors of TF/VIIa</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">4568</span><span class="NLM_x">–</span> <span class="NLM_lpage">4574</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2007.05.090</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=10.1016%2Fj.bmcl.2007.05.090" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=4568-4574&author=J.+I.+Trujilloauthor=H.+Huangauthor=W.+L.+Neumannauthor=M.+W.+Mahoneyauthor=S.+Longauthor=W.+Huangauthor=D.+J.+Garlandauthor=C.+Kusturinauthor=Z.+Abbasauthor=M.+S.+Southauthor=D.+B.+Reitz&title=Design%2C+synthesis%2C+and+biological+evaluation+of+pyrazinones+containing+novel+P1+needles+as+inhibitors+of+TF%2FVIIa&doi=10.1016%2Fj.bmcl.2007.05.090"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.05.090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.05.090%26sid%3Dliteratum%253Aachs%26aulast%3DTrujillo%26aufirst%3DJ.%2BI.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DNeumann%26aufirst%3DW.%2BL.%26aulast%3DMahoney%26aufirst%3DM.%2BW.%26aulast%3DLong%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DGarland%26aufirst%3DD.%2BJ.%26aulast%3DKusturin%26aufirst%3DC.%26aulast%3DAbbas%26aufirst%3DZ.%26aulast%3DSouth%26aufirst%3DM.%2BS.%26aulast%3DReitz%26aufirst%3DD.%2BB.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520pyrazinones%2520containing%2520novel%2520P1%2520needles%2520as%2520inhibitors%2520of%2520TF%252FVIIa%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D4568%26epage%3D4574%26doi%3D10.1016%2Fj.bmcl.2007.05.090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Vijaykumar, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rai, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaghafi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ton, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torkelson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leahy, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riggs, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sprengeler, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shrader, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Bryan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cabuslay, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanford, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gjerstadt, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sukbuntherng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, W. B.</span><span> </span><span class="NLM_article-title">Efforts toward oral bioavailability in factor VIIa inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">3829</span><span class="NLM_x">–</span> <span class="NLM_lpage">3832</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2006.04.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=10.1016%2Fj.bmcl.2006.04.018" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=3829-3832&author=D.+Vijaykumarauthor=R.+Raiauthor=M.+Shaghafiauthor=T.+Tonauthor=S.+Torkelsonauthor=E.+M.+Leahyauthor=J.+R.+Riggsauthor=H.+Huauthor=P.+A.+Sprengelerauthor=W.+D.+Shraderauthor=C.+O%E2%80%99Bryanauthor=R.+Cabuslayauthor=E.+Sanfordauthor=E.+Gjerstadtauthor=L.+Liuauthor=J.+Sukbuntherngauthor=W.+B.+Young&title=Efforts+toward+oral+bioavailability+in+factor+VIIa+inhibitors&doi=10.1016%2Fj.bmcl.2006.04.018"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.04.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.04.018%26sid%3Dliteratum%253Aachs%26aulast%3DVijaykumar%26aufirst%3DD.%26aulast%3DRai%26aufirst%3DR.%26aulast%3DShaghafi%26aufirst%3DM.%26aulast%3DTon%26aufirst%3DT.%26aulast%3DTorkelson%26aufirst%3DS.%26aulast%3DLeahy%26aufirst%3DE.%2BM.%26aulast%3DRiggs%26aufirst%3DJ.%2BR.%26aulast%3DHu%26aufirst%3DH.%26aulast%3DSprengeler%26aufirst%3DP.%2BA.%26aulast%3DShrader%26aufirst%3DW.%2BD.%26aulast%3DO%25E2%2580%2599Bryan%26aufirst%3DC.%26aulast%3DCabuslay%26aufirst%3DR.%26aulast%3DSanford%26aufirst%3DE.%26aulast%3DGjerstadt%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DSukbuntherng%26aufirst%3DJ.%26aulast%3DYoung%26aufirst%3DW.%2BB.%26atitle%3DEfforts%2520toward%2520oral%2520bioavailability%2520in%2520factor%2520VIIa%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D3829%26epage%3D3832%26doi%3D10.1016%2Fj.bmcl.2006.04.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Groebke Zbinden, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banner, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ackermann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Arcy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirchhofer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, Y.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tschopp, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallbaum, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, L.</span><span> </span><span class="NLM_article-title">Design of selective phenylglycine amide tissue factor/factor VIIa inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">817</span><span class="NLM_x">–</span> <span class="NLM_lpage">822</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2004.10.092</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=10.1016%2Fj.bmcl.2004.10.092" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=817-822&author=K.+Groebke+Zbindenauthor=D.+W.+Bannerauthor=J.+Ackermannauthor=A.+D%E2%80%99Arcyauthor=D.+Kirchhoferauthor=Y.-H.+Jiauthor=T.+B.+Tschoppauthor=S.+Wallbaumauthor=L.+Weber&title=Design+of+selective+phenylglycine+amide+tissue+factor%2Ffactor+VIIa+inhibitors&doi=10.1016%2Fj.bmcl.2004.10.092"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2004.10.092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2004.10.092%26sid%3Dliteratum%253Aachs%26aulast%3DGroebke%2BZbinden%26aufirst%3DK.%26aulast%3DBanner%26aufirst%3DD.%2BW.%26aulast%3DAckermann%26aufirst%3DJ.%26aulast%3DD%25E2%2580%2599Arcy%26aufirst%3DA.%26aulast%3DKirchhofer%26aufirst%3DD.%26aulast%3DJi%26aufirst%3DY.-H.%26aulast%3DTschopp%26aufirst%3DT.%2BB.%26aulast%3DWallbaum%26aufirst%3DS.%26aulast%3DWeber%26aufirst%3DL.%26atitle%3DDesign%2520of%2520selective%2520phenylglycine%2520amide%2520tissue%2520factor%252Ffactor%2520VIIa%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D817%26epage%3D822%26doi%3D10.1016%2Fj.bmcl.2004.10.092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Cheney, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bozarth, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metzler, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morin, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newitt, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nirschl, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rendina, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamura, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wurtz, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seiffert, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wexler, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Priestley, E. S.</span><span> </span><span class="NLM_article-title">Discovery of novel P1 groups for coagulation factor VIIa inhibition using fragment-based screening</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">2799</span><span class="NLM_x">–</span> <span class="NLM_lpage">2808</span><span class="refDoi"> DOI: 10.1021/jm501982k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501982k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=1%3ACAS%3A528%3ADC%252BC2MXktlequrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2799-2808&author=L.+D.+Cheneyauthor=M.+J.+Bozarthauthor=J.+W.+Metzlerauthor=E.+P.+Morinauthor=L.+Muellerauthor=A.+J.+Newittauthor=H.+A.+Nirschlauthor=R.+A.+Rendinaauthor=K.+J.+Tamuraauthor=A.+Weiauthor=X.+Wenauthor=R.+N.+Wurtzauthor=A.+D.+Seiffertauthor=R.+R.+Wexlerauthor=E.+S.+Priestley&title=Discovery+of+novel+P1+groups+for+coagulation+factor+VIIa+inhibition+using+fragment-based+screening&doi=10.1021%2Fjm501982k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of novel P1 groups for coagulation factor VIIa inhibition using fragment-based screening</span></div><div class="casAuthors">Cheney, Daniel L.; Bozarth, Jeffrey M.; Metzler, William J.; Morin, Paul E.; Mueller, Luciano; Newitt, John A.; Nirschl, Alexandra H.; Rendina, Alan R.; Tamura, James K.; Wei, Anzhi; Wen, Xiao; Wurtz, Nicholas R.; Seiffert, Dietmar A.; Wexler, Ruth R.; Priestley, E. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2799-2808</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A multidisciplinary, fragment-based screening approach involving protein ensemble docking and biochem. and NMR assays is described.  This approach led to the discovery of several structurally diverse, neutral surrogates for cationic factor VIIa P1 groups, which are generally assocd. with poor pharmacokinetic (PK) properties.  Among the novel factor VIIa inhibitory fragments identified were aryl halides, lactams, and heterocycles.  Crystallog. structures for several bound fragments were obtained, leading to the successful design of a potent factor VIIa inhibitor with a neutral lactam P1 and improved permeability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp66c92wxmo8bVg90H21EOLACvtfcHk0ljE7Z1VyXsekg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXktlequrs%253D&md5=e092f0e39b3c63d80c12ba4770d977f0</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm501982k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501982k%26sid%3Dliteratum%253Aachs%26aulast%3DCheney%26aufirst%3DL.%2BD.%26aulast%3DBozarth%26aufirst%3DM.%2BJ.%26aulast%3DMetzler%26aufirst%3DJ.%2BW.%26aulast%3DMorin%26aufirst%3DE.%2BP.%26aulast%3DMueller%26aufirst%3DL.%26aulast%3DNewitt%26aufirst%3DA.%2BJ.%26aulast%3DNirschl%26aufirst%3DH.%2BA.%26aulast%3DRendina%26aufirst%3DR.%2BA.%26aulast%3DTamura%26aufirst%3DK.%2BJ.%26aulast%3DWei%26aufirst%3DA.%26aulast%3DWen%26aufirst%3DX.%26aulast%3DWurtz%26aufirst%3DR.%2BN.%26aulast%3DSeiffert%26aufirst%3DA.%2BD.%26aulast%3DWexler%26aufirst%3DR.%2BR.%26aulast%3DPriestley%26aufirst%3DE.%2BS.%26atitle%3DDiscovery%2520of%2520novel%2520P1%2520groups%2520for%2520coagulation%2520factor%2520VIIa%2520inhibition%2520using%2520fragment-based%2520screening%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2799%26epage%3D2808%26doi%3D10.1021%2Fjm501982k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacutin-Porte, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glunz, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nirschl, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wurtz, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luettgen, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rendina, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harper, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anumula, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheney, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knabb, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wexler, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Priestley, E. S.</span><span> </span><span class="NLM_article-title">Design and synthesis of phenylpyrrolidine phenylglycinamides as highly potent and selective TF-FVIIa inhibitors</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">188</span><span class="NLM_x">–</span> <span class="NLM_lpage">192</span><span class="refDoi"> DOI: 10.1021/ml400453z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400453z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=1%3ACAS%3A528%3ADC%252BC3sXitVShsr%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=188-192&author=X.+Zhangauthor=W.+Jiangauthor=S.+Jacutin-Porteauthor=W.+P.+Glunzauthor=Y.+Zouauthor=X.+Chengauthor=H.+A.+Nirschlauthor=R.+N.+Wurtzauthor=M.+J.+Luettgenauthor=R.+A.+Rendinaauthor=G.+Luoauthor=M.+T.+Harperauthor=A.+Weiauthor=R.+Anumulaauthor=L.+D.+Cheneyauthor=M.+R.+Knabbauthor=C.+P.+Wongauthor=R.+R.+Wexlerauthor=E.+S.+Priestley&title=Design+and+synthesis+of+phenylpyrrolidine+phenylglycinamides+as+highly+potent+and+selective+TF-FVIIa+inhibitors&doi=10.1021%2Fml400453z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of phenylpyrrolidine phenylglycinamides as highly potent and selective TF-FVIIA inhibitors</span></div><div class="casAuthors">Zhang, Xiaojun; Jiang, Wen; Jacutin-Porte, Swanee; Glunz, Peter W.; Zou, Yan; Cheng, Xuhong; Nirschl, Alexandra H.; Wurtz, Nicholas R.; Luettgen, Joseph M.; Rendina, Alan R.; Luo, Gang; Harper, Timothy M.; Wei, Anzhi; Anumula, Rushith; Cheney, Daniel L.; Knabb, Robert M.; Wong, Pancras C.; Wexler, Ruth R.; Priestley, E. Scott</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">188-192</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibitors of the Tissue Factor/Factor VIIa (TF-FVIIa) complex are promising novel anticoagulants that show excellent efficacy and minimal bleeding in preclin. models.  On the basis of a zwitterionic phenylglycine acylsulfonamide and phenylglycine benzylamide (I) (X = SO2, CH2) was shown to possess improved permeability and oral bioavailability.  Optimization of the benzylamide, guided by X-ray crystallog., led to a potent TF-FVIIa inhibitor (II) with promising oral bioavailability, but promiscuous activity in an in vitro safety panel of receptors and enzymes.  Introducing an acid on the pyrrolidine ring, guided by mol. modeling, resulted in highly potent, selective, and efficacious TF-FVIIa inhibitors with clean in vitro safety profile.  The pyrrolidine acid (III) showed a moderate clearance, low vol. of distribution, and a short t1/2 in dog PK studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHkKWlxgabXbVg90H21EOLACvtfcHk0lh22cetY55Raw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXitVShsr%252FE&md5=9888c52aae462e47f7b50d96f661fb9c</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fml400453z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400453z%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DJiang%26aufirst%3DW.%26aulast%3DJacutin-Porte%26aufirst%3DS.%26aulast%3DGlunz%26aufirst%3DW.%2BP.%26aulast%3DZou%26aufirst%3DY.%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DNirschl%26aufirst%3DH.%2BA.%26aulast%3DWurtz%26aufirst%3DR.%2BN.%26aulast%3DLuettgen%26aufirst%3DM.%2BJ.%26aulast%3DRendina%26aufirst%3DR.%2BA.%26aulast%3DLuo%26aufirst%3DG.%26aulast%3DHarper%26aufirst%3DM.%2BT.%26aulast%3DWei%26aufirst%3DA.%26aulast%3DAnumula%26aufirst%3DR.%26aulast%3DCheney%26aufirst%3DL.%2BD.%26aulast%3DKnabb%26aufirst%3DM.%2BR.%26aulast%3DWong%26aufirst%3DC.%2BP.%26aulast%3DWexler%26aufirst%3DR.%2BR.%26aulast%3DPriestley%26aufirst%3DE.%2BS.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520phenylpyrrolidine%2520phenylglycinamides%2520as%2520highly%2520potent%2520and%2520selective%2520TF-FVIIa%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D188%26epage%3D192%26doi%3D10.1021%2Fml400453z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Priestley, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheney, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeLucca, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luettgen, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rendina, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wexler, R. R.</span><span> </span><span class="NLM_article-title">Structure-based design of macrocyclic coagulation factor VIIa inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">6225</span><span class="NLM_x">–</span> <span class="NLM_lpage">6236</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00788</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00788" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFejtb%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=6225-6236&author=E.+S.+Priestleyauthor=D.+L.+Cheneyauthor=I.+DeLuccaauthor=A.+Weiauthor=J.+M.+Luettgenauthor=A.+R.+Rendinaauthor=P.+C.+Wongauthor=R.+R.+Wexler&title=Structure-based+design+of+macrocyclic+coagulation+factor+VIIa+inhibitors&doi=10.1021%2Facs.jmedchem.5b00788"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of Macrocyclic Coagulation Factor VIIa Inhibitors</span></div><div class="casAuthors">Priestley, E. Scott; Cheney, Daniel L.; DeLucca, Indawati; Wei, Anzhi; Luettgen, Joseph M.; Rendina, Alan R.; Wong, Pancras C.; Wexler, Ruth R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6225-6236</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">On the basis of a crystal structure of a phenylpyrrolidine lead and subsequent mol. modeling results, we designed and synthesized a novel series of macrocyclic FVIIa inhibitors.  The optimal 16-membered macrocycle was 60-fold more potent than an acyclic analog.  Further potency optimization by incorporation of P1' alkyl sulfone and P2 Me groups provided a macrocycle with TF/FVIIa Ki = 1.6 nM, excellent selectivity against a panel of seven serine proteases, and FVII-deficient prothrombin time EC2x = 1.2 μM.  Discovery of this potent, selective macrocyclic scaffold opens new possibilities for the development of orally bioavailable FVIIa inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIZvUgkobQ3bVg90H21EOLACvtfcHk0lh22cetY55Raw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFejtb%252FM&md5=881772bfb89d6097de1cfc14f6c7bb8b</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00788%26sid%3Dliteratum%253Aachs%26aulast%3DPriestley%26aufirst%3DE.%2BS.%26aulast%3DCheney%26aufirst%3DD.%2BL.%26aulast%3DDeLucca%26aufirst%3DI.%26aulast%3DWei%26aufirst%3DA.%26aulast%3DLuettgen%26aufirst%3DJ.%2BM.%26aulast%3DRendina%26aufirst%3DA.%2BR.%26aulast%3DWong%26aufirst%3DP.%2BC.%26aulast%3DWexler%26aufirst%3DR.%2BR.%26atitle%3DStructure-based%2520design%2520of%2520macrocyclic%2520coagulation%2520factor%2520VIIa%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D6225%26epage%3D6236%26doi%3D10.1021%2Facs.jmedchem.5b00788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Glunz, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheney, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladziata, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wurtz, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wexler, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Priestley, E. S.</span><span> </span><span class="NLM_article-title">Atropisomer control in macrocyclic factor VIIa inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">4007</span><span class="NLM_x">–</span> <span class="NLM_lpage">4018</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00244</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00244" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=1%3ACAS%3A528%3ADC%252BC28XkvVyjsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=4007-4018&author=W.+P.+Glunzauthor=L.+Muellerauthor=L.+D.+Cheneyauthor=V.+Ladziataauthor=Y.+Zouauthor=N.+R.+Wurtzauthor=A.+Weiauthor=P.+Wongauthor=R.+R.+Wexlerauthor=E.+S.+Priestley&title=Atropisomer+control+in+macrocyclic+factor+VIIa+inhibitors&doi=10.1021%2Facs.jmedchem.6b00244"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Atropisomer Control in Macrocyclic Factor VIIa Inhibitors</span></div><div class="casAuthors">Glunz, Peter W.; Mueller, Luciano; Cheney, Daniel L.; Ladziata, Vladimir; Zou, Yan; Wurtz, Nicholas R.; Wei, Anzhi; Wong, Pancras C.; Wexler, Ruth R.; Priestley, E. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4007-4018</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Incorporation of a Me group onto a macrocyclic FVIIa inhibitor improves potency 10-fold but is accompanied by atropisomerism due to restricted bond rotation in the macrocyclic structure, as demonstrated by NMR studies.  We designed a conformational constraint favoring the desired atropisomer in which this Me group interacts with the S2 pocket of FVIIa.  A macrocyclic inhibitor incorporating this constraint was prepd. and demonstrated by NMR to reside predominantly in the desired conformation.  This modification improved potency 180-fold relative to the unsubstituted, racemic macrocycle and improved selectivity.  An X-ray crystal structure of a closely related analog in the FVIIa active site was obtained and matches the NMR and modeled conformations, confirming that this conformational constraint does indeed direct the Me group into the S2 pocket as designed.  The resulting rationally designed, conformationally stable template enables further optimization of these macrocyclic inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUQwjeZSkab7Vg90H21EOLACvtfcHk0lj3a_j4RfcYWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XkvVyjsrs%253D&md5=d09b959e52dcafe4465978ec5d1c23c3</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00244&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00244%26sid%3Dliteratum%253Aachs%26aulast%3DGlunz%26aufirst%3DW.%2BP.%26aulast%3DMueller%26aufirst%3DL.%26aulast%3DCheney%26aufirst%3DL.%2BD.%26aulast%3DLadziata%26aufirst%3DV.%26aulast%3DZou%26aufirst%3DY.%26aulast%3DWurtz%26aufirst%3DN.%2BR.%26aulast%3DWei%26aufirst%3DA.%26aulast%3DWong%26aufirst%3DP.%26aulast%3DWexler%26aufirst%3DR.%2BR.%26aulast%3DPriestley%26aufirst%3DE.%2BS.%26atitle%3DAtropisomer%2520control%2520in%2520macrocyclic%2520factor%2520VIIa%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D4007%26epage%3D4018%26doi%3D10.1021%2Facs.jmedchem.6b00244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Petasis, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zavialov, I. A.</span><span> </span><span class="NLM_article-title">A new and practical synthesis of α-amino acids from alkenyl boronic acids</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">445</span><span class="NLM_x">–</span> <span class="NLM_lpage">446</span><span class="refDoi"> DOI: 10.1021/ja963178n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja963178n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=1%3ACAS%3A528%3ADyaK2sXhtFejurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=1997&pages=445-446&author=N.+A.+Petasisauthor=I.+A.+Zavialov&title=A+new+and+practical+synthesis+of+%CE%B1-amino+acids+from+alkenyl+boronic+acids&doi=10.1021%2Fja963178n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">A New and Practical Synthesis of α-Amino Acids from Alkenyl Boronic Acids</span></div><div class="casAuthors">Petasis, Nicos A.; Zavialov, Ilia A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">445-446</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Alkenylboronic acids and boronates react in a variety of solvents with amines and glyoxylic or pyruvic acid to give β,γ-unsatd. α-amino acid derivs.  This three-component boronic acid Mannich reaction normally proceeds at room temp., it does not require anhyd. or oxygen-free conditions and the product can be isolated by filtration.  Amino acids with very high diastereoselectivities (>99% de) can be obtained by using 2-phenylglycinol as the amine component.  This method was employed in a short synthesis of enantiomerically pure homophenylalanine (>99% ee).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfuL3SIKvR17Vg90H21EOLACvtfcHk0lj3a_j4RfcYWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhtFejurw%253D&md5=85bdfe5943f85111e4f89f181334fdd8</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fja963178n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja963178n%26sid%3Dliteratum%253Aachs%26aulast%3DPetasis%26aufirst%3DN.%2BA.%26aulast%3DZavialov%26aufirst%3DI.%2BA.%26atitle%3DA%2520new%2520and%2520practical%2520synthesis%2520of%2520%25CE%25B1-amino%2520acids%2520from%2520alkenyl%2520boronic%2520acids%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1997%26volume%3D119%26spage%3D445%26epage%3D446%26doi%3D10.1021%2Fja963178n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Zhang, X.; Nirschl, A. A.; Zou, Y.; Priestley, E. S.</span>: <span> </span><span class="NLM_article-title">Preparation of phenylglycinamide and pyridylglycinamide derivatives useful as anticoagulants. (Bristol-Myers Squibb)</span>. PCT Int. Appl. WO2007002313,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=X.+Zhang&author=A.+A.+Nirschl&author=Y.+Zou&author=E.+S.+Priestley&title=Preparation+of+phenylglycinamide+and+pyridylglycinamide+derivatives+useful+as+anticoagulants.+%28Bristol-Myers+Squibb%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26atitle%3DPreparation%2520of%2520phenylglycinamide%2520and%2520pyridylglycinamide%2520derivatives%2520useful%2520as%2520anticoagulants.%2520%2528Bristol-Myers%2520Squibb%2529%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Zhang, X.; Glunz, W. P.; Priestley, S. E.; Johnson, A. J.; Wurtz, R. N.; Ladziata, V.</span>: <span> </span><span class="NLM_article-title">Macrocyclic compounds as factor VIIa inhibitors and their preparation. (Bristol-Myers Squibb)</span>. PCT Int. WO2013184734,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=X.+Zhang&author=W.+P.+Glunz&author=S.+E.+Priestley&author=A.+J.+Johnson&author=R.+N.+Wurtz&author=V.+Ladziata&title=Macrocyclic+compounds+as+factor+VIIa+inhibitors+and+their+preparation.+%28Bristol-Myers+Squibb%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26atitle%3DMacrocyclic%2520compounds%2520as%2520factor%2520VIIa%2520inhibitors%2520and%2520their%2520preparation.%2520%2528Bristol-Myers%2520Squibb%2529%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Kansy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senner, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gubernator, K.</span><span> </span><span class="NLM_article-title">Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1007</span><span class="NLM_x">–</span> <span class="NLM_lpage">1010</span><span class="refDoi"> DOI: 10.1021/jm970530e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm970530e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=1%3ACAS%3A528%3ADyaK1cXhs12kt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=1007-1010&author=M.+Kansyauthor=F.+Sennerauthor=K.+Gubernator&title=Physicochemical+high+throughput+screening%3A+parallel+artificial+membrane+permeation+assay+in+the+description+of+passive+absorption+processes&doi=10.1021%2Fjm970530e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Physicochemical High Throughput Screening: Parallel Artificial Membrane Permeation Assay in the Description of Passive Absorption Processes</span></div><div class="casAuthors">Kansy, Manfred; Senner, Frank; Gubernator, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1007-1010</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The majority of pharmaceutical discovery projects aim for an orally available form of a new therapeutic principle.  One obstacle for per oral treatment is intestinal absorption.  A simple predictive exptl. method to assess the potential of intestinal absorption is therefore highly welcome.  The authors describe here the PAMPA (Parallel Artificial Membrane Permeation Assay) method, a simple, robust, high throughput screen (HTS) which has been shown to be predictive for passive diffusion through membranes and thus for oral absorption.  In addn. PAMPA can deliver information in parallel on the lipophilicity, the ionization state and the soly. of a compd.  Therefore PAMPA complements HTS, combinatorial chem. and parallel synthesis efforts in preclin. pharmaceutical research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqcwCGodCr1rVg90H21EOLACvtfcHk0lj3a_j4RfcYWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhs12kt70%253D&md5=85d8ab409313b583de52348eb4d895da</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm970530e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970530e%26sid%3Dliteratum%253Aachs%26aulast%3DKansy%26aufirst%3DM.%26aulast%3DSenner%26aufirst%3DF.%26aulast%3DGubernator%26aufirst%3DK.%26atitle%3DPhysicochemical%2520high%2520throughput%2520screening%253A%2520parallel%2520artificial%2520membrane%2520permeation%2520assay%2520in%2520the%2520description%2520of%2520passive%2520absorption%2520processes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D1007%26epage%3D1010%26doi%3D10.1021%2Fjm970530e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Glunz, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delucca, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nirschl, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weigelt, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheney, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anumula, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luettgen, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rendina, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harpel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knabb, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wexler, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Priestley, E. S.</span><span> </span><span class="NLM_article-title">Non-benzamidine acylsulfonylamide TF-FVIIa inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">5244</span><span class="NLM_x">–</span> <span class="NLM_lpage">5248</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.06.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=10.1016%2Fj.bmcl.2013.06.027" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=5244-5248&author=P.+W.+Glunzauthor=X.+Zhangauthor=Y.+Zouauthor=I.+Deluccaauthor=A.+H.+Nirschlauthor=X.+Chengauthor=C.+A.+Weigeltauthor=D.+L.+Cheneyauthor=A.+Weiauthor=R.+Anumulaauthor=J.+M.+Luettgenauthor=A.+R.+Rendinaauthor=M.+Harpelauthor=G.+Luoauthor=R.+Knabbauthor=P.+C.+Wongauthor=R.+R.+Wexlerauthor=E.+S.+Priestley&title=Non-benzamidine+acylsulfonylamide+TF-FVIIa+inhibitors&doi=10.1016%2Fj.bmcl.2013.06.027"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.06.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.06.027%26sid%3Dliteratum%253Aachs%26aulast%3DGlunz%26aufirst%3DP.%2BW.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZou%26aufirst%3DY.%26aulast%3DDelucca%26aufirst%3DI.%26aulast%3DNirschl%26aufirst%3DA.%2BH.%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DWeigelt%26aufirst%3DC.%2BA.%26aulast%3DCheney%26aufirst%3DD.%2BL.%26aulast%3DWei%26aufirst%3DA.%26aulast%3DAnumula%26aufirst%3DR.%26aulast%3DLuettgen%26aufirst%3DJ.%2BM.%26aulast%3DRendina%26aufirst%3DA.%2BR.%26aulast%3DHarpel%26aufirst%3DM.%26aulast%3DLuo%26aufirst%3DG.%26aulast%3DKnabb%26aufirst%3DR.%26aulast%3DWong%26aufirst%3DP.%2BC.%26aulast%3DWexler%26aufirst%3DR.%2BR.%26aulast%3DPriestley%26aufirst%3DE.%2BS.%26atitle%3DNon-benzamidine%2520acylsulfonylamide%2520TF-FVIIa%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D5244%26epage%3D5248%26doi%3D10.1016%2Fj.bmcl.2013.06.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Hagmann, K. W.</span><span> </span><span class="NLM_article-title">The many roles for fluorine in medicinal chemistry</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">4359</span><span class="NLM_x">–</span> <span class="NLM_lpage">4369</span><span class="refDoi"> DOI: 10.1021/jm800219f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800219f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=1%3ACAS%3A528%3ADC%252BD1cXns1WjtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4359-4369&author=K.+W.+Hagmann&title=The+many+roles+for+fluorine+in+medicinal+chemistry&doi=10.1021%2Fjm800219f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">The Many Roles for Fluorine in Medicinal Chemistry</span></div><div class="casAuthors">Hagmann, William K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4359-4369</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkZV7sio8RhbVg90H21EOLACvtfcHk0li3w7-msyasVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXns1WjtLo%253D&md5=821f8076bb0f632f687b1c90b05dd382</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm800219f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800219f%26sid%3Dliteratum%253Aachs%26aulast%3DHagmann%26aufirst%3DK.%2BW.%26atitle%3DThe%2520many%2520roles%2520for%2520fluorine%2520in%2520medicinal%2520chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4359%26epage%3D4369%26doi%3D10.1021%2Fjm800219f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><div class="note"><p class="first last">p<i>K</i><sub>a</sub> of the corresponding 1,6-diaminoisoquinoline was calculated using the</p></div>Jaguar Quantum Chemical Software Package, <span class="NLM_edition">version 6.0</span>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=pKa+of+the+corresponding+1%2C6-diaminoisoquinoline+was+calculated+using+theJaguar+Quantum+Chemical+Software+Package%2C+version+6.0%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+2005."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DJaguar%2520Quantum%2520Chemical%2520Software%2520Package%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><div class="note"><p class="first last">For example, see Protein Data Bank (PDB) entries <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4X8V">4X8V</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ZXY">4ZXY</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ZXX">4ZXX</a> at <a href="http://www.pdb.org" class="extLink">www.pdb.org</a>. Additional crystallographic structures of fluorinated P1s with similarly elaborated macrocycle linkers were utilized as well which will be published in due course</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=For+example%2C+see+Protein+Data+Bank+%28PDB%29+entries+4X8V%2C+4ZXY%2C+and+4ZXX+at+www.pdb.org.+Additional+crystallographic+structures+of+fluorinated+P1s+with+similarly+elaborated+macrocycle+linkers+were+utilized+as+well+which+will+be+published+in+due+course."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span>The PyMOL Molecular Graphics System, <span class="NLM_edition">version 1.7</span>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+PyMOL+Molecular+Graphics+System%2C+version+1.7%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+2014."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520PyMOL%2520Molecular%2520Graphics%2520System%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><div class="note"><p class="first last">Pharmacokinetic (PK) studies were conducted in accordance with the NIH Guide for the Care and Use of Laboratory Animals, and the regulations of the Animal Care and Use Committee of the Bristol-Myers Squibb Company by methods described in the following reference:</p></div><span class="NLM_contrib-group">He, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brogdon, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grace, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graden, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olah, T. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unger, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luettgen, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knabb, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinto, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, P. Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wexler, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decicco, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christ, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossman, S. J.</span><span> </span><span class="NLM_article-title">N-in-1 Dosing pharmacokinetics in drug discovery: experience, theoretical and practical considerations</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">2568</span><span class="NLM_x">–</span> <span class="NLM_lpage">2580</span><span class="refDoi"> DOI: 10.1002/jps.21196</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=10.1002%2Fjps.21196" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2008&pages=2568-2580&author=K.+Heauthor=M.+Qianauthor=H.+Wongauthor=S.+A.+Baiauthor=B.+Heauthor=B.+Brogdonauthor=J.+E.+Graceauthor=B.+Xinauthor=J.+Wuauthor=S.+X.+Renauthor=H.+Zengauthor=Y.+Dengauthor=D.+M.+Gradenauthor=T.+V.+Olahauthor=S.+E.+Ungerauthor=J.+M.+Luettgenauthor=R.+M.+Knabbauthor=D.+J.+Pintoauthor=P.+Y.+S.+Lamauthor=J.+Duanauthor=R.+R.+Wexlerauthor=C.+P.+Deciccoauthor=D.+D.+Christauthor=S.+J.+Grossman&title=N-in-1+Dosing+pharmacokinetics+in+drug+discovery%3A+experience%2C+theoretical+and+practical+considerations&doi=10.1002%2Fjps.21196"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1002%2Fjps.21196&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.21196%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DK.%26aulast%3DQian%26aufirst%3DM.%26aulast%3DWong%26aufirst%3DH.%26aulast%3DBai%26aufirst%3DS.%2BA.%26aulast%3DHe%26aufirst%3DB.%26aulast%3DBrogdon%26aufirst%3DB.%26aulast%3DGrace%26aufirst%3DJ.%2BE.%26aulast%3DXin%26aufirst%3DB.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DRen%26aufirst%3DS.%2BX.%26aulast%3DZeng%26aufirst%3DH.%26aulast%3DDeng%26aufirst%3DY.%26aulast%3DGraden%26aufirst%3DD.%2BM.%26aulast%3DOlah%26aufirst%3DT.%2BV.%26aulast%3DUnger%26aufirst%3DS.%2BE.%26aulast%3DLuettgen%26aufirst%3DJ.%2BM.%26aulast%3DKnabb%26aufirst%3DR.%2BM.%26aulast%3DPinto%26aufirst%3DD.%2BJ.%26aulast%3DLam%26aufirst%3DP.%2BY.%2BS.%26aulast%3DDuan%26aufirst%3DJ.%26aulast%3DWexler%26aufirst%3DR.%2BR.%26aulast%3DDecicco%26aufirst%3DC.%2BP.%26aulast%3DChrist%26aufirst%3DD.%2BD.%26aulast%3DGrossman%26aufirst%3DS.%2BJ.%26atitle%3DN-in-1%2520Dosing%2520pharmacokinetics%2520in%2520drug%2520discovery%253A%2520experience%252C%2520theoretical%2520and%2520practical%2520considerations%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2008%26volume%3D97%26spage%3D2568%26epage%3D2580%26doi%3D10.1002%2Fjps.21196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 11 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Peng Wu, Michael Givskov, <span class="NLM_string-name hlFld-ContribAuthor">Thomas E. Nielsen</span>. </span><span class="cited-content_cbyCitation_article-title">Reactivity and Synthetic Applications of Multicomponent Petasis Reactions. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2019,</strong> <em>119 </em>
                                    (20)
                                     , 11245-11290. <a href="https://doi.org/10.1021/acs.chemrev.9b00214" title="DOI URL">https://doi.org/10.1021/acs.chemrev.9b00214</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.9b00214&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.9b00214%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DReactivity%252Band%252BSynthetic%252BApplications%252Bof%252BMulticomponent%252BPetasis%252BReactions%26aulast%3DWu%26aufirst%3DPeng%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D05042019%26date%3D27082019%26volume%3D119%26issue%3D20%26spage%3D11245%26epage%3D11290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">Peter M. Fischer</span>. </span><span class="cited-content_cbyCitation_article-title">Design of Small-Molecule Active-Site Inhibitors of the S1A Family Proteases as Procoagulant and Anticoagulant Drugs. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (9)
                                     , 3799-3822. <a href="https://doi.org/10.1021/acs.jmedchem.7b00772" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00772</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00772&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00772%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Bof%252BSmall-Molecule%252BActive-Site%252BInhibitors%252Bof%252Bthe%252BS1A%252BFamily%252BProteases%252Bas%252BProcoagulant%252Band%252BAnticoagulant%252BDrugs%26aulast%3DFischer%26aufirst%3DPeter%2BM.%26date%3D2018%26date%3D2017%26date%3D2017%26date%3D25052017%26date%3D09112017%26date%3D26102017%26volume%3D61%26issue%3D9%26spage%3D3799%26epage%3D3822" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jeremy M.  Richter</span>, <span class="hlFld-ContribAuthor ">Daniel L.  Cheney</span>, <span class="hlFld-ContribAuthor ">J. Alex  Bates</span>, <span class="hlFld-ContribAuthor ">Anzhi  Wei</span>, <span class="hlFld-ContribAuthor ">Joseph M.  Luettgen</span>, <span class="hlFld-ContribAuthor ">Alan R.  Rendina</span>, <span class="hlFld-ContribAuthor ">Timothy M.  Harper</span>, <span class="hlFld-ContribAuthor ">Rangaraj  Narayanan</span>, <span class="hlFld-ContribAuthor ">Pancras C.  Wong</span>, <span class="hlFld-ContribAuthor ">Dietmar  Seiffert</span>, <span class="hlFld-ContribAuthor ">Ruth R.  Wexler</span>, and <span class="hlFld-ContribAuthor ">E. Scott  Priestley</span>  . </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of Novel Meta-Linked Phenylglycine Macrocyclic FVIIa Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>8 </em>
                                    (1)
                                     , 67-72. <a href="https://doi.org/10.1021/acsmedchemlett.6b00375" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.6b00375</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.6b00375&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.6b00375%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252BNovel%252BMeta-Linked%252BPhenylglycine%252BMacrocyclic%252BFVIIa%252BInhibitors%26aulast%3DRichter%26aufirst%3DJeremy%2BM.%26date%3D2017%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D23092016%26date%3D01112016%26date%3D07112016%26date%3D12012017%26date%3D01112016%26volume%3D8%26issue%3D1%26spage%3D67%26epage%3D72" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nikoletta  Harsági</span>, <span class="hlFld-ContribAuthor ">György  Keglevich</span>. </span><span class="cited-content_cbyCitation_article-title">The Hydrolysis of Phosphinates and Phosphonates: A Review. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (10)
                                     , 2840. <a href="https://doi.org/10.3390/molecules26102840" title="DOI URL">https://doi.org/10.3390/molecules26102840</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26102840&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26102840%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DThe%252BHydrolysis%252Bof%252BPhosphinates%252Band%252BPhosphonates%25253A%252BA%252BReview%26aulast%3DHars%25C3%25A1gi%26aufirst%3DNikoletta%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D10%26spage%3D2840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thuy  Van Lam van</span>, <span class="hlFld-ContribAuthor ">Teodora  Ivanova</span>, <span class="hlFld-ContribAuthor ">Kornelia  Hardes</span>, <span class="hlFld-ContribAuthor ">Miriam Ruth  Heindl</span>, <span class="hlFld-ContribAuthor ">Rory E.  Morty</span>, <span class="hlFld-ContribAuthor ">Eva  Böttcher‐Friebertshäuser</span>, <span class="hlFld-ContribAuthor ">Iris  Lindberg</span>, <span class="hlFld-ContribAuthor ">Manuel E.  Than</span>, <span class="hlFld-ContribAuthor ">Sven O.  Dahms</span>, <span class="hlFld-ContribAuthor ">Torsten  Steinmetzer</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Characterization of Macrocyclic Inhibitors of the Proprotein Convertase Furin. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2019,</strong> <em>14 </em>
                                    (6)
                                     , 673-685. <a href="https://doi.org/10.1002/cmdc.201800807" title="DOI URL">https://doi.org/10.1002/cmdc.201800807</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201800807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201800807%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BCharacterization%252Bof%252BMacrocyclic%252BInhibitors%252Bof%252Bthe%252BProprotein%252BConvertase%252BFurin%26aulast%3DVan%2BLam%25E2%2580%2585van%26aufirst%3DThuy%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D6%26spage%3D673%26epage%3D685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mare  Oja</span>, <span class="hlFld-ContribAuthor ">Uko  Maran</span>. </span><span class="cited-content_cbyCitation_article-title">pH-permeability profiles for drug substances: Experimental detection, comparison with human intestinal absorption and modelling. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmaceutical Sciences</span><span> <strong>2018,</strong> <em>123 </em>, 429-440. <a href="https://doi.org/10.1016/j.ejps.2018.07.014" title="DOI URL">https://doi.org/10.1016/j.ejps.2018.07.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejps.2018.07.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejps.2018.07.014%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmaceutical%2520Sciences%26atitle%3DpH-permeability%252Bprofiles%252Bfor%252Bdrug%252Bsubstances%25253A%252BExperimental%252Bdetection%25252C%252Bcomparison%252Bwith%252Bhuman%252Bintestinal%252Babsorption%252Band%252Bmodelling%26aulast%3DOja%26aufirst%3DMare%26date%3D2018%26volume%3D123%26spage%3D429%26epage%3D440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sulejman  Alihodžić</span>, <span class="hlFld-ContribAuthor ">Mirjana  Bukvić</span>, <span class="hlFld-ContribAuthor ">Ivaylo J.  Elenkov</span>, <span class="hlFld-ContribAuthor ">Antun  Hutinec</span>, <span class="hlFld-ContribAuthor ">Sanja  Koštrun</span>, <span class="hlFld-ContribAuthor ">Dijana  Pešić</span>, <span class="hlFld-ContribAuthor ">Gordon  Saxty</span>, <span class="hlFld-ContribAuthor ">Linda  Tomašković</span>, <span class="hlFld-ContribAuthor ">Dinko  Žiher</span>. </span><span class="cited-content_cbyCitation_article-title">Current Trends in Macrocyclic Drug Discovery and beyond -Ro5. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 113-233. <a href="https://doi.org/10.1016/bs.pmch.2018.01.002" title="DOI URL">https://doi.org/10.1016/bs.pmch.2018.01.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.pmch.2018.01.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.pmch.2018.01.002%26sid%3Dliteratum%253Aachs%26atitle%3DCurrent%252BTrends%252Bin%252BMacrocyclic%252BDrug%252BDiscovery%252Band%252Bbeyond%252B-Ro5%26aulast%3DAlihod%25C5%25BEi%25C4%2587%26aufirst%3DSulejman%26date%3D2018%26spage%3D113%26epage%3D233%26pub%3DElsevier%26date%3D2018%26volume%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter W.  Glunz</span>. </span><span class="cited-content_cbyCitation_article-title">Recent encounters with atropisomerism in drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (2)
                                     , 53-60. <a href="https://doi.org/10.1016/j.bmcl.2017.11.050" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.11.050</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.11.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.11.050%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DRecent%252Bencounters%252Bwith%252Batropisomerism%252Bin%252Bdrug%252Bdiscovery%26aulast%3DGlunz%26aufirst%3DPeter%2BW.%26date%3D2018%26volume%3D28%26issue%3D2%26spage%3D53%26epage%3D60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicholas R.  Wurtz</span>, <span class="hlFld-ContribAuthor ">Brandon L.  Parkhurst</span>, <span class="hlFld-ContribAuthor ">Indawati  DeLucca</span>, <span class="hlFld-ContribAuthor ">Peter W.  Glunz</span>, <span class="hlFld-ContribAuthor ">Wen  Jiang</span>, <span class="hlFld-ContribAuthor ">Xiaojun  Zhang</span>, <span class="hlFld-ContribAuthor ">Daniel L.  Cheney</span>, <span class="hlFld-ContribAuthor ">Jeffrey M.  Bozarth</span>, <span class="hlFld-ContribAuthor ">Alan R.  Rendina</span>, <span class="hlFld-ContribAuthor ">Anzhi  Wei</span>, <span class="hlFld-ContribAuthor ">Tim  Harper</span>, <span class="hlFld-ContribAuthor ">Joseph M.  Luettgen</span>, <span class="hlFld-ContribAuthor ">Yiming  Wu</span>, <span class="hlFld-ContribAuthor ">Pancras C.  Wong</span>, <span class="hlFld-ContribAuthor ">Dietmar A.  Seiffert</span>, <span class="hlFld-ContribAuthor ">Ruth R.  Wexler</span>, <span class="hlFld-ContribAuthor ">E. Scott  Priestley</span>. </span><span class="cited-content_cbyCitation_article-title">Neutral macrocyclic factor VIIa inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (12)
                                     , 2650-2654. <a href="https://doi.org/10.1016/j.bmcl.2017.04.008" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.04.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.04.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.04.008%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DNeutral%252Bmacrocyclic%252Bfactor%252BVIIa%252Binhibitors%26aulast%3DWurtz%26aufirst%3DNicholas%2BR.%26date%3D2017%26volume%3D27%26issue%3D12%26spage%3D2650%26epage%3D2654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Charlotte M  Sevrain</span>, <span class="hlFld-ContribAuthor ">Mathieu  Berchel</span>, <span class="hlFld-ContribAuthor ">Hélène  Couthon</span>, <span class="hlFld-ContribAuthor ">Paul-Alain  Jaffrès</span>. </span><span class="cited-content_cbyCitation_article-title">Phosphonic acid: preparation and applications. </span><span class="cited-content_cbyCitation_journal-name">Beilstein Journal of Organic Chemistry</span><span> <strong>2017,</strong> <em>13 </em>, 2186-2213. <a href="https://doi.org/10.3762/bjoc.13.219" title="DOI URL">https://doi.org/10.3762/bjoc.13.219</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3762/bjoc.13.219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3762%2Fbjoc.13.219%26sid%3Dliteratum%253Aachs%26jtitle%3DBeilstein%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DPhosphonic%252Bacid%25253A%252Bpreparation%252Band%252Bapplications%26aulast%3DSevrain%26aufirst%3DCharlotte%2BM%26date%3D2017%26date%3D2017%26volume%3D13%26spage%3D2186%26epage%3D2213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vladimir (Uladzimir)  Ladziata</span>, <span class="hlFld-ContribAuthor ">Peter W.  Glunz</span>, <span class="hlFld-ContribAuthor ">Yan  Zou</span>, <span class="hlFld-ContribAuthor ">Xiaojun  Zhang</span>, <span class="hlFld-ContribAuthor ">Wen  Jiang</span>, <span class="hlFld-ContribAuthor ">Swanee  Jacutin-Porte</span>, <span class="hlFld-ContribAuthor ">Daniel L.  Cheney</span>, <span class="hlFld-ContribAuthor ">Anzhi  Wei</span>, <span class="hlFld-ContribAuthor ">Joseph M.  Luettgen</span>, <span class="hlFld-ContribAuthor ">Timothy M.  Harper</span>, <span class="hlFld-ContribAuthor ">Pancras C.  Wong</span>, <span class="hlFld-ContribAuthor ">Dietmar  Seiffert</span>, <span class="hlFld-ContribAuthor ">Ruth R.  Wexler</span>, <span class="hlFld-ContribAuthor ">E. Scott  Priestley</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and P1′ SAR exploration of potent macrocyclic tissue factor-factor VIIa inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (20)
                                     , 5051-5057. <a href="https://doi.org/10.1016/j.bmcl.2016.08.088" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.08.088</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.08.088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.08.088%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252BP1%2525E2%252580%2525B2%252BSAR%252Bexploration%252Bof%252Bpotent%252Bmacrocyclic%252Btissue%252Bfactor-factor%252BVIIa%252Binhibitors%26aulast%3DLadziata%26aufirst%3DVladimir%2B%2528Uladzimir%2529%26date%3D2016%26volume%3D26%26issue%3D20%26spage%3D5051%26epage%3D5057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00469/20160811/images/medium/jm-2016-004697_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00469/20160811/images/large/jm-2016-004697_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00469&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00469/20160811/images/medium/jm-2016-004697_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00469/20160811/images/large/jm-2016-004697_0002.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Optimization of P′ and fluorination of P1 in <b>1</b> led to the discovery of lead compound <b>13</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00469/20160811/images/large/jm-2016-004697_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00469&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00469/20160811/images/medium/jm-2016-004697_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00469/20160811/images/large/jm-2016-004697_0005.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Macrocyclic Inhibitors <b>1</b> and <b>8</b>–<b>10</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00469/20160811/images/large/jm-2016-004697_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00469&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) DMF/CH<sub>3</sub>CN (1:2), 80 °C; (b) BOP, DIEA, DMF/CH<sub>3</sub>CN (1:2), 51–77% for 2 steps; (c) phosgene, CH<sub>3</sub>CN/CH<sub>2</sub>Cl<sub>2</sub> (1:1), then TEA; (d) chiral HPLC, 37–49% for 2 steps; (e) TFA/CH<sub>2</sub>Cl<sub>2</sub> or 4.0 N HCl in dioxane/EtOAc, 36–60%; (f) LiOH, THF, 40 °C, 51%.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00469/20160811/images/medium/jm-2016-004697_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00469/20160811/images/large/jm-2016-004697_0006.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Macrocyclic Inhibitors <b>2</b> and <b>7</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00469/20160811/images/large/jm-2016-004697_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00469&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) BOP, DIEA, DMF/CH<sub>3</sub>CN (1:2), 54–59%; (b) Pd/C, H<sub>2</sub> balloon, MeOH, 82–89%; (c) phosgene, CH<sub>3</sub>CN/CH<sub>2</sub>Cl<sub>2</sub> (1:1), then TEA; (d) chiral HPLC, 12–32% for 2 steps; (e) TFA/CH<sub>2</sub>Cl<sub>2</sub>, 44–90%.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00469/20160811/images/medium/jm-2016-004697_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00469/20160811/images/large/jm-2016-004697_0007.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Macrocyclic Inhibitors <b>3</b>–<b>6</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00469/20160811/images/large/jm-2016-004697_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00469&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Pd(OAc)<sub>2</sub>, dppp, CO (25 psi), TEA, DMSO/MeOH (2:1), 80 °C, 83%; (b) LiOH, THF/H<sub>2</sub>O (2:1), 57%; (c) EDC/HOBt, NH<sub>4</sub>Cl, DIEA, 97% for <b>4</b>; HATU, <i>N</i>-methylmorpholine, DMF, 29–39% for <b>5</b>–<b>6</b>; (d) TFA, 80–90%.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00469/20160811/images/medium/jm-2016-004697_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00469/20160811/images/large/jm-2016-004697_0008.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Macrocyclic Inhibitors <b>11</b>–<b>13</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00469/20160811/images/large/jm-2016-004697_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00469&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) DMF/CH<sub>3</sub>CN (1:2), 80 °C; (b) BOP, TEA, DMF/CH<sub>3</sub>CN (1:2), 38–54% for two steps; (c) phosgene, CH<sub>3</sub>CN/CH<sub>2</sub>Cl<sub>2</sub> (1:1), then TEA; (d) chiral HPLC, 34–43% for 2 steps; (e) TFA/CH<sub>2</sub>Cl<sub>2</sub> or 4.0 N HCl in dioxane/EtOAc, 17–90%.</p></p></figure><figure data-id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00469/20160811/images/medium/jm-2016-004697_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00469/20160811/images/large/jm-2016-004697_0009.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Fluoro-Substituted Aminoisoquinolines <b>25a</b>–<b>c</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00469/20160811/images/large/jm-2016-004697_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00469&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) POCl<sub>3</sub>, 100 °C, >95%; (b) NH<sub>3</sub>, HO(CH<sub>2</sub>)<sub>2</sub>OH, 130 °C, 50–64%; (c) (Boc)<sub>2</sub>O, DMAP (cat.), CH<sub>3</sub>CN, 66–77%; (d) Pd(OH)<sub>2</sub>, H<sub>2</sub> (55 psi), EtOH, 90–96%; (e) Selectfluor, MeOH/CH<sub>3</sub>CN (1:1), 82 °C, 99%; (f) 4.0 HCl, dioxane/CH<sub>3</sub>CN (1:1), 65 °C, 98%; (g) Pd(OAc)<sub>2</sub>, benzophenone imine, BINAP, Cs<sub>2</sub>CO<sub>3</sub>, toluene, 90 °C, then HCl, THF/H<sub>2</sub>O, 79%; (h) Pd/C, H<sub>2</sub> (balloon), HCl (cat.), MeOH, 99%.</p></p></figure><figure data-id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00469/20160811/images/medium/jm-2016-004697_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00469/20160811/images/large/jm-2016-004697_0003.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Model of <b>13</b> bound in FVIIa. Graphics were generated with the program PyMOL.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00469/20160811/images/large/jm-2016-004697_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00469&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00469/20160811/images/medium/jm-2016-004697_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00469/20160811/images/large/jm-2016-004697_0004.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Antithrombotic effects of compound <b>13</b> in the rabbit ECAT model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00469/20160811/images/large/jm-2016-004697_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00469&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i59">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57854" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57854" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 36 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Henry, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, R. U.</span><span> </span><span class="NLM_article-title">Recent research developments in the direct inhibition of coagulation proteinases - inhibitors of the initiation phase</span> <span class="citation_source-journal">Cardiovasc. Hematol. Agents Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">323</span><span class="NLM_x">–</span> <span class="NLM_lpage">336</span><span class="refDoi"> DOI: 10.2174/187152508785909519</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=10.2174%2F187152508785909519" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2008&pages=323-336&author=L.+B.+Henryauthor=R.+U.+Desai&title=Recent+research+developments+in+the+direct+inhibition+of+coagulation+proteinases+-+inhibitors+of+the+initiation+phase&doi=10.2174%2F187152508785909519"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.2174%2F187152508785909519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152508785909519%26sid%3Dliteratum%253Aachs%26aulast%3DHenry%26aufirst%3DL.%2BB.%26aulast%3DDesai%26aufirst%3DR.%2BU.%26atitle%3DRecent%2520research%2520developments%2520in%2520the%2520direct%2520inhibition%2520of%2520coagulation%2520proteinases%2520-%2520inhibitors%2520of%2520the%2520initiation%2520phase%26jtitle%3DCardiovasc.%2520Hematol.%2520Agents%2520Med.%2520Chem.%26date%3D2008%26volume%3D6%26spage%3D323%26epage%3D336%26doi%3D10.2174%2F187152508785909519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Soejima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuguchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuguchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwanaga, S.</span><span> </span><span class="NLM_article-title">Factor VIIa modified in the 170 loop shows enhanced catalytic activity but does not change the zymogen-like property</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">17229</span><span class="NLM_x">–</span> <span class="NLM_lpage">17235</span><span class="refDoi"> DOI: 10.1074/jbc.M009206200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=10.1074%2Fjbc.M009206200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=17229-17235&author=K.+Soejimaauthor=J.+Mizuguchiauthor=M.+Yuguchiauthor=T.+Nakagakiauthor=S.+Higashiauthor=S.+Iwanaga&title=Factor+VIIa+modified+in+the+170+loop+shows+enhanced+catalytic+activity+but+does+not+change+the+zymogen-like+property&doi=10.1074%2Fjbc.M009206200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M009206200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M009206200%26sid%3Dliteratum%253Aachs%26aulast%3DSoejima%26aufirst%3DK.%26aulast%3DMizuguchi%26aufirst%3DJ.%26aulast%3DYuguchi%26aufirst%3DM.%26aulast%3DNakagaki%26aufirst%3DT.%26aulast%3DHigashi%26aufirst%3DS.%26aulast%3DIwanaga%26aufirst%3DS.%26atitle%3DFactor%2520VIIa%2520modified%2520in%2520the%2520170%2520loop%2520shows%2520enhanced%2520catalytic%2520activity%2520but%2520does%2520not%2520change%2520the%2520zymogen-like%2520property%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D17229%26epage%3D17235%26doi%3D10.1074%2Fjbc.M009206200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Golino, P.</span><span> </span><span class="NLM_article-title">The inhibitors of the tissue factor:factor VII pathway</span> <span class="citation_source-journal">Thromb. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">V257</span><span class="NLM_x">–</span> <span class="NLM_lpage">V265</span><span class="refDoi"> DOI: 10.1016/S0049-3848(02)00079-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=10.1016%2FS0049-3848%2802%2900079-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2002&pages=V257-V265&author=P.+Golino&title=The+inhibitors+of+the+tissue+factor%3Afactor+VII+pathway&doi=10.1016%2FS0049-3848%2802%2900079-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS0049-3848%2802%2900079-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0049-3848%252802%252900079-8%26sid%3Dliteratum%253Aachs%26aulast%3DGolino%26aufirst%3DP.%26atitle%3DThe%2520inhibitors%2520of%2520the%2520tissue%2520factor%253Afactor%2520VII%2520pathway%26jtitle%3DThromb.%2520Res.%26date%3D2002%26volume%3D106%26spage%3DV257%26epage%3DV265%26doi%3D10.1016%2FS0049-3848%2802%2900079-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Houston, D. S.</span><span> </span><span class="NLM_article-title">Tissue factor - a therapeutic target for thrombotic disorders</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">174</span><span class="refDoi"> DOI: 10.1517/14728222.6.2.159</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=10.1517%2F14728222.6.2.159" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=12223078" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=1%3ACAS%3A528%3ADC%252BD38Xjs1KhtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2002&pages=159-174&author=D.+S.+Houston&title=Tissue+factor+-+a+therapeutic+target+for+thrombotic+disorders&doi=10.1517%2F14728222.6.2.159"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Tissue factor - a therapeutic target for thrombotic disorders</span></div><div class="casAuthors">Houston, Donald S.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">159-174</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Exposure of blood to tissue factor (TF) sets off the coagulation cascade.  TF is a transmembrane protein that serves as an essential cofactor for activated coagulation factor VII (FVIIa).  TF may be exposed locally by vascular injury (such as balloon angioplasty) or by spontaneous rupture of an atherosclerotic plaque.  Expression of TF may also be induced on monocytes and endothelial cells in conditions like sepsis and cancer, causing a more generalized activation of clotting.  TF may thus play a central role in thrombosis in a no. of settings, and attention has turned to blocking TF as a means to prevent thrombosis.  Inhibiting the inducible expression of TF by monocytes can be achieved by "deactivating" cytokines, such as interleukin (IL)-4, -10 and -13, or by certain prostanoids; by drugs that modify signal transduction, such as pentoxifylline, retinoic acid or vitamin D3, or by antisense oligonucleotides.  Such approaches are for the most part at a preclin. stage.  The function of TF can be blocked by antibodies that prevent the binding of FVIIa to TF; by active site-inhibited FVIIa, which competes with native FVIIa for binding; by antibodies or small mols. that block the function of the TF/FVIIa complex; and by mols., such as TF pathway inhibitor or nematode anticoagulant peptide C2, which inhibit the active site of FVIIa in the TF/FVIIa complex after first binding to activated factor X.  The latter two agents have entered Phase II clin. trials.  Perhaps most intriguing is the use of anti-TF agents locally, which holds the promise of stopping thrombosis at a specific site of injury without the bleeding risk assocd. with systemic anticoagulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwePXJMpIGx7Vg90H21EOLACvtfcHk0lgU52AbNF3N0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xjs1KhtLs%253D&md5=eff403c5cf411f1d4e006fd253126b43</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1517%2F14728222.6.2.159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.6.2.159%26sid%3Dliteratum%253Aachs%26aulast%3DHouston%26aufirst%3DD.%2BS.%26atitle%3DTissue%2520factor%2520-%2520a%2520therapeutic%2520target%2520for%2520thrombotic%2520disorders%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2002%26volume%3D6%26spage%3D159%26epage%3D174%26doi%3D10.1517%2F14728222.6.2.159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Arnold, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Upshaw, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prydz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chand, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotian, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bantia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu, Y. S.</span><span> </span><span class="NLM_article-title">The antithrombotic and anti-inflammatory effects of BCX-3607, a small molecule tissue factor/factor VIIa inhibitor</span> <span class="citation_source-journal">Thromb. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">343</span><span class="NLM_x">–</span> <span class="NLM_lpage">349</span><span class="refDoi"> DOI: 10.1016/j.thromres.2005.03.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=10.1016%2Fj.thromres.2005.03.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=16378835" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=1%3ACAS%3A528%3ADC%252BD28XksVyj" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2006&pages=343-349&author=C.+S.+Arnoldauthor=C.+Parkerauthor=R.+Upshawauthor=H.+Prydzauthor=P.+Chandauthor=P.+Kotianauthor=S.+Bantiaauthor=Y.+S.+Babu&title=The+antithrombotic+and+anti-inflammatory+effects+of+BCX-3607%2C+a+small+molecule+tissue+factor%2Ffactor+VIIa+inhibitor&doi=10.1016%2Fj.thromres.2005.03.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The antithrombotic and anti-inflammatory effects of BCX-3607, a small molecule tissue factor/factor VIIa inhibitor</span></div><div class="casAuthors">Arnold, C. Shane; Parker, Cynthia; Upshaw, Ramanda; Prydz, Hans; Chand, Pooran; Kotian, Pravin; Bantia, Shanta; Babu, Y. Sudhakar</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">343-349</span>CODEN:
                <span class="NLM_cas:coden">THBRAA</span>;
        ISSN:<span class="NLM_cas:issn">0049-3848</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Tissue factor (TF) is a transmembrane glycoprotein that binds its zymogen cofactor, Factor VIIa (FVIIa) on the cell surface.  Together (TF/FVIIa) they activate Factor X (FX) and Factor IX (FIX) and start the extrinsic pathway of blood coagulation.  As such, the TF/FVIIa complex plays an important role in normal physiol. as well as in thrombotic diseases such as unstable angina (UA), disseminated intravascular coagulation (DIC), and deep vein thrombosis (DVT).  In addn. to its function as an initiator of coagulation, TF/FVIIa plays an important role in inflammation.  Expression of TF on the cell surface and its appearance as a sol. mol. are characteristic features of acute and chronic inflammation in conditions such as sepsis and atherosclerosis.  Here we demonstrate that BCX-3607, a small mol. potent inhibitor of TF/FVIIa, reduces thrombus wt. in an animal model of DVT.  BCX-3607 also decreases the level of interleukin-6 (IL-6) in a LPS-stimulated mouse model of endotoxemia.  Addnl., in vitro studies indicate that BCX-3607 blocks the generation of TF/FVIIa-induced IL-8 mRNA in human keratinocytes and reduces the TF/FVIIa-mediated generation of IL-6 and IL-8 in human umbilical vein endothelial cells (HUVEC).  Therefore, BCX-3607 might block the TF/FVIIa-mediated coagulation and inflammation assocd. with pathol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPjwtCzXOm2LVg90H21EOLACvtfcHk0lgU52AbNF3N0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XksVyj&md5=4252b9eb75f303c34b111a0db12a62d3</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.thromres.2005.03.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.thromres.2005.03.015%26sid%3Dliteratum%253Aachs%26aulast%3DArnold%26aufirst%3DC.%2BS.%26aulast%3DParker%26aufirst%3DC.%26aulast%3DUpshaw%26aufirst%3DR.%26aulast%3DPrydz%26aufirst%3DH.%26aulast%3DChand%26aufirst%3DP.%26aulast%3DKotian%26aufirst%3DP.%26aulast%3DBantia%26aufirst%3DS.%26aulast%3DBabu%26aufirst%3DY.%2BS.%26atitle%3DThe%2520antithrombotic%2520and%2520anti-inflammatory%2520effects%2520of%2520BCX-3607%252C%2520a%2520small%2520molecule%2520tissue%2520factor%252Ffactor%2520VIIa%2520inhibitor%26jtitle%3DThromb.%2520Res.%26date%3D2006%26volume%3D117%26spage%3D343%26epage%3D349%26doi%3D10.1016%2Fj.thromres.2005.03.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Olivero, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eigenbrot, C. G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldsmith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robarge, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artis, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flygare, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rawson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutherlin, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadkhodayan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beresini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, L. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeGuzman, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banner, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ultsch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marzec, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanson, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Refino, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunting, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirchhofer, D.</span><span> </span><span class="NLM_article-title">A selective, slow binding inhibitor of factor VIIa binds to a nonstandard active site conformation and attenuates thrombus formation in vivo</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">9160</span><span class="NLM_x">–</span> <span class="NLM_lpage">9169</span><span class="refDoi"> DOI: 10.1074/jbc.M409068200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=10.1074%2Fjbc.M409068200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=15632123" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitVCitLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=9160-9169&author=A.+G.+Oliveroauthor=C.+G.+R.+Eigenbrotauthor=R.+Goldsmithauthor=K.+Robargeauthor=D.+R.+Artisauthor=J.+Flygareauthor=T.+Rawsonauthor=D.+P.+Sutherlinauthor=S.+Kadkhodayanauthor=M.+Beresiniauthor=L.+O.+Elliottauthor=G.+G.+DeGuzmanauthor=D.+W.+Bannerauthor=M.+Ultschauthor=U.+Marzecauthor=S.+R.+Hansonauthor=C.+Refinoauthor=S.+Buntingauthor=D.+Kirchhofer&title=A+selective%2C+slow+binding+inhibitor+of+factor+VIIa+binds+to+a+nonstandard+active+site+conformation+and+attenuates+thrombus+formation+in+vivo&doi=10.1074%2Fjbc.M409068200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">A Selective, Slow Binding Inhibitor of Factor VIIa Binds to a Nonstandard Active Site Conformation and Attenuates Thrombus Formation in Vivo</span></div><div class="casAuthors">Olivero, Alan G.; Eigenbrot, Charles; Goldsmith, Richard; Robarge, Kirk; Artis, Dean R.; Flygare, John; Rawson, Thomas; Sutherlin, Daniel P.; Kadkhodayan, Saloumeh; Beresini, Maureen; Elliott, Linda O.; DeGuzman, Geralyn G.; Banner, David W.; Ultsch, Mark; Marzec, Ulla; Hanson, Stephen R.; Refino, Canio; Bunting, Stuart; Kirchhofer, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">9160-9169</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The serine protease factor VIIa (FVIIa) in complex with its cellular cofactor tissue factor (TF) initiates the blood coagulation reactions.  TF·FVIIa is also implicated in thrombosis-related disorders and constitutes an appealing therapeutic target for treatment of cardiovascular diseases.  To this end, we generated the FVIIa active site inhibitor G17905, which displayed great potency toward TF·FVIIa (Ki = 0.35 ± 0.11 nM).  G17905 did not appreciably inhibit 12 of the 14 examd. trypsin-like serine proteases, consistent with its TF·FVIIa-specific activity in clotting assays.  The crystal structure of the FVIIa·G17905 complex provides insight into the mol. basis of the high selectivity.  It shows that compared with other serine proteases, FVIIa is uniquely equipped to accommodate conformational disturbances in the Gln217-Gly219 region caused by the ortho-hydroxy group of the inhibitor's aminobenzamidine moiety located in the S1 recognition pocket.  Moreover, the structure revealed a novel, nonstandard conformation of FVIIa active site in the region of the oxyanion hole, a "flipped" Lys192-Gly193 peptide bond.  Macromol. substrate activation assays demonstrated that G17905 is a noncompetitive, slow-binding inhibitor.  Nevertheless, G17905 effectively inhibited thrombus formation in a baboon arterio-venous shunt model, reducing platelet and fibrin deposition by ∼70% at 0.4 mg/kg + 0.1 mg/kg/min infusion.  Therefore, the in vitro potency of G17905, characterized by slow binding kinetics, correlated with efficacious antithrombotic activity in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqBsqLvuUrX7Vg90H21EOLACvtfcHk0liKFc5dx9gLjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitVCitLc%253D&md5=55ce1fbbe36808a4c495f9c6768e2397</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M409068200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M409068200%26sid%3Dliteratum%253Aachs%26aulast%3DOlivero%26aufirst%3DA.%2BG.%26aulast%3DEigenbrot%26aufirst%3DC.%2BG.%2BR.%26aulast%3DGoldsmith%26aufirst%3DR.%26aulast%3DRobarge%26aufirst%3DK.%26aulast%3DArtis%26aufirst%3DD.%2BR.%26aulast%3DFlygare%26aufirst%3DJ.%26aulast%3DRawson%26aufirst%3DT.%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26aulast%3DKadkhodayan%26aufirst%3DS.%26aulast%3DBeresini%26aufirst%3DM.%26aulast%3DElliott%26aufirst%3DL.%2BO.%26aulast%3DDeGuzman%26aufirst%3DG.%2BG.%26aulast%3DBanner%26aufirst%3DD.%2BW.%26aulast%3DUltsch%26aufirst%3DM.%26aulast%3DMarzec%26aufirst%3DU.%26aulast%3DHanson%26aufirst%3DS.%2BR.%26aulast%3DRefino%26aufirst%3DC.%26aulast%3DBunting%26aufirst%3DS.%26aulast%3DKirchhofer%26aufirst%3DD.%26atitle%3DA%2520selective%252C%2520slow%2520binding%2520inhibitor%2520of%2520factor%2520VIIa%2520binds%2520to%2520a%2520nonstandard%2520active%2520site%2520conformation%2520and%2520attenuates%2520thrombus%2520formation%2520in%2520vivo%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D9160%26epage%3D9169%26doi%3D10.1074%2Fjbc.M409068200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Salyers, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szalony, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suleymanov, O. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parlow, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">South, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholson, N. S.</span><span> </span><span class="NLM_article-title">Assessment of bleeding propensity in non-human primates by combination of selective tissue factor/VIIa inhibition and aspirin compared to warfarin and aspirin treatment</span> <span class="citation_source-journal">Pharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">100</span><span class="NLM_x">–</span> <span class="NLM_lpage">106</span><span class="refDoi"> DOI: 10.1159/000074674</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=10.1159%2F000074674" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2004&pages=100-106&author=A.+K.+Salyersauthor=J.+A.+Szalonyauthor=O.+D.+Suleymanovauthor=J.+J.+Parlowauthor=R.+S.+Woodauthor=M.+S.+Southauthor=N.+S.+Nicholson&title=Assessment+of+bleeding+propensity+in+non-human+primates+by+combination+of+selective+tissue+factor%2FVIIa+inhibition+and+aspirin+compared+to+warfarin+and+aspirin+treatment&doi=10.1159%2F000074674"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1159%2F000074674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000074674%26sid%3Dliteratum%253Aachs%26aulast%3DSalyers%26aufirst%3DA.%2BK.%26aulast%3DSzalony%26aufirst%3DJ.%2BA.%26aulast%3DSuleymanov%26aufirst%3DO.%2BD.%26aulast%3DParlow%26aufirst%3DJ.%2BJ.%26aulast%3DWood%26aufirst%3DR.%2BS.%26aulast%3DSouth%26aufirst%3DM.%2BS.%26aulast%3DNicholson%26aufirst%3DN.%2BS.%26atitle%3DAssessment%2520of%2520bleeding%2520propensity%2520in%2520non-human%2520primates%2520by%2520combination%2520of%2520selective%2520tissue%2520factor%252FVIIa%2520inhibition%2520and%2520aspirin%2520compared%2520to%2520warfarin%2520and%2520aspirin%2520treatment%26jtitle%3DPharmacology%26date%3D2004%26volume%3D70%26spage%3D100%26epage%3D106%26doi%3D10.1159%2F000074674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Suleymanov, O. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szalony, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salyers, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lachance, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parlow, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">South, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholson, N. S.</span><span> </span><span class="NLM_article-title">Pharmacological interruption of acute thrombus formation with minimal hemorrhagic complications by a small molecule tissue factor/factor VIIa inhibitor: Comparison to factor Xa and thrombin inhibition in a nonhuman primate thrombosis model</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">306</span><span class="NLM_x">, </span> <span class="NLM_fpage">1115</span><span class="NLM_x">–</span> <span class="NLM_lpage">1121</span><span class="refDoi"> DOI: 10.1124/jpet.103.052779</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=10.1124%2Fjpet.103.052779" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=12829728" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmvVehtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=306&publication_year=2003&pages=1115-1121&author=O.+D.+Suleymanovauthor=J.+A.+Szalonyauthor=A.+K.+Salyersauthor=R.+M.+Lachanceauthor=J.+J.+Parlowauthor=M.+S.+Southauthor=R.+S.+Woodauthor=N.+S.+Nicholson&title=Pharmacological+interruption+of+acute+thrombus+formation+with+minimal+hemorrhagic+complications+by+a+small+molecule+tissue+factor%2Ffactor+VIIa+inhibitor%3A+Comparison+to+factor+Xa+and+thrombin+inhibition+in+a+nonhuman+primate+thrombosis+model&doi=10.1124%2Fjpet.103.052779"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological interruption of acute thrombus formation with minimal hemorrhagic complications by a small molecule tissue factor/factor VIIa inhibitor: Comparison to factor Xa and thrombin inhibition in a nonhuman primate thrombosis model</span></div><div class="casAuthors">Suleymanov, Osman D.; Szalony, James A.; Salyers, Anita K.; Lachance, Rhonda M.; Parlow, John J.; South, Michael S.; Wood, Rhonda S.; Nicholson, Nancy S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">306</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1115-1121</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">This study was designed to evaluate the antithrombotic efficacy and bleeding propensity of a selective, small-mol. inhibitor of tissue factor/factor VIIa (TF/VIIa) in comparison to small-mol., selective inhibitors of factor Xa and thrombin in a nonhuman primate model of thrombosis.  Acute, spontaneous thrombus formation was induced by electrolytic injury to the intimal surface of a femoral blood vessel, which results in thrombus propagation at the injured site.  The TF/FVIIa inhibitor 3-amino-5-[1-[2-({4-[amino(imino)methyl]benzyl}amino)-2-oxo-ethyl]-3-chloro-5-(isopropylamino)-6-oxo-1,6-dihydropyrazin-2-yl]benzoic acid dihydrochloride (PHA-927F) was fully effective in prevention of thrombosis-induced vessel occlusion at a dose of 400 μg/kg/min, i.v., in the arterial vasculature (femoral artery).  Neither the ED nor multiples up to 4.4-fold the effective arterial plasma concn. elicited any significant effect on bleeding time or blood loss from either the bleeding time site or the surgical (femoral isolation) site.  Small-mol. inhibitors of factor Xa or thrombin were effective arterial antithrombotic agents; however, in contrast to the TF/FVIIa inhibitor, they both elicited substantial increases in bleeding propensity at the ED and at multiples of the effective plasma concn.  These data indicate that TF/VIIa inhibition effectively prevented arterial thrombosis with less impact on bleeding parameters than equiv. doses of factor Xa and thrombin inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9P761Xvt4yLVg90H21EOLACvtfcHk0lgyCRXYo9DTzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmvVehtLg%253D&md5=b2bb7c0a9d7cb160404d7848be9436f3</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1124%2Fjpet.103.052779&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.103.052779%26sid%3Dliteratum%253Aachs%26aulast%3DSuleymanov%26aufirst%3DO.%2BD.%26aulast%3DSzalony%26aufirst%3DJ.%2BA.%26aulast%3DSalyers%26aufirst%3DA.%2BK.%26aulast%3DLachance%26aufirst%3DR.%2BM.%26aulast%3DParlow%26aufirst%3DJ.%2BJ.%26aulast%3DSouth%26aufirst%3DM.%2BS.%26aulast%3DWood%26aufirst%3DR.%2BS.%26aulast%3DNicholson%26aufirst%3DN.%2BS.%26atitle%3DPharmacological%2520interruption%2520of%2520acute%2520thrombus%2520formation%2520with%2520minimal%2520hemorrhagic%2520complications%2520by%2520a%2520small%2520molecule%2520tissue%2520factor%252Ffactor%2520VIIa%2520inhibitor%253A%2520Comparison%2520to%2520factor%2520Xa%2520and%2520thrombin%2520inhibition%2520in%2520a%2520nonhuman%2520primate%2520thrombosis%2520model%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2003%26volume%3D306%26spage%3D1115%26epage%3D1121%26doi%3D10.1124%2Fjpet.103.052779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Szalony, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suleymanov, O. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salyers, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panzer-Knodle, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blom, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaChance, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Case, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parlow, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">South, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholson, N. S.</span><span> </span><span class="NLM_article-title">Administration of a small molecule tissue factor/Factor VIIa inhibitor in a non-human primate thrombosis model of venous thrombosis: effects on thrombus formation and bleeding time</span> <span class="citation_source-journal">Thromb. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">174</span><span class="refDoi"> DOI: 10.1016/j.thromres.2003.10.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=10.1016%2Fj.thromres.2003.10.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=14967414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=1%3ACAS%3A280%3ADC%252BD2c%252FnvVOktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2003&pages=167-174&author=J.+A.+Szalonyauthor=O.+D.+Suleymanovauthor=A.+K.+Salyersauthor=S.+G.+Panzer-Knodleauthor=J.+D.+Blomauthor=R.+M.+LaChanceauthor=B.+L.+Caseauthor=J.+J.+Parlowauthor=M.+S.+Southauthor=R.+S.+Woodauthor=N.+S.+Nicholson&title=Administration+of+a+small+molecule+tissue+factor%2FFactor+VIIa+inhibitor+in+a+non-human+primate+thrombosis+model+of+venous+thrombosis%3A+effects+on+thrombus+formation+and+bleeding+time&doi=10.1016%2Fj.thromres.2003.10.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Administration of a small molecule tissue factor/factor VIIa inhibitor in a non-human primate thrombosis model of venous thrombosis: effects on thrombus formation and bleeding time</span></div><div class="casAuthors">Szalony James A; Suleymanov Osman D; Salyers Anita K; Panzer-Knodle Susan G; Blom Jason D; LaChance Rhonda M; Case Brenda L; Parlow John J; South Michael S; Wood Rhonda S; Nicholson Nancy S</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">167-74</span>
        ISSN:<span class="NLM_cas:issn">0049-3848</span>.
    </div><div class="casAbstract">INTRODUCTION:  Pharmacological treatment of deep vein thrombosis (DVT) in the future may target inhibitors of specific procoagulant proteins.  This study used a non-human primate model to test the effect of PHA-798, a specific inhibitor of the tissue factor/Factor VIIa complex (TF/VIIa), on venous thrombus formation.  MATERIALS AND METHODS:  PHA inhibits the TF/VIIa complex with an IC(50) of 13.5 nM (K(i) 9 nM) and is more than 2000-fold selective for the TF/VIIa complex with respect to IC(50)s for factor Xa and thrombin.  In the model, a thrombogenic surface was introduced into the vena cava of a primate, and the amount of thrombus accumulated after 30 min was determined.  RESULTS:  PHA-798 reduced thrombus formation on the thrombogenic surface in a dose-dependent manner (56+/-1.9% and 85+/-0.3% inhibition with 100 and 200 microg/kg/min PHA-798, respectively) indicating that the model is sensitive to TF/VIIa inhibition.  Treatment with 1 mg/kg intravenous (IV) acetyl salicylic acid (ASA) resulted in only a slight (4-12%), non-significant inhibition of thrombus formation.  However, the combination of 100 microg/kg/min PHA-798 and 1 mg/kg ASA resulted in an 89% inhibition of thrombus formation.  Additionally, while ASA alone increased bleeding time (BT) from 3.3 min at baseline to 4.6 min following treatment, addition of PHA-798 (100 microg/kg/min) to ASA did not significantly increase the BT further (4.7 min).  CONCLUSIONS:  The results of this study indicate that inhibition of TF/VIIa may be safe and effective for the prevention of the proprogation of venous thrombosis and that the combination of ASA and PHA may provide increased efficacy with little change in safety.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQmXRQK21QlEJHZzFRCXxVKfW6udTcc2ebAa1zYoFiskrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c%252FnvVOktA%253D%253D&md5=8bf40ca317c6f2a99976ecc2a6ee279c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.thromres.2003.10.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.thromres.2003.10.017%26sid%3Dliteratum%253Aachs%26aulast%3DSzalony%26aufirst%3DJ.%2BA.%26aulast%3DSuleymanov%26aufirst%3DO.%2BD.%26aulast%3DSalyers%26aufirst%3DA.%2BK.%26aulast%3DPanzer-Knodle%26aufirst%3DS.%2BG.%26aulast%3DBlom%26aufirst%3DJ.%2BD.%26aulast%3DLaChance%26aufirst%3DR.%2BM.%26aulast%3DCase%26aufirst%3DB.%2BL.%26aulast%3DParlow%26aufirst%3DJ.%2BJ.%26aulast%3DSouth%26aufirst%3DM.%2BS.%26aulast%3DWood%26aufirst%3DR.%2BS.%26aulast%3DNicholson%26aufirst%3DN.%2BS.%26atitle%3DAdministration%2520of%2520a%2520small%2520molecule%2520tissue%2520factor%252FFactor%2520VIIa%2520inhibitor%2520in%2520a%2520non-human%2520primate%2520thrombosis%2520model%2520of%2520venous%2520thrombosis%253A%2520effects%2520on%2520thrombus%2520formation%2520and%2520bleeding%2520time%26jtitle%3DThromb.%2520Res.%26date%3D2003%26volume%3D112%26spage%3D167%26epage%3D174%26doi%3D10.1016%2Fj.thromres.2003.10.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Szalony, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taite, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girard, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholson, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaChance, R. M.</span><span> </span><span class="NLM_article-title">Pharmacological intervention at disparate sites in the coagulation cascade: comparison of anti-thrombotic efficacy vs. bleeding propensity in a rat model of acute arterial thrombosis</span> <span class="citation_source-journal">J. Thromb. Thrombolysis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">113</span><span class="NLM_x">–</span> <span class="NLM_lpage">121</span><span class="refDoi"> DOI: 10.1023/A:1023228827733</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=10.1023%2FA%3A1023228827733" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=12714830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=1%3ACAS%3A528%3ADC%252BD3sXislyju7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2002&pages=113-121&author=J.+A.+Szalonyauthor=B.+B.+Taiteauthor=T.+J.+Girardauthor=N.+S.+Nicholsonauthor=R.+M.+LaChance&title=Pharmacological+intervention+at+disparate+sites+in+the+coagulation+cascade%3A+comparison+of+anti-thrombotic+efficacy+vs.+bleeding+propensity+in+a+rat+model+of+acute+arterial+thrombosis&doi=10.1023%2FA%3A1023228827733"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological Intervention at Disparate Sites in the Coagulation Cascade: Comparison of Anti-thrombotic Efficacy vs. Bleeding Propensity in a Rat Model of Acute Arterial Thrombosis</span></div><div class="casAuthors">Szalony, James A.; Taite, Beatrice B.; Girard, Thomas J.; Nicholson, Nancy S.; LaChance, Rhonda M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Thrombosis and Thrombolysis</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">113-121</span>CODEN:
                <span class="NLM_cas:coden">JTTHFF</span>;
        ISSN:<span class="NLM_cas:issn">0929-5305</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">The Tissue Factor/Factor VIIa (TF/FVIIa) complex is an attractive target for pharmacol. interruption of thrombin generation and hence blood coagulation, as this complex is the initiation point of the extrinsic pathway of coagulation.  TF is a cell membrane-assocd. protein that interacts with sol. FVIIa to activate factors IX and X resulting in a cascade of events that leads to thrombin generation and eventual fibrin deposition.  The goal of this non-randomized study was to evaluate XK1, a specific protein inhibitor of TF/FVIIa, and compare antithrombotic efficacy and bleeding propensity to a previously described Factor Xa (FXa) inhibitor (SC-83157/SN 429) and a direct-acting thrombin inhibitor (SC-79407/L-374087) in an acute rat model of arterial thrombosis.  All saline-treated animals experienced occlusion of the carotid artery due to acute thrombus formation within 20 min.  Rats treated with XK1 exhibited a dose-dependent inhibition of thrombus formation with full antithrombotic efficacy and no change in bleeding time or total blood loss at a dose of 4.5 mg/kg, i.v. administered over a 60 min period.  FXa inhibition with SC-83157 resulted in complete inhibition of thrombus formation at a dose of 1.2 mg/kg, i.v.; however, this effect was assocd. with substantial blood loss.  Thrombin inhibition with SC-79407 also afforded complete protection from thrombus formation and occlusion at a dose of 2.58 mg/kg, i.v., and like SC-83157, was assocd. with substantial blood loss.  These data imply that TF/FVIIa inhibition confers protection from acute thrombosis without concomitant changes in bleeding, indicating that this target (TF/FVIIa) may provide improved sepn. of efficacy vs. bleeding side-effects than interruption of coagulation by directly inhibiting either FXa or thrombin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHae8oWa6ph7Vg90H21EOLACvtfcHk0lgyCRXYo9DTzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXislyju7w%253D&md5=20775c9852acbb3416f88e7abab360ed</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1023%2FA%3A1023228827733&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1023228827733%26sid%3Dliteratum%253Aachs%26aulast%3DSzalony%26aufirst%3DJ.%2BA.%26aulast%3DTaite%26aufirst%3DB.%2BB.%26aulast%3DGirard%26aufirst%3DT.%2BJ.%26aulast%3DNicholson%26aufirst%3DN.%2BS.%26aulast%3DLaChance%26aufirst%3DR.%2BM.%26atitle%3DPharmacological%2520intervention%2520at%2520disparate%2520sites%2520in%2520the%2520coagulation%2520cascade%253A%2520comparison%2520of%2520anti-thrombotic%2520efficacy%2520vs.%2520bleeding%2520propensity%2520in%2520a%2520rat%2520model%2520of%2520acute%2520arterial%2520thrombosis%26jtitle%3DJ.%2520Thromb.%2520Thrombolysis%26date%3D2002%26volume%3D14%26spage%3D113%26epage%3D121%26doi%3D10.1023%2FA%3A1023228827733" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Wong, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luettgen, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rendina, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kettner, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knabb, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wexler, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Priestley, E. S.</span><span> </span><span class="NLM_article-title">BMS-593214, an active site-directed factor VIIa inhibitor: Enzyme kinetics, antithrombotic and antihaemostatic studies</span> <span class="citation_source-journal">Thromb. Haemostasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">261</span><span class="NLM_x">–</span> <span class="NLM_lpage">269</span><span class="refDoi"> DOI: 10.1160/TH10-01-0025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=10.1160%2FTH10-01-0025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=20589312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFaju77M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2010&pages=261-269&author=P.+C.+Wongauthor=J.+M.+Luettgenauthor=A.+R.+Rendinaauthor=C.+A.+Kettnerauthor=B.+Xinauthor=R.+M.+Knabbauthor=R.+R.+Wexlerauthor=E.+S.+Priestley&title=BMS-593214%2C+an+active+site-directed+factor+VIIa+inhibitor%3A+Enzyme+kinetics%2C+antithrombotic+and+antihaemostatic+studies&doi=10.1160%2FTH10-01-0025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">BMS-593214, an active site-directed factor VIIa inhibitor: enzyme kinetics, antithrombotic and antihemostatic studies</span></div><div class="casAuthors">Wong, Pancras C.; Luettgen, Joseph M.; Rendina, Alan R.; Kettner, Charles A.; Xin, Baomin; Knabb, Robert M.; Wexler, Ruth R.; Priestley, E. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">261-269</span>CODEN:
                <span class="NLM_cas:coden">THHADQ</span>;
        ISSN:<span class="NLM_cas:issn">0340-6245</span>.
    
            (<span class="NLM_cas:orgname">Schattauer GmbH</span>)
        </div><div class="casAbstract">Factor (F) VIIa in assocn. with tissue factor (TF) is the primary in vivo initiator of blood coagulation and activates FX and FIX to generate thrombin, which plays a key role in the pathogenesis of thrombosis.  We evaluated the enzyme kinetics, antithrombotic and antihemostatic properties of BMS-593214, an active-site, direct FVIIa inhibitor.  Studies were conducted in enzymic assays, and in anesthetized rabbit models of elec.-induced carotid arterial thrombosis (AT), thread-induced vena cava venous thrombosis (VT) and cuticle bleeding time (BT).  Antithrombotic efficacy of BMS-593214 given i.v. was evaluated for both the prevention and treatment of AT and VT.  BMS-593214 displayed direct, competitive inhibition of human FVIIa in the hydrolysis of a tripeptide substrate with Ki of 5 nM.  However, it acted as a noncompetitive inhibitor of the activation of the physiol. substrate FX by TF/VIIa with Ki of 9.3 nM.  BMS-593214 showed selectivity for FVIIa and exhibited species differences in TF-FVIIa-dependent anticoagulation with similar potency in human and rabbit plasma.  BMS-593214 was efficacious in the prevention and treatment models of AT and VT with ED50 values of 1.1 to 3.1 mg/kg.  Furthermore, BMS-593214 exhibited a wide therapeutic window with respect to BT.  These results suggest that inhibition of FVIIa with small-mol. active-site inhibitors represents a promising antithrombotic approach for the development of new therapies for the prevention and treatment of AT and VT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqK14c5SoyEXLVg90H21EOLACvtfcHk0lgByk8D8Som7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFaju77M&md5=5f7058b79c6fe0cd23ccbd632741a625</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1160%2FTH10-01-0025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1160%252FTH10-01-0025%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DP.%2BC.%26aulast%3DLuettgen%26aufirst%3DJ.%2BM.%26aulast%3DRendina%26aufirst%3DA.%2BR.%26aulast%3DKettner%26aufirst%3DC.%2BA.%26aulast%3DXin%26aufirst%3DB.%26aulast%3DKnabb%26aufirst%3DR.%2BM.%26aulast%3DWexler%26aufirst%3DR.%2BR.%26aulast%3DPriestley%26aufirst%3DE.%2BS.%26atitle%3DBMS-593214%252C%2520an%2520active%2520site-directed%2520factor%2520VIIa%2520inhibitor%253A%2520Enzyme%2520kinetics%252C%2520antithrombotic%2520and%2520antihaemostatic%2520studies%26jtitle%3DThromb.%2520Haemostasis%26date%3D2010%26volume%3D104%26spage%3D261%26epage%3D269%26doi%3D10.1160%2FTH10-01-0025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Young, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mordenti, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torkelson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shrader, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolesnikov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rai, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leahy, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sprengeler, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katz, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janc, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elrod, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marzec, U. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanson, S. R.</span><span> </span><span class="NLM_article-title">Factor VIIa inhibitors: Chemical optimization, preclinical pharmacokinetics, pharmacodynamics, and efficacy in an arterial baboon thrombosis model</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">2037</span><span class="NLM_x">–</span> <span class="NLM_lpage">2041</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2005.12.059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=10.1016%2Fj.bmcl.2005.12.059" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=2037-2041&author=W.+B.+Youngauthor=J.+Mordentiauthor=S.+Torkelsonauthor=W.+D.+Shraderauthor=A.+Kolesnikovauthor=R.+Raiauthor=L.+Liuauthor=H.+Huauthor=E.+M.+Leahyauthor=M.+J.+Greenauthor=P.+A.+Sprengelerauthor=B.+A.+Katzauthor=C.+Yuauthor=J.+W.+Jancauthor=K.+C.+Elrodauthor=U.+M.+Marzecauthor=S.+R.+Hanson&title=Factor+VIIa+inhibitors%3A+Chemical+optimization%2C+preclinical+pharmacokinetics%2C+pharmacodynamics%2C+and+efficacy+in+an+arterial+baboon+thrombosis+model&doi=10.1016%2Fj.bmcl.2005.12.059"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2005.12.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2005.12.059%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DW.%2BB.%26aulast%3DMordenti%26aufirst%3DJ.%26aulast%3DTorkelson%26aufirst%3DS.%26aulast%3DShrader%26aufirst%3DW.%2BD.%26aulast%3DKolesnikov%26aufirst%3DA.%26aulast%3DRai%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DHu%26aufirst%3DH.%26aulast%3DLeahy%26aufirst%3DE.%2BM.%26aulast%3DGreen%26aufirst%3DM.%2BJ.%26aulast%3DSprengeler%26aufirst%3DP.%2BA.%26aulast%3DKatz%26aufirst%3DB.%2BA.%26aulast%3DYu%26aufirst%3DC.%26aulast%3DJanc%26aufirst%3DJ.%2BW.%26aulast%3DElrod%26aufirst%3DK.%2BC.%26aulast%3DMarzec%26aufirst%3DU.%2BM.%26aulast%3DHanson%26aufirst%3DS.%2BR.%26atitle%3DFactor%2520VIIa%2520inhibitors%253A%2520Chemical%2520optimization%252C%2520preclinical%2520pharmacokinetics%252C%2520pharmacodynamics%252C%2520and%2520efficacy%2520in%2520an%2520arterial%2520baboon%2520thrombosis%2520model%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D2037%26epage%3D2041%26doi%3D10.1016%2Fj.bmcl.2005.12.059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Zbinden, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banner, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilpert, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Himber, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lave, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riederer, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tschopp, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obst-Sander, U.</span><span> </span><span class="NLM_article-title">Dose-dependent antithrombotic activity of an orally active tissue factor/factor VIIa inhibitor without concomitant enhancement of bleeding propensity</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">5357</span><span class="NLM_x">–</span> <span class="NLM_lpage">5369</span><span class="refDoi"> DOI: 10.1016/j.bmc.2006.03.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=10.1016%2Fj.bmc.2006.03.042" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=5357-5369&author=K.+G.+Zbindenauthor=D.+W.+Bannerauthor=K.+Hilpertauthor=J.+Himberauthor=T.+Laveauthor=M.+A.+Riedererauthor=M.+Stahlauthor=T.+B.+Tschoppauthor=U.+Obst-Sander&title=Dose-dependent+antithrombotic+activity+of+an+orally+active+tissue+factor%2Ffactor+VIIa+inhibitor+without+concomitant+enhancement+of+bleeding+propensity&doi=10.1016%2Fj.bmc.2006.03.042"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2006.03.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2006.03.042%26sid%3Dliteratum%253Aachs%26aulast%3DZbinden%26aufirst%3DK.%2BG.%26aulast%3DBanner%26aufirst%3DD.%2BW.%26aulast%3DHilpert%26aufirst%3DK.%26aulast%3DHimber%26aufirst%3DJ.%26aulast%3DLave%26aufirst%3DT.%26aulast%3DRiederer%26aufirst%3DM.%2BA.%26aulast%3DStahl%26aufirst%3DM.%26aulast%3DTschopp%26aufirst%3DT.%2BB.%26aulast%3DObst-Sander%26aufirst%3DU.%26atitle%3DDose-dependent%2520antithrombotic%2520activity%2520of%2520an%2520orally%2520active%2520tissue%2520factor%252Ffactor%2520VIIa%2520inhibitor%2520without%2520concomitant%2520enhancement%2520of%2520bleeding%2520propensity%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D5357%26epage%3D5369%26doi%3D10.1016%2Fj.bmc.2006.03.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Giugliano, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiviott, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stone, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweiger, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouchard, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leesar, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulder, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deitcher, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCabe, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braunwald, E.</span><span> </span><span class="NLM_article-title">Recombinant nematode anticoagulant protein c2 in patients with non-ST-segment elevation acute coronary syndrome: the ANTHEM-TIMI-32 trial</span> <span class="citation_source-journal">J. Am. Coll. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">2398</span><span class="NLM_x">–</span> <span class="NLM_lpage">2407</span><span class="refDoi"> DOI: 10.1016/j.jacc.2007.02.065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=10.1016%2Fj.jacc.2007.02.065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=17599602" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=1%3ACAS%3A528%3ADC%252BD2sXntFyhs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2007&pages=2398-2407&author=R.+P.+Giuglianoauthor=S.+D.+Wiviottauthor=P.+H.+Stoneauthor=D.+I.+Simonauthor=M.+J.+Schweigerauthor=A.+Bouchardauthor=M.+A.+Leesarauthor=M.+A.+Goulderauthor=S.+R.+Deitcherauthor=C.+H.+McCabeauthor=E.+Braunwald&title=Recombinant+nematode+anticoagulant+protein+c2+in+patients+with+non-ST-segment+elevation+acute+coronary+syndrome%3A+the+ANTHEM-TIMI-32+trial&doi=10.1016%2Fj.jacc.2007.02.065"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Recombinant Nematode Anticoagulant Protein c2 in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome: the ANTHEM-TIMI-32 Trial</span></div><div class="casAuthors">Giugliano, Robert P.; Wiviott, Stephen D.; Stone, Peter H.; Simon, Daniel I.; Schweiger, Marc J.; Bouchard, Alain; Leesar, Massoud A.; Goulder, Michael A.; Deitcher, Steven R.; McCabe, Carolyn H.; Braunwald, Eugene</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American College of Cardiology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">2398-2407</span>CODEN:
                <span class="NLM_cas:coden">JACCDI</span>;
        ISSN:<span class="NLM_cas:issn">0735-1097</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Objectives: We sought to evaluate the safety and efficacy of recombinant nematode anticoagulant protein c2 (rNAPc2) in patients with non-ST-segment elevation acute coronary syndrome (nSTE-ACS).  Background: Recombinant NAPc2 is a potent inhibitor of the tissue factor/factor VIIa complex that has the potential to reduce ischemic complications mediated by thrombin generation.  Methods: A total of 203 patients were randomized 4:1 to double-blinded i.v. rNAPc2 or placebo every 48 h for a total of 1 to 3 doses in 8 ascending panels (1.5 to 10 μg/kg).  All patients received aspirin, unfractionated heparin (UFH), or enoxaparin and early catheterization; clopidogrel and glycoprotein IIb/IIIa blockers were encouraged.  Two subsequent open-label panels evaluated 10 μg/kg rNAPc2 with half-dose UFH (n = 26) and no UFH (n = 26).  The primary end point was the rate of major plus minor bleeding.  Pharmacokinetics, pharmacodynamics, continuous electrocardiog., and clin. events were assessed.  Results: Recombinant NAPc2 did not significantly increase major plus minor bleeding (3.7% vs. 2.5%; p = NS) despite increasing the international normalized ratio in a dose-related fashion (trend p ≤ 0.0001).  Higher-dose rNAPc2 (≥7.5 μg/kg) suppressed prothrombin fragment F1.2 generation compared with placebo and reduced ischemia by >50% compared to placebo and lower-dose rNAPc2.  Thrombotic bailout requiring open-label anticoagulant occurred in 5 of 26 patients treated without UFH, but none in the half-dose UFH group (19% vs. 0%; p = 0.051).  Conclusions: In patients with nSTE-ACS managed with std. antithrombotics and an early invasive approach, addnl. proximal inhibition of the coagulation cascade with rNAPc2 was well tolerated. rNAPc2 doses ≥7.5 μg/kg suppressed F1.2 and reduced ischemia, though some heparin may be necessary to avoid procedure-related thrombus formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqr5uob7lm2DbVg90H21EOLACvtfcHk0lgnnRgbHlbhRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXntFyhs74%253D&md5=72d19940ea9410323c4f8e7c324d5347</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.jacc.2007.02.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jacc.2007.02.065%26sid%3Dliteratum%253Aachs%26aulast%3DGiugliano%26aufirst%3DR.%2BP.%26aulast%3DWiviott%26aufirst%3DS.%2BD.%26aulast%3DStone%26aufirst%3DP.%2BH.%26aulast%3DSimon%26aufirst%3DD.%2BI.%26aulast%3DSchweiger%26aufirst%3DM.%2BJ.%26aulast%3DBouchard%26aufirst%3DA.%26aulast%3DLeesar%26aufirst%3DM.%2BA.%26aulast%3DGoulder%26aufirst%3DM.%2BA.%26aulast%3DDeitcher%26aufirst%3DS.%2BR.%26aulast%3DMcCabe%26aufirst%3DC.%2BH.%26aulast%3DBraunwald%26aufirst%3DE.%26atitle%3DRecombinant%2520nematode%2520anticoagulant%2520protein%2520c2%2520in%2520patients%2520with%2520non-ST-segment%2520elevation%2520acute%2520coronary%2520syndrome%253A%2520the%2520ANTHEM-TIMI-32%2520trial%26jtitle%3DJ.%2520Am.%2520Coll.%2520Cardiol.%26date%3D2007%26volume%3D49%26spage%3D2398%26epage%3D2407%26doi%3D10.1016%2Fj.jacc.2007.02.065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Priestley, E. S.</span><span> </span><span class="NLM_article-title">Tissue factor-fVIIa inhibition: update on an unfinished quest for a novel oral antithrombotic</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1440</span><span class="NLM_x">–</span> <span class="NLM_lpage">1444</span><span class="refDoi"> DOI: 10.1016/j.drudis.2014.05.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=10.1016%2Fj.drudis.2014.05.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=24881783" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVShtL3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=1440-1444&author=E.+S.+Priestley&title=Tissue+factor-fVIIa+inhibition%3A+update+on+an+unfinished+quest+for+a+novel+oral+antithrombotic&doi=10.1016%2Fj.drudis.2014.05.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Tissue factor-fVIIa inhibition: update on an unfinished quest for a novel oral antithrombotic</span></div><div class="casAuthors">Priestley, E. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1440-1444</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The tissue factor-coagulation factor VIIa complex (TF-fVIIa) is a well-validated biol. target and has been the focus of extensive research directed toward the discovery of novel oral antithrombotics.  This review briefly summarizes the key antithrombotic target validation data and provides an update on recent advances in small mol. TF-fVIIa inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7zNpJzOd-MrVg90H21EOLACvtfcHk0lgnnRgbHlbhRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVShtL3K&md5=262318fbf25e17dd13dae0c323d699f5</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2014.05.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2014.05.023%26sid%3Dliteratum%253Aachs%26aulast%3DPriestley%26aufirst%3DE.%2BS.%26atitle%3DTissue%2520factor-fVIIa%2520inhibition%253A%2520update%2520on%2520an%2520unfinished%2520quest%2520for%2520a%2520novel%2520oral%2520antithrombotic%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2014%26volume%3D19%26spage%3D1440%26epage%3D1444%26doi%3D10.1016%2Fj.drudis.2014.05.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Talhout, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engberts, J.</span><span> </span><span class="NLM_article-title">Thermodynamic analysis of binding of p-substituted benzamidines to trypsin</span> <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">268</span><span class="NLM_x">, </span> <span class="NLM_fpage">1554</span><span class="NLM_x">–</span> <span class="NLM_lpage">1560</span><span class="refDoi"> DOI: 10.1046/j.1432-1327.2001.01991.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=10.1046%2Fj.1432-1327.2001.01991.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=11248672" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitlSktbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=268&publication_year=2001&pages=1554-1560&author=R.+Talhoutauthor=J.+Engberts&title=Thermodynamic+analysis+of+binding+of+p-substituted+benzamidines+to+trypsin&doi=10.1046%2Fj.1432-1327.2001.01991.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Thermodynamic analysis of binding of p-substituted benzamidines to trypsin</span></div><div class="casAuthors">Talhout, Reinskje; Engberts, Jan B. F. N.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">268</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1554-1560</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">Understanding the structural basis of inhibitor-enzyme interactions, important for the design of new drugs, requires a complete thermodn. characterization of the binding process as well as a description of the structure of the complex.  In this paper, the binding of p-substituted benzamidinium derivs. to the structurally well-characterized serine proteinase bovine pancreatic trypsin has been studied using isothermal titrn. calorimetry.  These expts. have permitted a complete characterization of the temp. dependence of the inhibitor-binding thermodn.  At 25°, both the enthalpy and entropy of binding are favorable for all studied derivs., but this is only true for a relatively narrow temp. range.  As binding is characterized by a neg. change in heat capacity, the process is characterized by enthalpy-entropy compensation, resulting in a change of the net thermodn. driving force for assocn. from entropic to enthalpic with increasing temp.  These phenomena are not unusual when hydrophobic forces play an important role.  The trend in the relative binding potencies can, to a significant extent, be attributed to the electron-donating/withdrawing character of the substituent at the para position, as shown by the Hammett σp+ plot for the different inhibitors; the more polar the p-substituted benzamidine, the less potent it will be as a trypsin inhibitor.  This behavior might result from a bulk solvation effect, meaning that the more polar, lower potency inhibitors will be more stabilized in water than the less polar, higher potency inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyMFBZp9jo8rVg90H21EOLACvtfcHk0lj6xZ51RiFBcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitlSktbc%253D&md5=f70ce474ada944add5d791244fe85c7d</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1046%2Fj.1432-1327.2001.01991.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1432-1327.2001.01991.x%26sid%3Dliteratum%253Aachs%26aulast%3DTalhout%26aufirst%3DR.%26aulast%3DEngberts%26aufirst%3DJ.%26atitle%3DThermodynamic%2520analysis%2520of%2520binding%2520of%2520p-substituted%2520benzamidines%2520to%2520trypsin%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D2001%26volume%3D268%26spage%3D1554%26epage%3D1560%26doi%3D10.1046%2Fj.1432-1327.2001.01991.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Hu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolesnikov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riggs, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesson, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephens, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leahy, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shrader, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sprengeler, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanford, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gjerstad, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cabuslay, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, W. B.</span><span> </span><span class="NLM_article-title">Potent 4-amino-5-azaindole factor VIIa inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">4567</span><span class="NLM_x">–</span> <span class="NLM_lpage">4570</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2006.06.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=10.1016%2Fj.bmcl.2006.06.016" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=4567-4570&author=H.+Huauthor=A.+Kolesnikovauthor=J.+R.+Riggsauthor=K.+E.+Wessonauthor=R.+Stephensauthor=E.+M.+Leahyauthor=W.+D.+Shraderauthor=P.+A.+Sprengelerauthor=M.+J.+Greenauthor=E.+Sanfordauthor=M.+Nguyenauthor=E.+Gjerstadauthor=R.+Cabuslayauthor=W.+B.+Young&title=Potent+4-amino-5-azaindole+factor+VIIa+inhibitors&doi=10.1016%2Fj.bmcl.2006.06.016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.06.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.06.016%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DH.%26aulast%3DKolesnikov%26aufirst%3DA.%26aulast%3DRiggs%26aufirst%3DJ.%2BR.%26aulast%3DWesson%26aufirst%3DK.%2BE.%26aulast%3DStephens%26aufirst%3DR.%26aulast%3DLeahy%26aufirst%3DE.%2BM.%26aulast%3DShrader%26aufirst%3DW.%2BD.%26aulast%3DSprengeler%26aufirst%3DP.%2BA.%26aulast%3DGreen%26aufirst%3DM.%2BJ.%26aulast%3DSanford%26aufirst%3DE.%26aulast%3DNguyen%26aufirst%3DM.%26aulast%3DGjerstad%26aufirst%3DE.%26aulast%3DCabuslay%26aufirst%3DR.%26aulast%3DYoung%26aufirst%3DW.%2BB.%26atitle%3DPotent%25204-amino-5-azaindole%2520factor%2520VIIa%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D4567%26epage%3D4570%26doi%3D10.1016%2Fj.bmcl.2006.06.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Miura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koike, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishihara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niimi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirayama, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shigenaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakai-Moritani, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tagawa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawasaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakamoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukamoto, S.-i.</span><span> </span><span class="NLM_article-title">Design, synthesis and biological activity of selective and orally available TF/FVIIa complex inhibitors containing non-amidine P1 ligands</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">160</span><span class="NLM_x">–</span> <span class="NLM_lpage">173</span><span class="refDoi"> DOI: 10.1016/j.bmc.2006.09.071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=10.1016%2Fj.bmc.2006.09.071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=17064913" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1CmtrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=160-173&author=M.+Miuraauthor=N.+Sekiauthor=T.+Koikeauthor=T.+Ishiharaauthor=T.+Niimiauthor=F.+Hirayamaauthor=T.+Shigenagaauthor=Y.+Sakai-Moritaniauthor=A.+Tagawaauthor=T.+Kawasakiauthor=S.+Sakamotoauthor=M.+Okadaauthor=M.+Ohtaauthor=S.-i.+Tsukamoto&title=Design%2C+synthesis+and+biological+activity+of+selective+and+orally+available+TF%2FFVIIa+complex+inhibitors+containing+non-amidine+P1+ligands&doi=10.1016%2Fj.bmc.2006.09.071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and biological activity of selective and orally available TF/FVIIa complex inhibitors containing non-amidine P1 ligands</span></div><div class="casAuthors">Miura, Masanori; Seki, Norio; Koike, Takanori; Ishihara, Tsukasa; Niimi, Tatsuya; Hirayama, Fukushi; Shigenaga, Takeshi; Sakai-Moritani, Yumiko; Tagawa, Ayako; Kawasaki, Tomihisa; Sakamoto, Shuichi; Okada, Minoru; Ohta, Mitsuaki; Tsukamoto, Shin-ichi</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">160-173</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">We found the novel selective and orally available non-amidine TF/FVIIa complex inhibitor 21e (I), 4-({[(1S)-(aminocarbonyl)-3-methylbutyl]amino}carbonyl)-2'-({[4- (aminomethyl)phenyl]amino}carbonyl)-4'-(methylamino)biphenyl-2-carboxylic acid.  The derivs. were synthesized by conversions of the iso-Bu moiety and the introduction of alkylamino groups to 4'-position of the central Ph ring of compds. 2a and 2b reported previously.  Some compds. show increased in vitro anti-TF/FVIIa and PT prolongation activities.  Among them, compd. 21e reached and sustained micromolar plasma concn. levels of up to 2 h after oral administration in mice.  Moreover, compd. 21e did not prolong the bleeding time even at the highest dose level in cynomolgus monkeys, while PT was prolonged 3.7-fold increases at this dose.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeyYBTGFY_DbVg90H21EOLACvtfcHk0lj6xZ51RiFBcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1CmtrbM&md5=5349b8f0727b66611a9fb43f04aa0365</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2006.09.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2006.09.071%26sid%3Dliteratum%253Aachs%26aulast%3DMiura%26aufirst%3DM.%26aulast%3DSeki%26aufirst%3DN.%26aulast%3DKoike%26aufirst%3DT.%26aulast%3DIshihara%26aufirst%3DT.%26aulast%3DNiimi%26aufirst%3DT.%26aulast%3DHirayama%26aufirst%3DF.%26aulast%3DShigenaga%26aufirst%3DT.%26aulast%3DSakai-Moritani%26aufirst%3DY.%26aulast%3DTagawa%26aufirst%3DA.%26aulast%3DKawasaki%26aufirst%3DT.%26aulast%3DSakamoto%26aufirst%3DS.%26aulast%3DOkada%26aufirst%3DM.%26aulast%3DOhta%26aufirst%3DM.%26aulast%3DTsukamoto%26aufirst%3DS.-i.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520activity%2520of%2520selective%2520and%2520orally%2520available%2520TF%252FFVIIa%2520complex%2520inhibitors%2520containing%2520non-amidine%2520P1%2520ligands%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D160%26epage%3D173%26doi%3D10.1016%2Fj.bmc.2006.09.071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Parlow, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurumbail, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stegeman, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stallings, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">South, M. S.</span><span> </span><span class="NLM_article-title">Design, synthesis, and crystal structure of selective 2-pyridone tissue factor VIIa inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">4696</span><span class="NLM_x">–</span> <span class="NLM_lpage">4701</span><span class="refDoi"> DOI: 10.1021/jm0301686</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0301686" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnt1Kktrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=4696-4701&author=J.+J.+Parlowauthor=R.+G.+Kurumbailauthor=R.+A.+Stegemanauthor=A.+M.+Stevensauthor=W.+C.+Stallingsauthor=M.+S.+South&title=Design%2C+synthesis%2C+and+crystal+structure+of+selective+2-pyridone+tissue+factor+VIIa+inhibitors&doi=10.1021%2Fjm0301686"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Crystal Structure of Selective 2-Pyridone Tissue Factor VIIa Inhibitors</span></div><div class="casAuthors">Parlow, John J.; Kurumbail, Ravi G.; Stegeman, Roderick A.; Stevens, Anna M.; Stallings, William C.; South, Michael S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">4696-4701</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Targeted 2-pyridones were selected as tissue factor VIIa inhibitors and prepd. from 2,6-dibromopyridine via a multistep synthesis.  A variety of chem. transformations, including regioselective nucleophilic addn., selective nitrogen alkylation, and a Suzuki coupling, afforded the targeted tissue factor VIIa inhibitors.  The pyridone core was selected as a replacement for the pyrazinone core of noncovalent tissue Factor VIIa inhibitors and designed such that their substitution pattern would occupy and interact with the S1, S2, and S3 pockets of the tissue factor VIIa enzyme.  These compds. were tested in several serine protease enzyme assays involved in the coagulation cascade exhibiting modest activity on tissue factor VIIa with excellent selectivity over thrombin and Factor Xa.  Finally, an X-ray crystal structure of one inhibitor bound to tissue factor VIIa was obtained and will be described.  Compds. thus prepd. and tested were 3-amino-5-[1-[2-[[[4-(aminoiminomethyl)phenyl]methyl]amino]-2-oxoethyl]-1,6-dihydro-5-[(1-methylethyl)amino]-6-oxo-2-pyridinyl]benzoic acid and N-[[4-(aminoiminomethyl)phenyl]methyl]-6-(3,5-diaminophenyl)-3-[(1-methylethyl)amino]-2-oxo-1(2H)-pyridineacetamide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrt-RHbO3bWK7Vg90H21EOLACvtfcHk0lhGqj1TapcYGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnt1Kktrc%253D&md5=d463973a0ba48427f8131ae032c0637b</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm0301686&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0301686%26sid%3Dliteratum%253Aachs%26aulast%3DParlow%26aufirst%3DJ.%2BJ.%26aulast%3DKurumbail%26aufirst%3DR.%2BG.%26aulast%3DStegeman%26aufirst%3DR.%2BA.%26aulast%3DStevens%26aufirst%3DA.%2BM.%26aulast%3DStallings%26aufirst%3DW.%2BC.%26aulast%3DSouth%26aufirst%3DM.%2BS.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520crystal%2520structure%2520of%2520selective%25202-pyridone%2520tissue%2520factor%2520VIIa%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D4696%26epage%3D4701%26doi%3D10.1021%2Fjm0301686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Trujillo, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neumann, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahoney, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garland, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kusturin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbas, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">South, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reitz, D. B.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of pyrazinones containing novel P1 needles as inhibitors of TF/VIIa</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">4568</span><span class="NLM_x">–</span> <span class="NLM_lpage">4574</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2007.05.090</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=10.1016%2Fj.bmcl.2007.05.090" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=4568-4574&author=J.+I.+Trujilloauthor=H.+Huangauthor=W.+L.+Neumannauthor=M.+W.+Mahoneyauthor=S.+Longauthor=W.+Huangauthor=D.+J.+Garlandauthor=C.+Kusturinauthor=Z.+Abbasauthor=M.+S.+Southauthor=D.+B.+Reitz&title=Design%2C+synthesis%2C+and+biological+evaluation+of+pyrazinones+containing+novel+P1+needles+as+inhibitors+of+TF%2FVIIa&doi=10.1016%2Fj.bmcl.2007.05.090"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.05.090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.05.090%26sid%3Dliteratum%253Aachs%26aulast%3DTrujillo%26aufirst%3DJ.%2BI.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DNeumann%26aufirst%3DW.%2BL.%26aulast%3DMahoney%26aufirst%3DM.%2BW.%26aulast%3DLong%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DGarland%26aufirst%3DD.%2BJ.%26aulast%3DKusturin%26aufirst%3DC.%26aulast%3DAbbas%26aufirst%3DZ.%26aulast%3DSouth%26aufirst%3DM.%2BS.%26aulast%3DReitz%26aufirst%3DD.%2BB.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520pyrazinones%2520containing%2520novel%2520P1%2520needles%2520as%2520inhibitors%2520of%2520TF%252FVIIa%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D4568%26epage%3D4574%26doi%3D10.1016%2Fj.bmcl.2007.05.090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Vijaykumar, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rai, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaghafi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ton, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torkelson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leahy, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riggs, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sprengeler, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shrader, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Bryan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cabuslay, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanford, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gjerstadt, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sukbuntherng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, W. B.</span><span> </span><span class="NLM_article-title">Efforts toward oral bioavailability in factor VIIa inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">3829</span><span class="NLM_x">–</span> <span class="NLM_lpage">3832</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2006.04.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=10.1016%2Fj.bmcl.2006.04.018" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=3829-3832&author=D.+Vijaykumarauthor=R.+Raiauthor=M.+Shaghafiauthor=T.+Tonauthor=S.+Torkelsonauthor=E.+M.+Leahyauthor=J.+R.+Riggsauthor=H.+Huauthor=P.+A.+Sprengelerauthor=W.+D.+Shraderauthor=C.+O%E2%80%99Bryanauthor=R.+Cabuslayauthor=E.+Sanfordauthor=E.+Gjerstadtauthor=L.+Liuauthor=J.+Sukbuntherngauthor=W.+B.+Young&title=Efforts+toward+oral+bioavailability+in+factor+VIIa+inhibitors&doi=10.1016%2Fj.bmcl.2006.04.018"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.04.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.04.018%26sid%3Dliteratum%253Aachs%26aulast%3DVijaykumar%26aufirst%3DD.%26aulast%3DRai%26aufirst%3DR.%26aulast%3DShaghafi%26aufirst%3DM.%26aulast%3DTon%26aufirst%3DT.%26aulast%3DTorkelson%26aufirst%3DS.%26aulast%3DLeahy%26aufirst%3DE.%2BM.%26aulast%3DRiggs%26aufirst%3DJ.%2BR.%26aulast%3DHu%26aufirst%3DH.%26aulast%3DSprengeler%26aufirst%3DP.%2BA.%26aulast%3DShrader%26aufirst%3DW.%2BD.%26aulast%3DO%25E2%2580%2599Bryan%26aufirst%3DC.%26aulast%3DCabuslay%26aufirst%3DR.%26aulast%3DSanford%26aufirst%3DE.%26aulast%3DGjerstadt%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DSukbuntherng%26aufirst%3DJ.%26aulast%3DYoung%26aufirst%3DW.%2BB.%26atitle%3DEfforts%2520toward%2520oral%2520bioavailability%2520in%2520factor%2520VIIa%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D3829%26epage%3D3832%26doi%3D10.1016%2Fj.bmcl.2006.04.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Groebke Zbinden, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banner, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ackermann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Arcy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirchhofer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, Y.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tschopp, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallbaum, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, L.</span><span> </span><span class="NLM_article-title">Design of selective phenylglycine amide tissue factor/factor VIIa inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">817</span><span class="NLM_x">–</span> <span class="NLM_lpage">822</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2004.10.092</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=10.1016%2Fj.bmcl.2004.10.092" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=817-822&author=K.+Groebke+Zbindenauthor=D.+W.+Bannerauthor=J.+Ackermannauthor=A.+D%E2%80%99Arcyauthor=D.+Kirchhoferauthor=Y.-H.+Jiauthor=T.+B.+Tschoppauthor=S.+Wallbaumauthor=L.+Weber&title=Design+of+selective+phenylglycine+amide+tissue+factor%2Ffactor+VIIa+inhibitors&doi=10.1016%2Fj.bmcl.2004.10.092"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2004.10.092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2004.10.092%26sid%3Dliteratum%253Aachs%26aulast%3DGroebke%2BZbinden%26aufirst%3DK.%26aulast%3DBanner%26aufirst%3DD.%2BW.%26aulast%3DAckermann%26aufirst%3DJ.%26aulast%3DD%25E2%2580%2599Arcy%26aufirst%3DA.%26aulast%3DKirchhofer%26aufirst%3DD.%26aulast%3DJi%26aufirst%3DY.-H.%26aulast%3DTschopp%26aufirst%3DT.%2BB.%26aulast%3DWallbaum%26aufirst%3DS.%26aulast%3DWeber%26aufirst%3DL.%26atitle%3DDesign%2520of%2520selective%2520phenylglycine%2520amide%2520tissue%2520factor%252Ffactor%2520VIIa%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D817%26epage%3D822%26doi%3D10.1016%2Fj.bmcl.2004.10.092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Cheney, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bozarth, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metzler, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morin, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newitt, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nirschl, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rendina, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamura, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wurtz, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seiffert, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wexler, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Priestley, E. S.</span><span> </span><span class="NLM_article-title">Discovery of novel P1 groups for coagulation factor VIIa inhibition using fragment-based screening</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">2799</span><span class="NLM_x">–</span> <span class="NLM_lpage">2808</span><span class="refDoi"> DOI: 10.1021/jm501982k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501982k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=1%3ACAS%3A528%3ADC%252BC2MXktlequrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2799-2808&author=L.+D.+Cheneyauthor=M.+J.+Bozarthauthor=J.+W.+Metzlerauthor=E.+P.+Morinauthor=L.+Muellerauthor=A.+J.+Newittauthor=H.+A.+Nirschlauthor=R.+A.+Rendinaauthor=K.+J.+Tamuraauthor=A.+Weiauthor=X.+Wenauthor=R.+N.+Wurtzauthor=A.+D.+Seiffertauthor=R.+R.+Wexlerauthor=E.+S.+Priestley&title=Discovery+of+novel+P1+groups+for+coagulation+factor+VIIa+inhibition+using+fragment-based+screening&doi=10.1021%2Fjm501982k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of novel P1 groups for coagulation factor VIIa inhibition using fragment-based screening</span></div><div class="casAuthors">Cheney, Daniel L.; Bozarth, Jeffrey M.; Metzler, William J.; Morin, Paul E.; Mueller, Luciano; Newitt, John A.; Nirschl, Alexandra H.; Rendina, Alan R.; Tamura, James K.; Wei, Anzhi; Wen, Xiao; Wurtz, Nicholas R.; Seiffert, Dietmar A.; Wexler, Ruth R.; Priestley, E. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2799-2808</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A multidisciplinary, fragment-based screening approach involving protein ensemble docking and biochem. and NMR assays is described.  This approach led to the discovery of several structurally diverse, neutral surrogates for cationic factor VIIa P1 groups, which are generally assocd. with poor pharmacokinetic (PK) properties.  Among the novel factor VIIa inhibitory fragments identified were aryl halides, lactams, and heterocycles.  Crystallog. structures for several bound fragments were obtained, leading to the successful design of a potent factor VIIa inhibitor with a neutral lactam P1 and improved permeability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp66c92wxmo8bVg90H21EOLACvtfcHk0lhm8H3McNoXAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXktlequrs%253D&md5=e092f0e39b3c63d80c12ba4770d977f0</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm501982k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501982k%26sid%3Dliteratum%253Aachs%26aulast%3DCheney%26aufirst%3DL.%2BD.%26aulast%3DBozarth%26aufirst%3DM.%2BJ.%26aulast%3DMetzler%26aufirst%3DJ.%2BW.%26aulast%3DMorin%26aufirst%3DE.%2BP.%26aulast%3DMueller%26aufirst%3DL.%26aulast%3DNewitt%26aufirst%3DA.%2BJ.%26aulast%3DNirschl%26aufirst%3DH.%2BA.%26aulast%3DRendina%26aufirst%3DR.%2BA.%26aulast%3DTamura%26aufirst%3DK.%2BJ.%26aulast%3DWei%26aufirst%3DA.%26aulast%3DWen%26aufirst%3DX.%26aulast%3DWurtz%26aufirst%3DR.%2BN.%26aulast%3DSeiffert%26aufirst%3DA.%2BD.%26aulast%3DWexler%26aufirst%3DR.%2BR.%26aulast%3DPriestley%26aufirst%3DE.%2BS.%26atitle%3DDiscovery%2520of%2520novel%2520P1%2520groups%2520for%2520coagulation%2520factor%2520VIIa%2520inhibition%2520using%2520fragment-based%2520screening%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2799%26epage%3D2808%26doi%3D10.1021%2Fjm501982k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacutin-Porte, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glunz, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nirschl, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wurtz, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luettgen, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rendina, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harper, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anumula, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheney, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knabb, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wexler, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Priestley, E. S.</span><span> </span><span class="NLM_article-title">Design and synthesis of phenylpyrrolidine phenylglycinamides as highly potent and selective TF-FVIIa inhibitors</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">188</span><span class="NLM_x">–</span> <span class="NLM_lpage">192</span><span class="refDoi"> DOI: 10.1021/ml400453z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400453z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=1%3ACAS%3A528%3ADC%252BC3sXitVShsr%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=188-192&author=X.+Zhangauthor=W.+Jiangauthor=S.+Jacutin-Porteauthor=W.+P.+Glunzauthor=Y.+Zouauthor=X.+Chengauthor=H.+A.+Nirschlauthor=R.+N.+Wurtzauthor=M.+J.+Luettgenauthor=R.+A.+Rendinaauthor=G.+Luoauthor=M.+T.+Harperauthor=A.+Weiauthor=R.+Anumulaauthor=L.+D.+Cheneyauthor=M.+R.+Knabbauthor=C.+P.+Wongauthor=R.+R.+Wexlerauthor=E.+S.+Priestley&title=Design+and+synthesis+of+phenylpyrrolidine+phenylglycinamides+as+highly+potent+and+selective+TF-FVIIa+inhibitors&doi=10.1021%2Fml400453z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of phenylpyrrolidine phenylglycinamides as highly potent and selective TF-FVIIA inhibitors</span></div><div class="casAuthors">Zhang, Xiaojun; Jiang, Wen; Jacutin-Porte, Swanee; Glunz, Peter W.; Zou, Yan; Cheng, Xuhong; Nirschl, Alexandra H.; Wurtz, Nicholas R.; Luettgen, Joseph M.; Rendina, Alan R.; Luo, Gang; Harper, Timothy M.; Wei, Anzhi; Anumula, Rushith; Cheney, Daniel L.; Knabb, Robert M.; Wong, Pancras C.; Wexler, Ruth R.; Priestley, E. Scott</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">188-192</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibitors of the Tissue Factor/Factor VIIa (TF-FVIIa) complex are promising novel anticoagulants that show excellent efficacy and minimal bleeding in preclin. models.  On the basis of a zwitterionic phenylglycine acylsulfonamide and phenylglycine benzylamide (I) (X = SO2, CH2) was shown to possess improved permeability and oral bioavailability.  Optimization of the benzylamide, guided by X-ray crystallog., led to a potent TF-FVIIa inhibitor (II) with promising oral bioavailability, but promiscuous activity in an in vitro safety panel of receptors and enzymes.  Introducing an acid on the pyrrolidine ring, guided by mol. modeling, resulted in highly potent, selective, and efficacious TF-FVIIa inhibitors with clean in vitro safety profile.  The pyrrolidine acid (III) showed a moderate clearance, low vol. of distribution, and a short t1/2 in dog PK studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHkKWlxgabXbVg90H21EOLACvtfcHk0ljCJPnvkRDfDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXitVShsr%252FE&md5=9888c52aae462e47f7b50d96f661fb9c</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fml400453z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400453z%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DJiang%26aufirst%3DW.%26aulast%3DJacutin-Porte%26aufirst%3DS.%26aulast%3DGlunz%26aufirst%3DW.%2BP.%26aulast%3DZou%26aufirst%3DY.%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DNirschl%26aufirst%3DH.%2BA.%26aulast%3DWurtz%26aufirst%3DR.%2BN.%26aulast%3DLuettgen%26aufirst%3DM.%2BJ.%26aulast%3DRendina%26aufirst%3DR.%2BA.%26aulast%3DLuo%26aufirst%3DG.%26aulast%3DHarper%26aufirst%3DM.%2BT.%26aulast%3DWei%26aufirst%3DA.%26aulast%3DAnumula%26aufirst%3DR.%26aulast%3DCheney%26aufirst%3DL.%2BD.%26aulast%3DKnabb%26aufirst%3DM.%2BR.%26aulast%3DWong%26aufirst%3DC.%2BP.%26aulast%3DWexler%26aufirst%3DR.%2BR.%26aulast%3DPriestley%26aufirst%3DE.%2BS.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520phenylpyrrolidine%2520phenylglycinamides%2520as%2520highly%2520potent%2520and%2520selective%2520TF-FVIIa%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D188%26epage%3D192%26doi%3D10.1021%2Fml400453z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Priestley, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheney, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeLucca, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luettgen, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rendina, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wexler, R. R.</span><span> </span><span class="NLM_article-title">Structure-based design of macrocyclic coagulation factor VIIa inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">6225</span><span class="NLM_x">–</span> <span class="NLM_lpage">6236</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00788</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00788" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFejtb%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=6225-6236&author=E.+S.+Priestleyauthor=D.+L.+Cheneyauthor=I.+DeLuccaauthor=A.+Weiauthor=J.+M.+Luettgenauthor=A.+R.+Rendinaauthor=P.+C.+Wongauthor=R.+R.+Wexler&title=Structure-based+design+of+macrocyclic+coagulation+factor+VIIa+inhibitors&doi=10.1021%2Facs.jmedchem.5b00788"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of Macrocyclic Coagulation Factor VIIa Inhibitors</span></div><div class="casAuthors">Priestley, E. Scott; Cheney, Daniel L.; DeLucca, Indawati; Wei, Anzhi; Luettgen, Joseph M.; Rendina, Alan R.; Wong, Pancras C.; Wexler, Ruth R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6225-6236</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">On the basis of a crystal structure of a phenylpyrrolidine lead and subsequent mol. modeling results, we designed and synthesized a novel series of macrocyclic FVIIa inhibitors.  The optimal 16-membered macrocycle was 60-fold more potent than an acyclic analog.  Further potency optimization by incorporation of P1' alkyl sulfone and P2 Me groups provided a macrocycle with TF/FVIIa Ki = 1.6 nM, excellent selectivity against a panel of seven serine proteases, and FVII-deficient prothrombin time EC2x = 1.2 μM.  Discovery of this potent, selective macrocyclic scaffold opens new possibilities for the development of orally bioavailable FVIIa inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIZvUgkobQ3bVg90H21EOLACvtfcHk0ljCJPnvkRDfDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFejtb%252FM&md5=881772bfb89d6097de1cfc14f6c7bb8b</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00788%26sid%3Dliteratum%253Aachs%26aulast%3DPriestley%26aufirst%3DE.%2BS.%26aulast%3DCheney%26aufirst%3DD.%2BL.%26aulast%3DDeLucca%26aufirst%3DI.%26aulast%3DWei%26aufirst%3DA.%26aulast%3DLuettgen%26aufirst%3DJ.%2BM.%26aulast%3DRendina%26aufirst%3DA.%2BR.%26aulast%3DWong%26aufirst%3DP.%2BC.%26aulast%3DWexler%26aufirst%3DR.%2BR.%26atitle%3DStructure-based%2520design%2520of%2520macrocyclic%2520coagulation%2520factor%2520VIIa%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D6225%26epage%3D6236%26doi%3D10.1021%2Facs.jmedchem.5b00788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Glunz, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheney, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladziata, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wurtz, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wexler, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Priestley, E. S.</span><span> </span><span class="NLM_article-title">Atropisomer control in macrocyclic factor VIIa inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">4007</span><span class="NLM_x">–</span> <span class="NLM_lpage">4018</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00244</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00244" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=1%3ACAS%3A528%3ADC%252BC28XkvVyjsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=4007-4018&author=W.+P.+Glunzauthor=L.+Muellerauthor=L.+D.+Cheneyauthor=V.+Ladziataauthor=Y.+Zouauthor=N.+R.+Wurtzauthor=A.+Weiauthor=P.+Wongauthor=R.+R.+Wexlerauthor=E.+S.+Priestley&title=Atropisomer+control+in+macrocyclic+factor+VIIa+inhibitors&doi=10.1021%2Facs.jmedchem.6b00244"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Atropisomer Control in Macrocyclic Factor VIIa Inhibitors</span></div><div class="casAuthors">Glunz, Peter W.; Mueller, Luciano; Cheney, Daniel L.; Ladziata, Vladimir; Zou, Yan; Wurtz, Nicholas R.; Wei, Anzhi; Wong, Pancras C.; Wexler, Ruth R.; Priestley, E. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4007-4018</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Incorporation of a Me group onto a macrocyclic FVIIa inhibitor improves potency 10-fold but is accompanied by atropisomerism due to restricted bond rotation in the macrocyclic structure, as demonstrated by NMR studies.  We designed a conformational constraint favoring the desired atropisomer in which this Me group interacts with the S2 pocket of FVIIa.  A macrocyclic inhibitor incorporating this constraint was prepd. and demonstrated by NMR to reside predominantly in the desired conformation.  This modification improved potency 180-fold relative to the unsubstituted, racemic macrocycle and improved selectivity.  An X-ray crystal structure of a closely related analog in the FVIIa active site was obtained and matches the NMR and modeled conformations, confirming that this conformational constraint does indeed direct the Me group into the S2 pocket as designed.  The resulting rationally designed, conformationally stable template enables further optimization of these macrocyclic inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUQwjeZSkab7Vg90H21EOLACvtfcHk0lhqgIfHLp2yuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XkvVyjsrs%253D&md5=d09b959e52dcafe4465978ec5d1c23c3</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00244&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00244%26sid%3Dliteratum%253Aachs%26aulast%3DGlunz%26aufirst%3DW.%2BP.%26aulast%3DMueller%26aufirst%3DL.%26aulast%3DCheney%26aufirst%3DL.%2BD.%26aulast%3DLadziata%26aufirst%3DV.%26aulast%3DZou%26aufirst%3DY.%26aulast%3DWurtz%26aufirst%3DN.%2BR.%26aulast%3DWei%26aufirst%3DA.%26aulast%3DWong%26aufirst%3DP.%26aulast%3DWexler%26aufirst%3DR.%2BR.%26aulast%3DPriestley%26aufirst%3DE.%2BS.%26atitle%3DAtropisomer%2520control%2520in%2520macrocyclic%2520factor%2520VIIa%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D4007%26epage%3D4018%26doi%3D10.1021%2Facs.jmedchem.6b00244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Petasis, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zavialov, I. A.</span><span> </span><span class="NLM_article-title">A new and practical synthesis of α-amino acids from alkenyl boronic acids</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">445</span><span class="NLM_x">–</span> <span class="NLM_lpage">446</span><span class="refDoi"> DOI: 10.1021/ja963178n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja963178n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=1%3ACAS%3A528%3ADyaK2sXhtFejurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=1997&pages=445-446&author=N.+A.+Petasisauthor=I.+A.+Zavialov&title=A+new+and+practical+synthesis+of+%CE%B1-amino+acids+from+alkenyl+boronic+acids&doi=10.1021%2Fja963178n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">A New and Practical Synthesis of α-Amino Acids from Alkenyl Boronic Acids</span></div><div class="casAuthors">Petasis, Nicos A.; Zavialov, Ilia A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">445-446</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Alkenylboronic acids and boronates react in a variety of solvents with amines and glyoxylic or pyruvic acid to give β,γ-unsatd. α-amino acid derivs.  This three-component boronic acid Mannich reaction normally proceeds at room temp., it does not require anhyd. or oxygen-free conditions and the product can be isolated by filtration.  Amino acids with very high diastereoselectivities (>99% de) can be obtained by using 2-phenylglycinol as the amine component.  This method was employed in a short synthesis of enantiomerically pure homophenylalanine (>99% ee).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfuL3SIKvR17Vg90H21EOLACvtfcHk0lhqgIfHLp2yuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhtFejurw%253D&md5=85bdfe5943f85111e4f89f181334fdd8</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fja963178n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja963178n%26sid%3Dliteratum%253Aachs%26aulast%3DPetasis%26aufirst%3DN.%2BA.%26aulast%3DZavialov%26aufirst%3DI.%2BA.%26atitle%3DA%2520new%2520and%2520practical%2520synthesis%2520of%2520%25CE%25B1-amino%2520acids%2520from%2520alkenyl%2520boronic%2520acids%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1997%26volume%3D119%26spage%3D445%26epage%3D446%26doi%3D10.1021%2Fja963178n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Zhang, X.; Nirschl, A. A.; Zou, Y.; Priestley, E. S.</span>: <span> </span><span class="NLM_article-title">Preparation of phenylglycinamide and pyridylglycinamide derivatives useful as anticoagulants. (Bristol-Myers Squibb)</span>. PCT Int. Appl. WO2007002313,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=X.+Zhang&author=A.+A.+Nirschl&author=Y.+Zou&author=E.+S.+Priestley&title=Preparation+of+phenylglycinamide+and+pyridylglycinamide+derivatives+useful+as+anticoagulants.+%28Bristol-Myers+Squibb%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26atitle%3DPreparation%2520of%2520phenylglycinamide%2520and%2520pyridylglycinamide%2520derivatives%2520useful%2520as%2520anticoagulants.%2520%2528Bristol-Myers%2520Squibb%2529%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Zhang, X.; Glunz, W. P.; Priestley, S. E.; Johnson, A. J.; Wurtz, R. N.; Ladziata, V.</span>: <span> </span><span class="NLM_article-title">Macrocyclic compounds as factor VIIa inhibitors and their preparation. (Bristol-Myers Squibb)</span>. PCT Int. WO2013184734,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=X.+Zhang&author=W.+P.+Glunz&author=S.+E.+Priestley&author=A.+J.+Johnson&author=R.+N.+Wurtz&author=V.+Ladziata&title=Macrocyclic+compounds+as+factor+VIIa+inhibitors+and+their+preparation.+%28Bristol-Myers+Squibb%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26atitle%3DMacrocyclic%2520compounds%2520as%2520factor%2520VIIa%2520inhibitors%2520and%2520their%2520preparation.%2520%2528Bristol-Myers%2520Squibb%2529%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Kansy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senner, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gubernator, K.</span><span> </span><span class="NLM_article-title">Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1007</span><span class="NLM_x">–</span> <span class="NLM_lpage">1010</span><span class="refDoi"> DOI: 10.1021/jm970530e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm970530e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=1%3ACAS%3A528%3ADyaK1cXhs12kt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=1007-1010&author=M.+Kansyauthor=F.+Sennerauthor=K.+Gubernator&title=Physicochemical+high+throughput+screening%3A+parallel+artificial+membrane+permeation+assay+in+the+description+of+passive+absorption+processes&doi=10.1021%2Fjm970530e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Physicochemical High Throughput Screening: Parallel Artificial Membrane Permeation Assay in the Description of Passive Absorption Processes</span></div><div class="casAuthors">Kansy, Manfred; Senner, Frank; Gubernator, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1007-1010</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The majority of pharmaceutical discovery projects aim for an orally available form of a new therapeutic principle.  One obstacle for per oral treatment is intestinal absorption.  A simple predictive exptl. method to assess the potential of intestinal absorption is therefore highly welcome.  The authors describe here the PAMPA (Parallel Artificial Membrane Permeation Assay) method, a simple, robust, high throughput screen (HTS) which has been shown to be predictive for passive diffusion through membranes and thus for oral absorption.  In addn. PAMPA can deliver information in parallel on the lipophilicity, the ionization state and the soly. of a compd.  Therefore PAMPA complements HTS, combinatorial chem. and parallel synthesis efforts in preclin. pharmaceutical research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqcwCGodCr1rVg90H21EOLACvtfcHk0lhLJZWIj389yA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhs12kt70%253D&md5=85d8ab409313b583de52348eb4d895da</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm970530e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970530e%26sid%3Dliteratum%253Aachs%26aulast%3DKansy%26aufirst%3DM.%26aulast%3DSenner%26aufirst%3DF.%26aulast%3DGubernator%26aufirst%3DK.%26atitle%3DPhysicochemical%2520high%2520throughput%2520screening%253A%2520parallel%2520artificial%2520membrane%2520permeation%2520assay%2520in%2520the%2520description%2520of%2520passive%2520absorption%2520processes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D1007%26epage%3D1010%26doi%3D10.1021%2Fjm970530e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Glunz, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delucca, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nirschl, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weigelt, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheney, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anumula, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luettgen, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rendina, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harpel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knabb, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wexler, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Priestley, E. S.</span><span> </span><span class="NLM_article-title">Non-benzamidine acylsulfonylamide TF-FVIIa inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">5244</span><span class="NLM_x">–</span> <span class="NLM_lpage">5248</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.06.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=10.1016%2Fj.bmcl.2013.06.027" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=5244-5248&author=P.+W.+Glunzauthor=X.+Zhangauthor=Y.+Zouauthor=I.+Deluccaauthor=A.+H.+Nirschlauthor=X.+Chengauthor=C.+A.+Weigeltauthor=D.+L.+Cheneyauthor=A.+Weiauthor=R.+Anumulaauthor=J.+M.+Luettgenauthor=A.+R.+Rendinaauthor=M.+Harpelauthor=G.+Luoauthor=R.+Knabbauthor=P.+C.+Wongauthor=R.+R.+Wexlerauthor=E.+S.+Priestley&title=Non-benzamidine+acylsulfonylamide+TF-FVIIa+inhibitors&doi=10.1016%2Fj.bmcl.2013.06.027"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.06.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.06.027%26sid%3Dliteratum%253Aachs%26aulast%3DGlunz%26aufirst%3DP.%2BW.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZou%26aufirst%3DY.%26aulast%3DDelucca%26aufirst%3DI.%26aulast%3DNirschl%26aufirst%3DA.%2BH.%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DWeigelt%26aufirst%3DC.%2BA.%26aulast%3DCheney%26aufirst%3DD.%2BL.%26aulast%3DWei%26aufirst%3DA.%26aulast%3DAnumula%26aufirst%3DR.%26aulast%3DLuettgen%26aufirst%3DJ.%2BM.%26aulast%3DRendina%26aufirst%3DA.%2BR.%26aulast%3DHarpel%26aufirst%3DM.%26aulast%3DLuo%26aufirst%3DG.%26aulast%3DKnabb%26aufirst%3DR.%26aulast%3DWong%26aufirst%3DP.%2BC.%26aulast%3DWexler%26aufirst%3DR.%2BR.%26aulast%3DPriestley%26aufirst%3DE.%2BS.%26atitle%3DNon-benzamidine%2520acylsulfonylamide%2520TF-FVIIa%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D5244%26epage%3D5248%26doi%3D10.1016%2Fj.bmcl.2013.06.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Hagmann, K. W.</span><span> </span><span class="NLM_article-title">The many roles for fluorine in medicinal chemistry</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">4359</span><span class="NLM_x">–</span> <span class="NLM_lpage">4369</span><span class="refDoi"> DOI: 10.1021/jm800219f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800219f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=1%3ACAS%3A528%3ADC%252BD1cXns1WjtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4359-4369&author=K.+W.+Hagmann&title=The+many+roles+for+fluorine+in+medicinal+chemistry&doi=10.1021%2Fjm800219f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">The Many Roles for Fluorine in Medicinal Chemistry</span></div><div class="casAuthors">Hagmann, William K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4359-4369</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkZV7sio8RhbVg90H21EOLACvtfcHk0lidSemSwCASUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXns1WjtLo%253D&md5=821f8076bb0f632f687b1c90b05dd382</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm800219f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800219f%26sid%3Dliteratum%253Aachs%26aulast%3DHagmann%26aufirst%3DK.%2BW.%26atitle%3DThe%2520many%2520roles%2520for%2520fluorine%2520in%2520medicinal%2520chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4359%26epage%3D4369%26doi%3D10.1021%2Fjm800219f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><div class="note"><p class="first last">p<i>K</i><sub>a</sub> of the corresponding 1,6-diaminoisoquinoline was calculated using the</p></div>Jaguar Quantum Chemical Software Package, <span class="NLM_edition">version 6.0</span>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=pKa+of+the+corresponding+1%2C6-diaminoisoquinoline+was+calculated+using+theJaguar+Quantum+Chemical+Software+Package%2C+version+6.0%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+2005."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DJaguar%2520Quantum%2520Chemical%2520Software%2520Package%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><div class="note"><p class="first last">For example, see Protein Data Bank (PDB) entries <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4X8V">4X8V</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ZXY">4ZXY</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ZXX">4ZXX</a> at <a href="http://www.pdb.org" class="extLink">www.pdb.org</a>. Additional crystallographic structures of fluorinated P1s with similarly elaborated macrocycle linkers were utilized as well which will be published in due course</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=For+example%2C+see+Protein+Data+Bank+%28PDB%29+entries+4X8V%2C+4ZXY%2C+and+4ZXX+at+www.pdb.org.+Additional+crystallographic+structures+of+fluorinated+P1s+with+similarly+elaborated+macrocycle+linkers+were+utilized+as+well+which+will+be+published+in+due+course."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span>The PyMOL Molecular Graphics System, <span class="NLM_edition">version 1.7</span>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+PyMOL+Molecular+Graphics+System%2C+version+1.7%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+2014."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520PyMOL%2520Molecular%2520Graphics%2520System%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><div class="note"><p class="first last">Pharmacokinetic (PK) studies were conducted in accordance with the NIH Guide for the Care and Use of Laboratory Animals, and the regulations of the Animal Care and Use Committee of the Bristol-Myers Squibb Company by methods described in the following reference:</p></div><span class="NLM_contrib-group">He, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brogdon, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grace, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graden, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olah, T. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unger, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luettgen, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knabb, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinto, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, P. Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wexler, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decicco, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christ, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossman, S. J.</span><span> </span><span class="NLM_article-title">N-in-1 Dosing pharmacokinetics in drug discovery: experience, theoretical and practical considerations</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">2568</span><span class="NLM_x">–</span> <span class="NLM_lpage">2580</span><span class="refDoi"> DOI: 10.1002/jps.21196</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;key=10.1002%2Fjps.21196" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2008&pages=2568-2580&author=K.+Heauthor=M.+Qianauthor=H.+Wongauthor=S.+A.+Baiauthor=B.+Heauthor=B.+Brogdonauthor=J.+E.+Graceauthor=B.+Xinauthor=J.+Wuauthor=S.+X.+Renauthor=H.+Zengauthor=Y.+Dengauthor=D.+M.+Gradenauthor=T.+V.+Olahauthor=S.+E.+Ungerauthor=J.+M.+Luettgenauthor=R.+M.+Knabbauthor=D.+J.+Pintoauthor=P.+Y.+S.+Lamauthor=J.+Duanauthor=R.+R.+Wexlerauthor=C.+P.+Deciccoauthor=D.+D.+Christauthor=S.+J.+Grossman&title=N-in-1+Dosing+pharmacokinetics+in+drug+discovery%3A+experience%2C+theoretical+and+practical+considerations&doi=10.1002%2Fjps.21196"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1002%2Fjps.21196&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.21196%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DK.%26aulast%3DQian%26aufirst%3DM.%26aulast%3DWong%26aufirst%3DH.%26aulast%3DBai%26aufirst%3DS.%2BA.%26aulast%3DHe%26aufirst%3DB.%26aulast%3DBrogdon%26aufirst%3DB.%26aulast%3DGrace%26aufirst%3DJ.%2BE.%26aulast%3DXin%26aufirst%3DB.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DRen%26aufirst%3DS.%2BX.%26aulast%3DZeng%26aufirst%3DH.%26aulast%3DDeng%26aufirst%3DY.%26aulast%3DGraden%26aufirst%3DD.%2BM.%26aulast%3DOlah%26aufirst%3DT.%2BV.%26aulast%3DUnger%26aufirst%3DS.%2BE.%26aulast%3DLuettgen%26aufirst%3DJ.%2BM.%26aulast%3DKnabb%26aufirst%3DR.%2BM.%26aulast%3DPinto%26aufirst%3DD.%2BJ.%26aulast%3DLam%26aufirst%3DP.%2BY.%2BS.%26aulast%3DDuan%26aufirst%3DJ.%26aulast%3DWexler%26aufirst%3DR.%2BR.%26aulast%3DDecicco%26aufirst%3DC.%2BP.%26aulast%3DChrist%26aufirst%3DD.%2BD.%26aulast%3DGrossman%26aufirst%3DS.%2BJ.%26atitle%3DN-in-1%2520Dosing%2520pharmacokinetics%2520in%2520drug%2520discovery%253A%2520experience%252C%2520theoretical%2520and%2520practical%2520considerations%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2008%26volume%3D97%26spage%3D2568%26epage%3D2580%26doi%3D10.1002%2Fjps.21196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4X8V" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4X8V','PDB','4X8V'); return false;">PDB: 4X8V</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ZXY" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ZXY','PDB','4ZXY'); return false;">PDB: 4ZXY</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ZXX" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ZXX','PDB','4ZXX'); return false;">PDB: 4ZXX</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i54"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00469">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_14473"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b00469">10.1021/acs.jmedchem.6b00469</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Descriptions of biological assays, syntheses and characterization data for <b>19b</b>,<b>c</b> and <b>21a</b>,<b>b</b>, key compound characterization of <b>13</b>. (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00469/suppl_file/jm6b00469_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00469/suppl_file/jm6b00469_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00469/suppl_file/jm6b00469_si_001.pdf">jm6b00469_si_001.pdf (1.5 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00469/suppl_file/jm6b00469_si_002.csv">jm6b00469_si_002.csv (1.86 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b00469&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b00469%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-15%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b00469" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67991b149ef71943","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
